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Ageing is a major risk factor for chronic liver disease in which reduced regeneration 
and age-associated chronic inflammation or “inflammageing” is observed. In ageing, 
mitochondrial respiratory chain dysfunction is shown to be a key arbitrator of the 
process, accruing somatic mitochondrial DNA (mtDNA) mutations with increasing 
time. Mechanisms linking these themes remain elusive; however, respiratory 
dysfunction is thought to be important in excess ROS production and apoptosis. 
Knock-in mitochondrial replicase γ (PolgA) mice are known to recapitulate some 
progeroid and phenotypic features of human ageing as a result of clonally expanded 
somatic mtDNA mutations. Basally whilst PolgA+/mut and PolgAmut/mut ageing mice 
livers was shown to be histologically normal, immunohistological analysis of tissues 
revealed reduced hepatocellular turnover in the presence of increasing mitochondrial 
respiratory deficiency. This proliferative defect was attributed to mitochondrial 
dysfunction within the liver parenchyma and specifically hepatocytes, observing 
reduced complex I expression. Subsequent subjection to mechanical stress by 
means of two-thirds partial hepatectomy in PolgA+/mut and PolgA+/mut mice also 
showed a blunted proliferative response. Additionally, accelerating ageing, 
mitochondrial dysfunction and downstream ROS production is linked to oxidative 
stress and altered proinflammatory signalling. Indeed, this study of PolgA+/mut and 
PolgAmut/mut mice reveals skewing towards a proinflammatory environment. Analysis 
revealed increased honing of neutrophils within the liver that when stimulated, 
releases increased amounts of ROS. Such a proinflammatory phenotype appears 
secondary to the proliferative defect, in which the PolgAmut/mut liver following exposure 
to acute oxidative CCl4 stress revealed delayed regeneration and cell cycle p16 
induction, as well as a failure to clear proinflammatory immune cells. Observations 
coincided with increasing induction of mitochondrial dysfunction and additional 
compensatory mechanisms of mitochondrial and antioxidant gene expression. The 
findings of this thesis suggests that complex I mitochondrial respiratory dysfunction 
plays a role in ageing hepatocellular regeneration, with ETC deficiency having further 
roles in regulating proinflammatory cell signalling. Dissecting the role of respiratory 
dysfunction in liver homeostasis and regeneration would enable understanding for 
therapeutic intervention in the context of ageing liver disease. 
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Chapter 1 | Introduction 
  
1.1 Overview of Liver physiology 
  
1.1.1 The Liver: Gross Anatomy and Physiology 
The human liver is a major organ located in the upper right quadrant of the abdomen, 
known for its integral physiological role across a variety of biological functions: from 
nutrient catabolism and protein synthesis to detoxification and energy metabolism. 
The liver accounts for around 2% of an individual’s total body weight, weighing ~1.5 
kg. Within this, the liver exhibits lobularity comprising four lobes: the posteriorly 
located caudate and quadrate lobes, and the anteriorly located left and right lobe 
(Strasberg, 2005). Of the four lobes, the right lobe exhibits the largest size: defined 
alongside the left lobe by the umbilical fissure and attachment by the falciform 
ligament (Strasberg, 2005). This differs from the murine liver in that it spans the 
entire subdiaphragmatic space and accounts for ~6% of the mouse’s total body 
weight at 2 grams in weight. Also shown to demonstrate quad-lobularity: the left lobe 
is the largest; however, distinct hemi-section of the right lobe by the transverse 
septum, dichotomises the lobe into two nearly equal halves (Treuting et al., 2018). In 
previous studies this can be described instead as two separate cranial and caudal 
lobes. Finally, the medial lobe sits the most ventrally and comprises two pyriform 
wings. The medial lobe connects to the remaining liver via a narrow central isthmus 
which protrudes the gallbladder (Treuting et al., 2018).  
 
Amongst its diverse profile of physiological functions, the mammalian liver is known 
uniquely for its regenerative capacity whereby lost cellular mass and function can be 
recovered following a variety of injurious insults. This remarkable function makes the 
liver of particular interest: whereby low cellular turnover and hepatocyte quiescence 
during homeostatic conditions gives way to a proliferative state to produce new cells: 
either by (1) mitotic division of existing cells or (2) expansion of the stem/progenitor 
cell portion, depending on the aetiology of injury (Miyaoka and Miyajima, 2013). 
Indeed, this integral role becomes particularly apparent in chronic liver injury if 
dysregulated, in which pathophysiological changes, if left unchecked are likely to 






Biliary   epithelial  
Blood  flow    
Hepatocytes account for 80% of liver mass, residing within the liver tissue 
architecture as part of functional units known as hepatic lobules (figure 1-1). Within 
these, hepatocytes line basolaterally alongside liver sinusoidal endothelial cells 
(LSECs), resident Kupffer macrophages and hepatic stellate cells (HSCs), a capillary 
channel known as a sinusoid, in which blood supply from the portal vein and hepatic 
artery percolate for vascular egress from the liver via the central vein (Stanger, 
2015).  In parallel, the apical membranes of adjacent hepatocytes form tight junctions 
to create a canaliculus for hepatocyte-secreted bile acids, which together with 
bilirubin and cholesterol combine to form bile. Bile is then transported along the 
canaliculae via the bile ducts for subsequent release into the duodenum during 
digestive fat emulsification (Stanger, 2015). The other primary functional cells, the 
parenchymal biliary epithelial cells (BECs), act as ductular conduits for passage 
between hepatocytes and the small intestine (Stanger, 2015). Taken together, this 
lobular structure incorporating proper placement of parenchymal and non-
parenchymal cells (NPCs) alike allows the liver to move blood counter-currently in a 
portal-to-centrilobular direction to the centrilobular-to-portal flow of bile – thus 
allowing the liver to conduct simultaneously its diverse metabolic, secretory, synthetic 
and detoxifying roles. 
  
Figure 1-1:  Schematic showing the liver lobule. Hepatocytes and biliary epithelial cells are 
organised into liver functional units known as hepatic lobules. Hepatocytes line the sinusoids, forming 
tight junction canaliculus for the secretion of bile acids. A counter-current flow of blood and bile occurs 
in the liver in which blood flows in the direction from the portal vein (PV) towards the central vein (CV), 
whilst bile acids flow from a CV to PV direction. Along the sinusoid, there is a hepatocyte 
differentiation gradient comprised of three zones; each zone differentiated to meet specific liver 





As highlighted previously, hepatocytes form the majority population of cells within the 
liver.  As a result, hepatocytes appear to execute the greatest body and range of 
work, from synthetic activities involving bile acid synthesis to cholesterol metabolism; 
equipped densely with mitochondria and endoplasmic reticulum to carry out such 
energetic processes. Other activities include serum protein and glutamine synthesis, 
as well as mediating energy metabolism for example through gluconeogenesis 
(Stanger et al., 2015). Finally, hepatocytes play an integral role in arbitrating the 
detoxification of digested products, in which absorbed molecules are fed into liver 
from the intestinal tract via portal circulation. This so-called ‘first pass metabolism’ 
allows the screening of potentially toxic compounds by the liver and removes them 
when encountered. Here, detoxification is mediated through the arsenal of 
hepatocyte P450 detoxifying enzymes allowing for elimination into the bile or urine  
(Park, 1982). Of which, urea formation is also part of the hepatocyte portfolio of 
functions. 
 
1.1.1.2 Biliary Epithelial Cells/Cholangiocytes 
 BECs, also known as cholangiocytes, are cuboidal cells that form the other cell 
majority of the liver parenchyma and are known to line the hepatic biliary tracts. 
Understood to be less metabolically active than liver hepatocytes, findings show 
BECs to possess an element of plasticity: in vitro immature BECs demonstrate the 
potential to differentiate into hepatocytes, an ability which is lost following maturation 
of the hepatic bile ducts (Tanimizu et al., 2013). As such, BECs have been proposed 
to be involved in the maintenance of liver homeostasis (see section 1.2.1). 
Collectively, BECs are long time established as conduits for hepatocyte-synthesised 
bile  within the liver tissue, passing along from the intrahepatic bile ducts to the larger 
extrahepatic biliary tract for removal into the intestinal duodenum (Stanger, 2015). 
BECs that line these biliary tracts are specialised for collection, storage and 
concentration of bile, allowing intermittent delivery of bile, as required for fat 
emulsification. Consequently, given the concentrated toxic nature of bile acids, 
blockage of the bile ducts either by infection or disease, appears to manifest into liver 
pathogenesis: for example, autoimmune destruction of the intrahepatic bile ducts 





1.1.1.3 Non-Parenchymal Cells and Hepatic Stellate Cells 
NPCs encompass cell types not derived from hepatocytes and BECs and are 
predominantly involved in a variety of other liver functions; they may be endothelial 
cells or immune cells such as liver resident Kupffer macrophages, derived from non-
endodermal origins (Stanger, 2015). Of particular note, NPCs of additional 
importance are fibroblasts, extracellular matrix (ECM) scar-forming cells involved in 
maintenance of normal hepatic tissue architecture through production of collagenous 
scaffolding proteins (Oakley and Mann, 2015). Here, hepatic fibroblasts can be 
divided in to two populations: HSCs and portal fibroblasts, of which the former is 
thought to be a major contributor to liver pathogenesis through chronic wound 
healing processes. Previous studies, including fate lineage-tracing, have shown that 
HSCs are a dominant contributor to fibrogenic pathogenesis, independent of the type 
of liver injury (Mederacke et al., 2013). Central to this is stimulation of HSCs from a 
quiescent, vitamin A and retinoid storing phenotype to an activated alpha smooth 
muscle active (α-SMA) positive myofibroblast, that can result in the excess and 
chronic deposition of ECM scar forming tissue if the insult persists (Pinzani and 
Rombouts, 2004; Chakraborty et al., 2012). This also coincides with the synthesis of 
fibrillar collagens, inhibitors of metalloproteinases and the induction of a 
proinflammatory response; the removal of α-SMA positive HSCs, demonstrates 
regression of the fibrogenic response and the induction of HSC apoptosis (Iredale et 
al., 1998).  
 
1.1.2 Liver Zonation and Ploidy  
Despite morphological similarities, hepatocyte functions differentiate depending on 
the liver lobule location. Hepatocytes of the liver can be conceptually divided into 
three main areas: (1) zone 1 comprising periportal hepatocytes, (2) zone 2 
comprising centrilobular hepatocytes, and (3) zone 3 hepatocytes located 
pericentrally, with hepatocytes for each zone adapted to specific liver functions 
(figure 1-1). Accordingly, zones are largely distinguished according to their metabolic 
function - under which liver patterning is seminally understood to be regulated by 
Wnt/β-catenin signalling (Sekine et al., 2006; Gebhardt and Hovhannisyan, 2010).  In 
the seminal paper by Benhamouche and colleagues (2006), differential expression of 
β-catenin is observed in pericentral hepatocytes whilst its negative regulator APC 




metabolic zonation along the liver’s portocentral axis (Benhamouche et al., 2006). 
The subsequent ablation of β-catenin within this study induces a periportal phenotype 
within pericentral hepatocytes (Benhamouche et al., 2006). Meanwhile, Wnt 
signalling ligands have been also been shown to act in concert to control metabolic 
zonation, proliferation and tissue homeostasis. In recent studies, Respondin 1 and 3 
(RSPO1, RSPO3) ligands, for example, are shown not only to act in concert with 
cognate receptors LGR4/5 to regulate metabolic zonation but also control zone-
specific parenchymal regeneration and the liver size in early stages of post-PHx 
when in combination with ZNRF3 (zinc and ring finger 3) / RNF43 (ring finger 43) (de 
Lau et al., 2014; Planas-Paz et al., 2016). These studies appear to highlight the 
complex interplay between metabolic zonation and liver growth control required to 
maintain liver homeostasis during hepatocellular turnover and active regeneration; 
abrogation of the various components of the Wnt signalling pathway resulting in the 
impaired hepatocyte differentiation and zonation, as well reduced hepatocyte 
proliferation (Planas-Paz et al., 2016).  
 
Other dynamic factors associated with zonal patterning may also include nutrients, 
growth factors (e.g. hepatocyte growth factor; HGF), and importantly blood 
oxygenation (Kietzmann, 2017). In zone 1 where periportal blood demonstrates 
higher oxygenation, mitochondrial numbers and hepatocyte intracellular pO2 versus 
pericentral cells, the oxidative capacities of periportal hepatocytes predominantly 
facilitate oxidative liver functions such as gluconeogenesis and fatty acid β-oxidation, 
whereas zone 3 pericentral hepatocytes are largely involved in processes such 
glycolysis and cytochrome P450-based drug detoxification (Loud, 1968; Schmucker 
et al., 1978; Jungermann and Kietzmann, 2000; Stanger, 2015). Evidence for zonal 
modulation by oxygen can be directed from earlier in vivo evidence showing anaemic 
transgenic mouse livers to induce erythropoietin (EPO) expression under sufficiently 
hypoxic conditions and appeared to be only detectable in pericentral hepatocytes 
(Koury et al., 1991). Meanwhile, factors responsive to oxygen availability, like 
hypoxia-inducible factor α (HIFα), have been also shown to be transcriptionally 
upregulated in pericentral zones (Kietzmann et al., 2001). Coincidentally, the 
literature collectively appears to suggest a complex link between oxygenation and 
Wnt/β-catenin-mediated control of metabolic zonation signalling, however not directly 




HIFα signalling, likely ascribed to β-catenin in HIF1α transcriptional promoter binding 
to induce cell survival and adaptation to hypoxia (Kaidi et al., 2007; Lehwald et al., 
2011). Under low conditions of oxygen, as in pericentral hepatocytes, APC is shown 
to be repressed leading to β-catenin-mediated induction of HIF signalling and cellular 
adaptation within zone 1, whilst periportal zones is reciprocally shown to repress β-
catenin signalling via APC expression (Benhamouche et al., 2006; Burke et al., 
2009). Clear phenotypes are yet to be seen however, when disruption of this zonal 
organisation is induced.  
 
1.2 Overview of Liver Regeneration 
  
The remarkable capability of the liver to recover lost cellular mass and function in 
response to injury makes the organ of particular interest. However, in contrast to 
other regenerative post-mitotic tissues such as the skin or colon, the liver 
demonstrates a quiescent (G0) state of low hepatocellular turnover with only 1-2% 
hepatocytes entering cell cycle at any given time (Michalopoulos and DeFrances, 
1997). Historically, the mechanisms of liver regeneration have been most classically 
understood through injurious models. The most notable and widely understood is 
partial hepatectomy (PHx), first described by Higgins (1931), in which regeneration 
follows removal of two-thirds (70%) of the liver, involving the median and left lateral 
lobes (see 1.2.1.1) (Higgins, 1931). Subsequent re-establishment of the liver’s 
homeostatic environment and loss of cellular mass post-PHx, is thought to 
predominantly occur via pre-existing hepatocyte hypertrophy and cellular 
hyperplasia; however, regeneration can also occur through expansion and 
differentiation of hepatic stem and progenitor cell as outlined in the below sections 
(Miyaoka et al., 2012; Miyaoka and Miyajima, 2013). 
  
1.2.1 Theories of Liver Homeostasis 
To date, many kinetic studies observing hepatophysiological homeostasis collectively 
propose normal hepatocyte turnover to occur in a so-called ‘streaming liver’ 
hypothesis-like manner. During which Zajicek and colleagues (1985) seminally 
describe the slow migration or “streaming” of hepatocytes along the portocentral axis, 
in the direction of the central vein through pulse-chase analysis of thymidine-injected 




clonally derived from the same cytochrome c oxidase-deficient source, units were 
shown to originate from close to the portal limiting plate and migrate in a direction 
towards the hepatic vein (Fellous et al., 2009).  
 
Additional evidence appears to support a periportal origin for hepatocytes: long-term 
cell DNA labelling retention studies have allowed investigation into hepatocyte 
‘stemness’ and clonogenic potential, specifically showing that labelling retention 
appears to occur in greater density within niches located close to portal tract  
(Kuwahara et al., 2008). Whilst in murine fate lineage tracing studies, X-gal staining 
of hepatocytes demonstrates their genetic lineage from SOX9-positive precursors 
that originate from the liver’s biliary duct and migrate towards the hepatic central vein 
to replace the liver parenchyma every 8-12 months, following tamoxifen intoxication 
(Furuyama et al., 2011). These observations would therefore appear to suggest that 
establishment of liver homeostasis through hepatocellular turnover is critically 
derived and maintained from the biliary tree compartment. However, these 
suggestions appear controversial due to the variation in data associated with biliary 
duct studies. For example, SOX9-postive ductal cells have been shown to have 
limited contribution towards the hepatocyte cell compartment following murine 
hepatic progenitor (oval) cell injury, whilst  lineage tracing of Sox9-positive ductal 
progeny demonstrates generation of the intrahepatic biliary cells including a few 
periportal hepatocytes in the absence of extensive parenchymal replacement 
(Carpentier et al., 2011; Tarlow et al., 2014). Moreover, in models of PHx and carbon 
tetrachloride (CCl4) intoxication, limited expression of hepatocyte specific fluorescent 
proteins (enhanced yellow fluorescent protein; EYFP) appears to conclusively reject 
the contribution of ductal liver progenitor cells in normal liver homeostasis (Malato et 
al., 2011).  
 
Taken together, the literature appears to refute the notion that liver homeostasis is 
maintained by hepatocyte streaming, instead proposing that liver homeostasis and 
cellular turnover occurs by division of pre-existing hepatocytes with minor input from 
progenitor cells within the bile ducts. Recent findings appear to propose that 
hepatocytes could derive from a progeny stem cell niche of hepatic vein endothelial 
cells, in which lineage tracing of Axin2-heptocytes alternatively shows migration of 




2015). Axin2 is shown to promote phosphorylation and proteosomal degradation of β-
catenin through negative regulation of Wnt, and in mice, forms a pericentral 
monolayer of Axin2-positive diploid hepatocytes (Jho et al., 2002; Wang et al., 2015). 
The subsequent observations made during lineage tracing appears to show 
hepatocytes to differentiate from progenitor cells with migration: becoming negative 
for progenitor marker Tbx3, as well as markers of pericentral and 
centrilobular/pericentral hepatocytes Wnt-mediated glucose synthetase (GS) and 
carbamoyl-phosphate synthase 1 (CPS-1) as they move towards the portal vein with 
time (Wang et al., 2015). This suggestion of centro-portal migration, however, failed 
to be recapitulated elsewhere in which Planas-Paz and colleagues (2016) failed to 
observe Lgr5-positive pericentral hepatocytes able to basally repopulate the liver, 
including after PHx, through observation of the RSPO-LGR4/5-ZNRF3/RNF43 
module involved in Wnt-potentiated metabolic liver zonation and regeneration. As 
such, the mechanism and population by which liver homeostasis is maintained, 
remains unclear.    
 
1.2.2 Liver Regeneration Models 
Animal models, and the ability to genetically manipulate them, exploit a variety of 
investigative tools that aid the understanding of the complex mechanisms that 
underpin liver regeneration. Much of our current understanding derives from 
commonly used acute and chronic liver damage models such as PHx and toxic drug 
injury; however, such models are only partially representative of the large range of 
pathophysiology observed within the human liver. For specific example, PHx is rarely 
undertaken in humans without the presence of cancers. Outlined below are classic 
examples of regenerative models commonly used in mice.  
 
1.2.2.1 Partial Hepatectomy (PHx) 
As previously highlighted, the most classical mode of hepatic injury to study 
regeneration, PHx, involves the two-thirds surgical removal of the liver in which the 
remnant caudate and right lateral lobes undergo tissue proliferation to recover lost 
cellular mass (Higgins, 1931). Recovery of the original liver mass transpires within 5-
7 days with peak proliferation occurring between 24 and 48 hours in rat and mice 




hyperplasia are highest and precedes a wave of cellular proliferation from non-
parenchymal cells (Michalopoulos, 2007; Miyaoka et al., 2012; Miyaoka and 
Miyajima, 2013; Mao et al., 2014).  
 
1.2.2.2 Carbon Tetrachloride Toxic Injury Model 
As well as PHx, the liver is able to regenerate in response to chemical-induced injury, 
the nature of which appears to hold more clinical relevance to certain liver diseases 
due to the induction of necrotic injury (Abu Rmilah et al., 2019). Specifically, carbon 
tetrachloride (CCl4) is a classical hepatoxic model, iteratively used to induce 
pathways of inflammatory and profibrotic injury. When acutely administered, CCl4 
results in the transient induction of an acute inflammatory phase with some 
extracellular matrix (ECM), followed by DNA synthesis and tissue recovery during 
parenchymal regeneration, which peaks at 24-48 hours post-toxic injury (Hatta, 1985; 
Doolittle et al., 1987). Conversely, repeated exposure from CCl4 induces chronic 
activation of the proinflammatory and profibrotic signalling pathways, resulting in the 
persistent activation of HSCs and their ECM scar forming phenotype. Chronic 
exposure subsequently results in the progressive development of liver scarring and 
cirrhosis, with loss of normal hepatocellular regeneration and function ascribed to 
significant losses of the liver parenchyma to collagenous ECM deposition unable to 
be degraded.  
 
Mechanistically, CCl4 exerts its hepatotoxic effect following its metabolism via the 
liver’s detoxification enzymes. Cytochrome P450 (CYP)2E1 metabolises CCl4 into 
highly reactive and toxic radicals trichloromethyl (CCl3*), and in the presence of 
oxygen, trichloromethyl peroxy (CCl3OO-) (Manibusan et al., 2007). Subsequently, 
these metabolite products are able to induce free radical propagation reactions with 
surrounding cellular structures, forming adducts with hepatocyte DNA, protein and 
carbohydrate macromolecules, as well as promoting lipid peroxidation to form 
propagating cytotoxic reactive aldehydes, 4-hydroxynonenal (4-HNE) and 
malondialdehyde (MDA), ultimately inducing hepatocellular damage (Hartley et al., 
1999; Abu Rmilah et al., 2019). Following intoxication, CCl4-induced toxic injury 
appears to induce pathogenic changes within 12-48 hours, peaking at 36 hours as 
marked by the significant serological release of liver enzyme and hepatocellular 




include the induction of hepatocyte ballooning and cell death, centrilobular fat 
deposition or ‘steatosis’ and tissue necrosis within 12-48 hours post-intoxication. 
Moreover, intoxication leads to the activation of Kupffer macrophages that negatively 
impacts the damaged tissue environment through additional release of damaging 
reactive oxygen species (ROS) and cytokines (Sipes et al., 1991; Edwards et al., 
1993; Seki et al., 2000). This damage appears to be concentrated pericentrally (zone 
3), in which centrilobular necrosis occurs in areas where CYP2E1 is highly 
expressed. Conversely, this type of injury is reversible if the CCl4 toxic insult is acute: 
liver regeneration ensues following cessation of injury and insult, in which an acute 
inflammatory response comprising recruited macrophages and polymorphonuclear 
leukocytes, such as neutrophils, mediate the removal of necrotic hepatocyte debris. 
 
 
1.2.3 Cellular Response to Liver Injury 
The process of liver regeneration is complex, involving a plethora of growth factors 
and cytokines that act in concert to regulate liver growth and size in the recovery 
period following injury. Involvement of regulating factors first came to light in studies 
by Moolten and Bucher (1967), in which cross carotid-to jugular circulatory parabiosis 
from hepatectomised to normal rats revealed the induction of hepatocyte mitosis in 
the absence of injury in the later, whereas this was absent in normal-to-normal 
parabiosis. Taken together, the study reveals the importance of serologically-present 
factors in driving liver regeneration in response to injury. To date, there are three 
distinct and critical steps of hepatic regeneration: (1) the priming phase, (2) 
proliferation phase and (3) termination phase (figure 1-2; sections 1.2.3.1 – 1.2.3.3).  
 
1.2.3.1 Cell Cycle 
In the human adult liver, approximately 0.05% of hepatocytes are in cell cycle at any 
given time (Furchtgott et al., 2009). Cell cycle is fundamental to growth; defined as a 
ubiquitous cellular process involving a chronological series of events that include 
DNA replication (S-phase) and the division of an individual’s genome (M-phase), in 
which the cell partitions into two daughter cells (figure 1-3) (Salazar-Roa and 
Malumbres, 2017). The process of cell cycle is complex and is regulated at many 
differing levels. Most notably, cyclin dependent kinases (CDKs; table 1-1) are 




yeast by Hartwell and colleagues (1970). CDKs, in turn, are regulated by CDK 
inhibitors (CKIs), whilst CDK activating proteins, cyclins, are able to be mediated 
through ubiquitin ligase-dependent degradation to arrest cell cycle (Salazar-Roa and 
Malumbres, 2017). Regulation in this manner gives rise to breaks in the cell cycle, 
also known as ‘gap phases’, each occurring before and after key DNA synthesising 
and mitotic stages in the cell cycle as key control system checkpoints, namely G1 
and G2 (before and after S phase-before cellular mitosis respectively) and the resting 
G0 phase (Vermeulen et al., 2003). Regulation at each of these phase checkpoints is 
key, preventing progression of defective cells through cell cycle and the possibility of 
their expansion.   
 
Checkpoint prevention of defective cell replication appears to be dependent on cell 
size and most notably the presence of DNA damage within these cells. DNA 
damage, for example, prevents S-phase DNA synthesis during G1 by means of Chk1 
and Chk2 phosphorylation by protein kinase ATR (ataxia telangiectasia and Rad3-
related) to maintain inactivity of Cdc25A and kinase CDK2 (Barnum and O'Connell, 
2014). Meanwhile at stages prior to M phase, cell cycle can be stalled at G2 by 
means also involving the Chk1/Chk2 and ATR/ATM kinases; however, involving the 
sequestration of cdc25 phosphatases that activate CDK1 within the CDK1/cyclin B 
complex (Lukas and Bartek, 2004; Lukas et al., 2004).    
 
As previously highlighted, CDKs are understood to be critical drivers of the cell cycle; 
however, require the additional partnering with cyclin proteins that regulate CDK 
substrate specificity and kinase activity to encourage progression. Cyclins are 
therefore likened to gears that regulate the driving activity of CDKs, assisting cyclin 
kinases in the transition between each cell cycle phase (Lim and Kaldis, 2013). The 
formation of CDK/cyclin complexes is therefore key; early yeast studies show the role 
for these complexes, whereby yeast CDK1 demonstrates the promotion of cycle 
phase transition via interactions with a number of cyclins (Nurse et al., 1976; Nurse 
and Thuriaux, 1980; Beach et al., 1982; Reed et al., 1982; Evans et al., 1983). When 
conditions are unfavourable, however, including during the presence of DNA 
damage, these complexes halted in turn – namely via negative regulation by CKIs. 
CKIs are of two types: belonging to the INK4 or Cip/Kip family of inhibitory proteins - 




complexes (Lim and Kaldis, 2013). Of the former, INK4 proteins (p16INK4a, p15INK4b, 
p18INK4cand p19INK4d) all comprise ankyrin repeat domains, showing preferential 
binding to CDK4 and CDK6 through monomeric interactions (Jeffrey et al., 2000). 
These interactions are understood to distort the CDK/cyclin interface at the CDK 
adenosine triphosphate (ATP)-binding pocket, preventing cell cycle progression by 
prohibiting interaction between CDK4 and CDK6 with their corresponding D-type 
cyclins (Jeffrey et al., 2000). By contrast, Cip/Kip family members (p21Cip1, p27Kip1 
and p57Kip2) comprise N-terminal CDK inhibitory domains and demonstrate inhibitory 
activity preferential to CDK2/cyclin E and CDK2/cyclin A complexes. Cip/Kip activity 
is mediated through heterodimeric binding to both CDK and cyclin subunits in a 
simultaneous manner – adding an additional level of regulation to CDK/cyclin 
complex formation (Russo et al., 1996; Pavletich, 1999). Binding of INK4 and Cip/Kip 
proteins, however, is not solely exclusive: Cip/Kip proteins have been previously 
demonstrated to bind CDK/cyclin D complexes, whilst p16-CDK4/6 interactions 
induces redistribution of p21 and p27 to induce CDK2 inactivation within the 
CDK2/cyclin E complex  (McConnell et al., 1999; Mitra et al., 1999; Vermeulen et al., 
2003) Nonetheless, the subsequent elevation of CKIs, by various inducible means, is 
widely observed to promote cell cycle arrest (Stein et al., 1999; Alani et al., 2001)  
 
Unsurprisingly CKIs are also regulated, the most basic mechanism by which is at a 
transcriptional level. CKI p21Cip1 for example, is widely understood to be under the 
transcriptional control of p53, following the transcription factor’s binding to p21 
promoter response elements (Thornborrow and Manfredi, 1999). Less well known, 
however, is the transcriptional regulation of INK4 proteins, although regulation for the 
most prominent family member p16INK4A is thought involve a complex plethora of 
molecular regulators. The best studied is mediation through transcription factors 
ETS1 and ETS2, downstream of ERK MAPK pathway stimulation; however, p16INK4 
is also shown to receive involve tight regulation from variety other factors including 
Pombe Repressor Complex (PRC) 1, PRC2, Bmi1 and transcriptional repressor ID1 
(Ohtani et al., 2001; Rayess et al., 2012). Elsewhere, it has been shown that 
mutations of activating molecules within the transcriptional pathway leads to an 





Figure 1-2 (above): Timeline of liver regeneration. Schematic showing timing kinetics of different 
liver cell types across the liver’s priming, proliferation and termination phases of liver regeneration. 
Hepatocyte DNA synthesis (red) peaks 24 hours, followed by DNA synthesis of cholangiocytes (black) 
and Kupffer cells (blue), as well as hepatic stellate cells (dark blue). Each phase characterised by 
gene expression profiles of cytokines and growth factors associated with liver parenchymal 
regeneration (table): tumour necrosis factor α (TNFα), interleukin-6 (IL-6), hepatocyte growth factor 
(HGF), epithelial growth factor (EGF); heparin-binding epithelial like growth factor (HB-EGF); tumour 





Table 1-1: Cell cycle inhibitors belonging to cyclin kinase inhibitor (CKI) families INK4 and 
Cip/Kip. CKI target specific cyclin dependent kinases (CDKs) and arrests cell cycle at different stages.  
Figure 1-3: Stages of cell cycle as regulated by CDK/Cyclin complexes. CDKs are regulated in 
turn by cyclin kinase inhibitors (CKIs) which in the presence of aberrant cellular changes such as DNA 








1.2.3.2 Priming Phase 
The priming phase of liver regeneration following injury begins with the activation of 
inflammatory cells, in which quiescent (G0) hepatocytes are stimulated to rapidly re-
enter the cell cycle for parenchymal restoration. The process is centrally coordinated 
by cytokines, including tumour necrosis factor-α (TNFα) and interleukin-6 (IL-6) 
secreted by tissue resident Kupffer macrophages activated in a MyD88-NF-κB 
dependent manner in response to resultant tissue debris (Iwai et al., 2001; Schwabe 
et al., 2006). Specifically, increased TNFα secretion is observed following PHx, 
demonstrating a critical role for the initiation of hepatocyte proliferation, as well as 
subsequent IL-6 expression following transient secretion in the murine liver 24-48 
hours post-surgery (Satoh et al., 1991; Yamada et al., 1997). Studies by Yamada 
and colleagues (1997) further demonstrate effects to mediated via TNF-
corresponding receptor type I (TNFR-1), with regenerative impairment observed 
during ablation of TNFR-I but not ablation of type II receptor (TNFR-II) (Yamada et 
al., 1997; Yamada et al., 1998).  
 
Subsequent secretion of IL-6 assists and primes the proliferative response through 
binding to its cognate receptor IL-6R – glycoprotein (gp) 130 complex, eliciting an 
immediate-early gene expression response through several downstream effector 
pathways, including Janus kinase (JAK)/STAT (Signal Transducer and Activator of 
Transcription 3) and P13k/Akt signalling. Amongst mitogenic factors expressed is 
transcription factor AP-1 c-fos and c-jun, known to functionally regulate cell cycle via 
its potentiation of cyclins including cyclin D1, as well as negative regulator SOCS3 
(suppressor of cytokine signalling) to prevent further hepatocyte cell cycle entry  
(Bakiri et al., 2000; Su et al., 2002). Whilst gp130 is readily present in most cells, IL-
6R is limited in its expression to hepatocytes. As such, the pleotropic cytoprotective 
and mitogenic effects of IL-6 appears to be limited to these cells (Schmidt-Arras and 
Rose-John, 2016). In line with this, data previously shows that singly administered IL-
6 appears to rescue hepatocyte proliferation in hepatectomised IL-6 knockout mice; 
however, when solely administered to laparotomy controls, parenchymal 
regeneration does not ensue (Blindenbacher et al., 2003). Taken together, the 
literature suggests that IL-6 alone does not exert a mitogenic effect. Accordingly, 
gp130 is able to induce hepatoregenerative signalling independent of IL-6R through 




Notch in mouse hepatocytes and HCC, yet the mechanisms are yet to be fully 
characterised within the context of classic liver regeneration and repair.  
 
Taken together, TNFα and IL-6 appears to control hepatocyte progression from G0 
into G1 phase, mediated through stimulation of an immediate-early transcriptional 
programme of gene expression. The subsequent loss or inhibition of TNFα and IL-6 
is therefore unsurprisingly shown to delay post-PHx regeneration, ascribed to cell 
cycle arrest via reduced receptor signal transduction.  
 
1.2.3.3 Proliferation Phase 
The proliferation phase of hepatic regeneration denotes the transition of G1 
hepatocytes into mitotic cell division. In rodents, the majority of mitotic division and 
ensuing parenchymal hyperplasia post-PHx already occurs by ~3 days and 
completes recovery of liver mass within 5-7 days. Driving this, progression of 
hepatocellular proliferation through G1 to mitosis is mediated by mitogenic factors, 
most importantly by growth factors. One of the first circulatory factors identified is 
HGF, shown previously to induce proliferative gene expression during delayed cell 
cycle in serum-free primary cultured hepatocytes, as well as cause liver hyperplasia 
in vivo (José Gómez-Lechón et al., 1995). HGF is therefore critical to liver 
regeneration, with conditional genetic ablation shown to compromise PHx liver 
regeneration (Nejak-Bowen et al., 2013). Accordingly, within 2 hours of injury plasma, 
HGF has been shown to significantly rise (between 13- and 17-fold) post-CCl4 and 
PHx injury respectively, mediated through its active conversion to pro-HGF by 
urokinase plasminogen activator (uPA) that binds and initiates activation of its 
cognate tyrosine kinase receptor HGFR or Met (Lindroos et al., 1991; Mars et al., 
1993). HGF stores are located within the ECM, in which uPA is a critical mediator 
and which prompts transformation of plasminogen and pro-matrix metalloproteinases 
(pro-MMPs) into plasmin and active MMPs within 24-48 hours - enzymes actively 
involved in ECM remodelling during liver regeneration (Kim et al., 1997). When 
depleted HGF stores are actively synthesised elsewhere, predominantly thought to 
involve contribution from activated non-parenchymal endothelial and HSCs in 
response to hepatocyte stimulation (Kinoshita et al., 1991; Skrtic et al., 1999).  
The subsequent delay of cellular mitosis as a result of diminished HGF signalling 




silencing (shRNA) of the Met gene, c-met, delays mature hepatocellular recovery 
through cell cycle arrest, as well as increases hepatocyte sensitivity to Fas-mediated 
apoptosis and persistent activation of proinflammatory reactions (Borowiak et al., 
2004; Huh et al., 2004; Paranjpe et al., 2007). Experimental analysis understands 
HGF to mediate these effects by cascade mitogen-activated protein kinase 
(MAPK)/Erk and phosphatidylinositol 3-kinase (PI3K)/Akt signalling downstream of 
cognate HGF receptor binding (Xiao et al., 2001; Borowiak et al., 2004; Suzuki et al., 
2009). Of the former, persistent Erk1/2 activation by HGF/Met binding is molecularly 
described within G2/M phase transition in activating downstream expression of 
checkpoint/cell cycle arrest genes including kinases CDK1, Plk1 and Aurora A and B 
- genes known to act in concert to aid execution of M phase gene transcription via 
transcription factor FoxM1 activation (Fu et al., 2008; Laoukili et al., 2008; Factor et 
al., 2010; Suryadinata et al., 2010). Other transcription factors, such as STAT3 and 
C/EBPβ, are also noted as functionally involved in the mitogenic signalling activity of 
HGF-mediated hepatocellular proliferation (Schaper et al., 1997; Wang et al., 2005). 
 
Corresponding ligands of the epithelial growth factor receptor (EGFR) comprise other 
mitogens besides HGF, including epithelial growth factor (EGF), heparin binding 
EGF-like growth factor (HB-EGF), amphiregulin and transforming growth factor-α 
(TGFα). Mobilised initially from sequestered ECM stores within the portal triad, EGF 
is thought critical in the stimulation of hepatocyte DNA synthesis ‘S phase’ transition 
at 24 hours, shown to significantly rise prior to this within 1-8 hours post-surgery 
(Noguchi et al., 1991). In line with this EGFR activation demonstrates mitogenic 
hepatoproliferative activity and liver hyperplasia following EGF stimulation, with 
subsequent depletion by submandibular gland removal shown to slow ensuing DNA 
synthesis (Bucher et al., 1977; McGowan et al., 1981; Noguchi et al., 1991). When 
treated post-PHx with exogenous EGF, this regenerative phenotype is able to be 
rescued (Noguchi et al., 1991).  
 
By comparison, HB-EGF, amphiregulin and TGFα are synthesised as precursor 
mitogens and are converted to their mature secretory forms following processing by 
extracellular proteases. Like EGF, HB-EGF, amphiregulin and TGFα are promptly 
synthesised following liver injury (within 1-6 hours) and exert their effects via EGFR 




experimental murine models outline the importance of each of these mitogens: 
specifically, ablation of amphiregulin and HB-EGF are demonstrated to impact 
negatively on liver regeneration, whilst TGFα-/- ablation in mice appear to have no 
observable effect (Oe et al., 2004). The overexpression of HB-EGF in transgenic 
mice accordingly shows accelerated parenchymal recovery as well as mediation of 
ECM fibrotic activity, whilst amphiregulin is predominantly implicated in tissue 
remodelling via regulation of ECM-producing cells, such as HSCs, inducing not only 
release of HGF but expression of hepatic growth-related transcription factors such as 
c-fos (Kiso et al., 2003; Perugorria et al., 2008; Guo et al., 2017). Taken together with 
HGF, examination of the proliferative phase reveals a complex interplay of signalling 
factors which in its absence, delays liver regeneration. 
 
1.2.3.4 Termination Phase 
Termination of liver regeneration ensues once 2.5% times the normal liver to body 
weight ratio is restored. The proliferative and mitogenic effects of growth factors 
understood to be predominantly counteracted by the tumour-suppressive cytokine 
transforming growth factor β (TGFβ), in which TGFβ peak increases in mRNA 
expression at ~72 hours post-PHx is consistent with late stages of liver regeneration  
(Hayashi and Carr, 1985; Nakamura et al., 1985; Braun et al., 1988; Fausto, 2000). 
Synthesised in both the spleen and non-parenchymal liver cells, TGFβ, in specific 
TGFβ1, is reported to elicit its anti-proliferative effects in a paracrine signalling 
manner on binding to its cognate TGFβ receptors I and II (TGFβR1/TGFβR2) located 
on surface of hepatocytes (Fausto et al., 2006). These effects follows the induction of 
downstream cytostatic and apoptotic gene expression: SMAD (Small Mothers 
Against Decapentaplegic) effector signalling, for example, is show to induce both cell 
cycle kinase inhibitor p21 and pro-apoptotic gene expression, such as Bim and 
CARD11 downstream of TGFR hepatocyte receptor binding, in turn halting cell cycle 
progression (Oberhammer et al., 1992; Schwall et al., 1993; Yasuda et al., 1993; 
Moustakas and Kardassis, 1998; Ramesh et al., 2008). It is therefore unsurprising 
that reduced activation of TGFβ is likely able to enhances hepatocyte susceptibility to 
persistent mitogenic activity; however, in the absence of TGFβ-signalling, hepatocyte 
proliferation is still able to be terminated once liver mass is restored -  consequently 





Other TGFβ family members are also shown to have a role during the termination 
phase of liver regeneration, including the involvement of activins and bone 
morphogenetic proteins (BMPs). Whilst such proteins are not solely committed to the 
termination of liver regeneration, of those prominently studied such as Activin A, their 
expression is consistent with the latter stages of liver regeneration and exerts anti-
proliferative cytostatic effects via a variety of signalling effectors, including SMAD-
dependent arrest via cyclin D1 and cyclin E suppression (Takamura et al., 2005; 
Chen et al., 2014). Supporting this is the subsequent antagonization of activin A by 
follistatin, in which hepatocyte proliferation is prolonged via enhanced hepatocyte 
DNA synthesis (Kogure et al., 1995). On the other hand, however, BMP7 and BMP4 
are shown to repress proliferation in vitro, alluded to the delineation of these BMPs in 
a paracrine inhibitory role (Kan et al., 2009). These studies therefore suggest the 
incomplete understanding of the extent to which activins and BMPs are involved in 
liver regeneration, more specifically whether in a proliferative or antiproliferative 
context.  
1.3 NF-κB Signalling in Liver Regeneration 
  
The transcription factor NF-κB regulates multiple aspects of liver homeostasis, 
serving as a pivotal mediator in a variety of downstream effector pathways: these 
include the careful coordination of hepatocyte survival and cell death, differentiation 
and immune cell signalling that ensues during liver regeneration (Iimuro and 
Fujimoto, 2010). The NF-κB family comprises five key member subunits: p50 (NF-
κB1), p52 (NF-κB2), p65 (RelA), RelB and c-Rel, which bind following their release 
from their inhibitory κB proteins (IκB) to NF-κB DNA response elements either as 
hetero- or homodimers to induce gene transcription during classical canonical 
signalling (figure 1-4) (Hayden and Ghosh, 2012). During liver regeneration, NF-κB 
DNA binding activity is shown to promptly increase after PHx, transcriptionally 
targeting a diverse profile of proliferative and inflammatory genes, including cytokines 
TNFα and IL-6 via activated Kupffer, PMNs and endothelial cells; c-fos and c-jun 
(Libermann and Baltimore, 1990; Tewari et al., 1992; Cressman et al., 1994; Liu et 
al., 2000). These genes form part of the immediate-early gene transcription profile 
quickly induced following tissue injury, as previously mentioned during the priming 





Unsurprisingly NF-κB is shown to blunt liver regeneration when inhibited, the 
repression of signalling on adenoviral IκB suppression and inactivation through 
inhibitor of κB kinase β (IKK2) subsequently shown to negatively impact post-PHx 
recovery (Iimuro et al., 1998; Maeda et al., 2005). In these studies, inhibition induces 
hepatocyte apoptosis, implicating NF-κB is not only a critical mediator of liver 
regeneration through transcription of immediate-early genes involved in 
hepatocellular proliferation, but through eliciting antiapoptotic effects. Conversely, 
further studies report that hepatocyte-specific adenoviral IκBα repression does not 
induce hepatocyte apoptosis post-PHx, but only in the presence of TNFα stimulation 
(Chaisson et al., 2002). By bypassing NF-κB signalling in this manner, it is proposed 
that NF-κB within hepatocytes is less critical, instead mediating liver regeneration 
through activation of the innate immune signalling arm. Accordingly, early NF-κB 
activation is shown to primarily occur in transgenic cis-NF-κB-EGFP mice Kupffer 
macrophages during post-PHx liver regeneration, whilst conditional NF-κB 
inactivation in haemopoetic-derived cells, including Kupffer macrophages reduces 
parenchymal recovery (Maeda et al., 2005; Yang et al., 2005). The activation of 
Kupffer cells is therefore thought to be critical in liver regeneration, specifically in the 
priming of hepatocyte G0-G1 phase transition, via NF-κB-depending transcription of 
cytokines TNFα and IL-6. 




Figure 1-4: The canonical (left) and non-canonical (right) pathways of NF-κB signalling. 
Canonical NF-κB signalling involves the binding of ligands to cognate surface receptor to induce 
adaptor protein stimulation such as MyD88 and tumour necrosis factor receptor (TNFR)-associated 
proteins that in turn mediates activation of the Inhibitor of κB kinase (IKK). IKK activation targets 
inhibitor of κB (IκB) for ubiquitination and proteasomal degradation which in turn allows for free NF-κB 
subunits to translocate to the nucleus to induce or repress gene transcription. Non-canonical NF-κB 
signalling involves the activation of IKKα by NF-κB inducing kinase (NIK). p100 is phosphorylated for 








1.4 Liver Regeneration and Ageing 
  
1.4.1 Ageing, Hepatic Regeneration and Liver Disease 
Whilst advancement in medical care and research has ensured a steady increase in 
human lifespan with 13% of the population comprising the elderly aged >65 years 
and older, prolonged living does not necessarily correlate to a longer health span 
(United Nations, 2017). Increasing age or “ageing” presents a number of challenges, 
most notably the greater vulnerability of the elderly to morbidity and premature 
mortality as a result of the progressive homeostatic decline experienced during the 
ageing process (Lopez-Otin et al., 2013). This deterioration contributes a primary risk 
factor for many chronic human diseases such as cancers, neurodegenerative and 
cardiovascular disease, diabetes, as well as for the context of this thesis, pathologies 
of the liver.  
 
In relation to ageing, gradual alterations to liver physiology and function occur under 
both normal and pathological conditions. Current research outlining structural or 
functional phenotypes in the ageing liver is less well documented, with initial reports 
on the aged livers suggesting any age-associated hepatic decline to be largely 
protected against due to hepatic regenerative capacity and compensatory 
mechanisms (O'Mahony and Schmucker, 1994; Schmucker, 2005; Frith et al., 2009)  
Frith et al.,2009; Schmucker and Sanchez, 2011). Nonetheless, studies also report 
increases in the incidence of hepatic pathologies and liver-associated mortality, 
associated with chronic liver disease within the elderly (Schmucker, 2005; 
Schmucker and Sanchez, 2011). Of the available comprehensive studies on ageing 
liver biology, a number of hepatic specific changes are observed with age: including 
the reduction in liver volume and hepatocyte cell numbers, hepatocyte hypertrophy, 
increased polyploidy and decreased mitochondrial density (Tauchi and Sato, 1968; 
Premoli et al., 2009; Gan et al., 2011). With these changes, reduced liver 
functionality is also reported as denoted by loss of hepatic phase I pharmacokinetics; 
however, it is important to note that clinical function tests often fail to capitulate liver 
function deficits associated with increasing age (Marchesini et al., 1988; Wynne et 





Whilst no liver disease is specific to older ages, increasing lifespan appears to 
correlate to the greater frequency of chronic liver diseases managed in older 
patients. Studies have shown, for example, increased clinical determinants observed 
in the older population, such as liver inflammation or ‘steatohepatitis' due to hepatic 
fat accumulation (steatosis), advanced fibrosis and severe histological markers like 
ballooning degeneration and megamitochondria, typically associated with diseases 
such as non-alcoholic fatty liver disease (NAFLD). NAFLD is a common spectral liver 
disease that affects 20-30% of the general UK population, of which frequency in the 
elderly is increased (Frith et al., 2009; Noureddin et al., 2013). Prevalence and 
severity of NAFLD, as with other studies, are positively associated with changes in 
the participant’s metabolic and anthropometric traits such as obesity, dyslipidaemia 
and diabetes; however, at a molecular basis, manifestation is thought to arise from 
cellular alterations primarily centred around mitochondrial dysfunction (Mansouri et 
al., 2018). Increased mitochondrial respiratory dysfunction, leading to ATP depletion 
and ROS generation, as well as impaired lipid metabolism and apoptosis are 
resultant key features of chronic disease and is also increasingly observed with age 
(section 1.6) (Chavin et al., 1999; Cortez-Pinto et al., 1999; Sanyal et al., 2001; 
Koliaki et al., 2015; Mansouri et al., 2018).  
 
Perhaps more clinically significant to this report is the marked decline in liver 
regeneration with age as seen in increasing mortality rates following tissue injury. 
Fatality following human liver resection is specifically shown to increase by 15% 
between 55 and 75 years of age, whilst in well-established murine models, survival 
post-PHx is reduced to between 40-60% in aged groups (Fortner and Lincer, 1990; 
Enkhbold et al., 2015). This reduction in mortality is likely ascribed to a variety 
factors, including the reduction in hepatocellular proliferation as observed in aged rat 
livers when compared to young controls (Stocker and Heine, 1971). Accordingly, 
HGF and its cognate HGFR are also shown to deplete with age, delaying the 
regenerative ability of aged murine subjects, as well as increasing post-PHx mortality 
following c-met genetic ablation (Huh et al., 2004; Enkhbold et al., 2015). Meanwhile, 
TGFβ expression is shown to be increased in aged mice, suggesting any delays in 
liver regeneration are ascribed to the constitutive stimulation of hepatocyte apoptosis 
(Zhou et al., 1993). Other examples of signalling pathways and genes associated 




(C/EBP family members) and Forkhead Box gene (FOXM1B), GSK3β and sirtuin 
(SIRT) 1 (Wang et al., 2001; Jin et al., 2009; Jin et al., 2011). Interestingly, in 
transgenic mice ablated for the hepatoproliferative-associated gene FOXM1B, 
subsequent adenovirus FOXM1B transfection is shown to restore regenerative 
capacity in aged animals beyond that of younger controls, whilst targeting of GSK3β 
and SIRT1 pathways are proposed to improve the prognosis of various age-
associated conditions (Lucas et al., 2001; Wang et al., 2001; Guarente, 2011).  
 
1.5 The PolgA mtDNA mutator mouse 
  
The development of the homozygous knock-in PolgA mouse (PolgD257A/D275A) by two 
separate research groups, demonstrating error-prone/exonucleases-deficient 
mitochondrial replicase DNA polymerase-γ, has been a critical driving force in 
elucidating the molecular mechanisms of the ageing process: proposing the role of 
mitochondrial dysfunction via mitochondrial DNA (mtDNA) mutagenesis (Trifunovic et 
al., 2004; Kujoth et al., 2005).  
 
Used as the model of interest for the present study, PolgA mice partially phenocopy 
some progeroid features of normal human ageing ranging from alopecia, kyphosis 
and frailty, reduced fertility, thymic atrophy, splenomegaly and bone marrow 
dysplasia, cardiomyopathy, and haemopoetic stem cell decline which coincides with 
increased frequency of mtDNA mutations in some tissues - including the liver 
(Trifunovic et al., 2004; Kujoth et al., 2005). Progressive deterioration of the 
mitochondria’s electron transport chain (ETC) is observed, resulting in reduced 
respiratory capacity and subsequently decreased ATP production from approximately 
12 weeks (Trifunovic et al., 2004; Kujoth et al., 2005). PolgA mice also demonstrate 
no markers of oxidative stress, nor show upregulation of antioxidants in earlier 
studies. Recent studies, however, using more sensitive in vivo detection methods 
show significant increases in oxidative stress marker H2O2 (Trifunovic et al., 2004; 
Kujoth et al., 2005; Logan et al., 2014). Instead, stochastic accumulation of mtDNA 
mutations is proposed as a mechanism of ageing for this model through increased 
activation of apoptotic cell death, as observed via increased TUNEL staining and 





Whilst these mice suggest a correlative role of mtDNA mutation to ageing, critical 
review of the model reveals mtDNA mutation frequency to be moderately higher in 
heterozygotes and vastly increased in homozygous mice compared to WTs - even 
exceeding those observed in aged humans (Vermulst et al., 2007). Despite this, 
PolgA heterozygotes appear phenotypically normal. Further scrutiny also establishes 
mutational burden of PolgA homozygous mice to be 500-fold higher than WTs before 
any obvious signs of progeroid ageing (Vermulst et al., 2007). Whereas on one hand 
it can be suggested that mitochondrial mutations does not appear to limit lifespan of 
normal ageing mice and thus fails to recapitulate the ageing process in humans, one 
key consideration is the continual turnover or ‘half-life’ of mtDNA over the vastly 
different lifespans between mice (~2-3 years) and humans (Khrapko and Vijg, 2007; 
Payne and Chinnery, 2015). MtDNA turnover is very similar between mice and 
humans; however, it is clear that aged mice turnover less cycles of mtDNA replication 
than their human counterpart over a lifespan (Payne and Chinnery, 2015). As such, 
the link between mtDNA mutations and ageing is not redundant: this is substantiated 
by recent data in which mtDNA mutations may be intrinsically linked to cycles of 
mtDNA replication by means of clonal expansion (see section 1.6.2.3 for an overview 
of mitochondrial theories of ageing). 
 
1.6 Mechanisms of Ageing 
  
Defined as a gradual loss of physiological integrity, resulting in an increased 
vulnerability to external stress, damage and even death, human ageing has been 
subject to increasing scientific scrutiny as a primary risk factor in most chronic 
pathologies (Lopez-Otin et al., 2013). Despite an incomplete understanding of its 
mechanisms, it is generally agreed that liver ageing and indeed the ageing process 
arises from damage to cellular, tissue and ultimately organ systems upon which over 
time accumulate (Payne and Chinnery, 2015). How this damage initiates presents a 
number of theories borrowed from the ageing field, including mtDNA dysfunction that 
arises from various postulated mechanisms such as clonal expansion of mutant 
mtDNA to the popular free radical theory. The latter of which proposes the 
mitochondrial organelle as the primary source of ROS, whose release has 
deleterious and mutagenic effects upon various cell compartments as well as mtDNA 




1.6.1 Evolutionary Theories of Ageing 
Variations in organismal longevity and lifespan posits evolutionary theories of ageing 
to be part genetically regulated, resulting in the inexorable, stochastic deterioration of 
an organism’s cell, tissue and organ homeostasis with increasing age (Finch and 
Tanzi, 1997; DiLoreto and Murphy, 2015). Genetic control of ageing was first 
postulated by August Weismann (1889): an ‘ageing gene’ as a means to naturally 
limit and minimise population growth (Weismann, 1891, 1889; reviewed Gavrilov and 
Gavrilova 2002). Subsequent updated arguments have since taken shape – including 
Medawar’s Mutation Accumulation Theory (1952), suggesting that ageing is an 
adverse sum of deleterious genomic mutations; William’s Antagonistic Pleiotropy 
Theory of Ageing (1957; reviewed Gavrilova and Gavrilova, 2002), proposing positive 
selection of genes for reproductive advantage that may prove detrimental in later life; 
and lastly Kirkwood’s Disposable Soma Theory. The latter of which makes a key 
influential hypothesis that ageing arises due to metabolic trade-offs between an 
organism’s cell repair mechanisms, and growth and reproduction due to the body’s 
finite resources (Kirkwood, 1977; Kirkwood et al., 1979; Kirkwood, 1997). 
Accordingly, the phenomenon of ageing and deterioration lies in the budgeting of 
energy towards cell repair and maintenance mechanisms, during which ageing 
cellular repair is continuous; however, somatic cell damage still accumulates due 
ineffective allocation of energy and thereby further drives the ageing process 
(Kirkwood, 1977). Energy is proposed to be pooled towards reproductive pathways to 
ensure propagation of a species rather than towards cell repair and maintenance. 
Whilst this is seemingly incompatible with William’s antagonistic pleiotropy, 
disposable soma appears to trace the onset of ageing to a place where repair 
mechanisms take place at an early stage (Choi, 2016). However, Kirkwood argues 
that the idea of negative selection against survival genes in favour of those 
favourable to organismal decline seems unlikely – thereby leading to the inconclusive 










1.6.2 Molecular Theories of Ageing 
1.6.2.1 The (mitochondrial) Free Radical Theory of Ageing 
The free radical theory proposes that age-related disruptions to cellular, tissue and 
organ homeostasis arises from the accumulative oxidative damage to cellular 
compartments caused by endogenous ROS (Harman, 1956). The production of 
damaging ROS, chiefly superoxide (O2.) and hydroxyl radicals, is believed to be 
predominantly derived from mitochondrial oxidative phosphorylation (OXPHOS), in 
which premature leakage of electrons from the mitochondria’s ETC (see section 1.7 
and 1.7.4 for mitochondrial biology overview), chiefly complex I and III, is able to 
reduce the high levels of oxygen consumed during cellular respiration to produce 
freely diffusing O2. and sequentially, hydroxyl radicals (Trifunovic and Larsson, 2008). 
Indeed, it has been suggested that of the total cellular ROS produced, around 90% 
can be traced back to the mitochondria; however, in early oxygen consumption 
studies with palmitoyl carnitine as substrate, only 0.15% is converted into detectable 
ROS (St-Pierre et al., 2002).  
 
With mitochondria identified as the dominant site of ROS production, key 
observations around the close proximity of mtDNA to the ETC proposes mtDNA as 
increasingly vulnerable to ROS-induced oxidative damage (Payne and Chinnery, 
2015). Alongside the mtDNA’s lack of protective histones, Harman’s free radical 
theory goes on to suggest a ‘vicious cycle’ hypothesis in which acquired mutations 
within the mtDNA disrupts functionality of respiratory complexes and causes partial 
uncoupling of the ETC by UCPs (uncoupling proteins). The latter in turn has been 
shown to augment ROS production and oxidative damage, reduce ATP production 
and lastly increase mtDNA mutagenesis (Harman, 1956). 
 
Interestingly, where organisms and individuals observe a longer or extended lifespan, 
correlative links are seen with reduced ROS production (Sohal et al., 1989; Sanz, 
2016). Longevity studies comparing pigeons with rats showed greater lifespan in the 
former, ascribed to a ~30% lower electron leakage and thus a consistently lower 
antioxidant activity in pigeon tissues (Ku and Sohal, 1993; Barja et al., 1994; Herrero 
and Barja, 1997). Meanwhile studies involving genetic manipulation or inhibition of 
pro-oxidant signalling appear to vary in support for the free radical theory. For 




have no effect in C. elegans; however, in Drosophila reduces ROS leakage without 
significant lifespan alterations (Sanz et al., 2010; Van Raamsdonk and Hekimi, 
2012). Furthermore, direct inhibition of complex I by the ubiquinone binding inhibitor 
rotenone, appears to increase C. elegans lifespan despite an increased generation of 
ROS (Yang and Hekimi, 2010). This contrasts with transgenic mice models in which 
ablation of antioxidants such as SOD2 has a deleterious effect on cellular DNA and 
proteins, as well as curtails lifespan due to increased oxidative DNA damage 
(Lebovitz et al., 1996; Williams et al., 1998; Huang et al., 2001; Melov et al., 2001).  
 
Mitochondrial ROS and the onset of ageing therefore appears to product conflicting 
results; however, mitochondrial function is still largely recognised to decline with age. 
In a number of studies, mammalian ageing appears to occur concomitantly with a 
number of structural and morphological changes to the mitochondria, including a 
tissue decrease in mitochondrial density, swelling, cristae abnormalities, reduced 
mtDNA copy numbers and protein levels (Sastre et al., 1996; Le Couteur et al., 
2001). Outlined changes are further exemplified in rat liver comparisons between old 
(24 months) and juvenile animals (3-4 months), whereby respiratory capacity is 
reduced ~40% and ATP levels decline (Stocco et al., 1977). Reduced mitochondrial 
respiration is also observed for example in human and rodent liver, heart and skeletal 
muscle tissues, with additional deteriorations observed for ETC complexes I and IV; 
however, activities remain unchanged in complexes II, III and V (Lenaz et al., 1997; 
Manczak et al., 2005; Navarro and Boveris, 2007). Reasons for such 
disproportionate declines remain elusive, though one review suggests that 
methodical differences as well as changes in cell type composition in tissue 
homogenates such as fibrosis or vascularisation may compound interpretation of 
mitochondrial function results (Bratic and Larsson, 2013). Nonetheless, the 
mitochondria play an integral role in cellular homeostasis through its OXPHOS 
functionality. As such, any disruptive change to the organelle is likely to be 
contributory factor towards disrupted homeostasis during the ageing process.  
 
1.6.2.2 Mitochondria and ageing: Clonal Expansion Theory 
Recent findings appear to challenge the mitochondrial free radical theory, with ageing 
proposed to be linked to tissue mitotic activity, whereby mtDNA mutations are 




from a single origin (Nekhaeva et al., 2002; Baines et al., 2014). Using a variety of 
techniques to capture mutation loads, experimental data shows mtDNA mutagenic 
frequency (as an indirect measure of mutation rate) to change very little over age, yet 
clonally expanded mtDNA mutations dramatically increase (Greaves and Turnbull, 
2009; Payne et al., 2013; Greaves et al., 2014). This expansion may be observed as 
mosaic events, visualised in practice by histochemical assay of COX/SDH activity. 
Multiple human tissues, for example, show mosaic COX deficiencies with age 
including the liver, brain, and muscle tissues (Cao et al., 2001; Bua et al., 2006; 
McDonald et al., 2008; Fellous et al., 2009). A causal role for mtDNA mutations in 
ageing is further elucidated in one study via the analysis of mitotic colorectal mucosal 
biopsies, in which next generation sequencing also shows ‘mosaic like’ COX 
deficiency in aged patients’ colonic crypts, originating from expansion of single point 
mutations (Taylor et al., 2003; Greaves et al., 2014). These findings therefore appear 
to propose a mechanistic link between the clonal expansion of mtDNA point 
mutations and the deterioration of tissues observed with age: expanded mtDNA point 
mutations are thought to either be positively selected during cellular replication or via 
random genetic drift, with recent studies in mitotic gut tissue appearing to strongly 
support an argument in favour of the latter (figure 1-5) (Elson et al., 2001; Baines et 






Meanwhile, cellular mitotic activity appears important in the clonal expansion of 
mutations in ageing tissue, as highlighted in variations in the mutation frequency 
detected between mitotic and post-mitotic tissues (Nekhaeva et al., 2002). 
Differences in mitotic buccal epithelia and post-mitotic cardiomyocytes, revealing two 
different mechanisms for the origin and clonal expansion in ageing mitotic versus 
post-mitotic tissues. As such, the lower incidence of mtDNA mutations in post-mitotic 
tissues is most likely ascribed to reduced cellular turnover and capacity to progress 
through cell cycle, characteristic of post-mitotic cells.  
  
Figure 1-5: Clonal expansion of mutant mtDNA molecules by random intracellular drift in 
mitotic tissues following cellular and mitotic replication. During cellular mitosis, mtDNA may be 
randomly lost or replicated in resultant daughter cells, in which inheritance of mutant mtDNA (red 
circles) may be further expanded and mutations propagated during relaxed mitochondrial replication 
and subsequent cycles of cell cycle progression (left diagram). Equally, parent cell division results in 
equal distribution of mutant mtDNA between daughter cells in the absence of clonal expansion (right 




A revised theory correlating mitochondrial dysfunction and ageing is therefore 
proposed, indicating oxidative damage and mtDNA replication errors result from early 
life events that give rise to mtDNA mutations that clonally expand throughout 
adulthood (Elson et al., 2001; Coller et al., 2005; Greaves et al., 2014). Accordingly, 
murine studies involving the progeroid PolgA mouse have demonstrated that there is 
progressive age-associated accumulation of mtDNA mutations within tissues, which 
are thought to clonally expand and cause OXPHOS defects in individual cells 
(Trifunovic et al., 2004; Kujoth et al., 2005; Baines et al., 2014). Early life events may 
be a critical factor in the development and expansion of mtDNA point mutations over 
time: maternal germline transmission studies showing wild type (WT) offspring from 
heterozygous PolgA+/mut mothers have a mild ageing phenotype, despite normal 
proof-reading capability (Ross et al., 2013). In the broader context, it is likely that 
ageing and its related deficits are a consequence of clonal expansion of early life 
mutagenesis as opposed to de novo mutagenesis that disrupts mitochondrial-
associated pathways including energy metabolism, apoptosis and senescence 
pathways, subsequently explored in section 1.7. 
 
1.6.2.3 MtDNA mutations in ageing 
MtDNA mutations are ~10-17 times more likely to occur than that of mutations within 
the nuclear genome, with mutation errors likely to occur during mtDNA replication 
(Neckelmann et al., 1987; Wallace et al., 1987; Taylor and Turnbull, 2005; Zheng et 
al., 2006). Of the first mtDNA mutations identified, the ‘common’ 4977 bp deletion, 
spanning the mitochondrial ATPase8 and ND5 gene, and flanked by a 13 bp 
homologous repeat, is often reported in numerous ageing tissue studies (Cortopassi 
and Arnheim, 1990; Cortopassi et al., 1992; Bua et al., 2006). In the majority of these 
studies, this mutation is detected in post-mitotic tissues, indicating mtDNA deletions 
are likely to occur in a tissue-dependent manner during ageing (Corral-Debrinski et 
al., 1992; Cortopassi et al., 1992). Accordingly, multiple mtDNA deletion mutations 
have also been observed elsewhere: for example, in isolated ageing skeletal muscle 
fibres stained negatively for COX/SDH activity, multiple age-accumulated deletions 
are associated with focal regions of respiratory function within the tissue (Kopsidas et 
al., 1998). Deletions appear to vary between different skeletal fibres; however, when 
subsequently isolated, single fibres revealed the presence of clonally expanded 




al., 2001). Since increasing prevalence of mtDNA deletions correlates with the 
ageing process, it is believed that these mtDNA deletions expand until a phenotypic 
threshold is exceeded whereby mitochondrial respiratory dysfunction and ageing 
tissue-related pathology ensues, for example ageing muscle fibre degeneration 
during sarcopenia (Herbst et al., 2007; Herbst et al., 2016).  
 
Interestingly, in the study by Taylor and colleagues (2003), no mtDNA deletion 
mutations were observed in the epithelial crypts of the aged human colon, rather an 
age-associated accumulation of mtDNA point mutations was observed. These 
mtDNA point mutations resulted in COX deficiency, with up to 15% of crypts being 
COX deficient by the age of 75 (Taylor et al., 2003). Subsequently, point mutations 
have been observed in other mitotic tissues, particularly in those that in some part 
rely on stem cell renewal: including the stomach and liver, for which a random 
intracellular drift is proposed to account for clonal expansion (Elson et al., 2001; 
McDonald et al., 2008; Fellous et al., 2009).  Conversely, the absence of mitosis in 
post-mitotic tissues, is likely to account for the rare incidence of point mutations 
observed in previous studies (Wang et al., 1997; Durham et al., 2006).  
First reports outlining mtDNA point mutation involvement in ageing are outlined in two 
studies by Munscher and colleagues (1993) and Zhang and colleagues (1993), in 
which investigations into A3243G and A8344G mutations, typically associated with 
MELAS (Mitochondrial myopathy, Encephalopathy, Lactic acidosis and Stroke) and 
MERRF (Myoclonic Epilepsy with Ragged Red Fibres) respectively revealed low 
level presence, even in aged brain tissues (Munscher et al., 1993; Zhang et al., 
1993). Low levels may be ascribed to less sensitive methods which subsequent 
measurements utilising PCR-based methods, revealed 10 times higher incidence of 
the m.3243A>G in adult mitotic and post-mitotic tissues when compared to younger 
subjects (Liu et al., 1997). Increasing levels in adult tissues are likely ascribed to the 
induction of mtDNA mutations in early life that expand with age. When modelling the 
incidence of point mutations in murine models, they were shown to increase during 
ageing.  Specifically, the ageing PolgAmut/mut mice (section 1.6.2.4) harbour a 10-fold 
increase in the frequency of mtDNA point mutations than their WT siblings due to 
replicative errors, and the majority of these mutations are transitions (Kujoth et al., 
2005; Vermulst et al., 2008).  As previously highlighted, these point mutations are 




showing no increased frequency in transversion mutations with time (Vermulst et al., 
2008; Edgar and Trifunovic, 2009; Ameur et al., 2011). As such, the literature 
appears to propose age-related decline to be correlated with the increase in mtDNA 
mutations and subsequent respiratory dysfunction, in which the onset of an 
observable phenotype is seen once the threshold for mtDNA mutations within 
affected cells is reached. Ageing decline may therefore be secondary to pathogenic 
changes within mutant cells, ascribed to the role of mitochondria in a number of 
physiological pathways (see section 1.7). However, such implications must remain 
cognisant, especially given that mtDNA mutation levels remain relatively low in WT 






1.7 Overview of Mitochondrial Biology 
  
Mitochondria are maternally inherited, dynamic and multifunctional organelles 
renowned for their principal function of energy metabolism through synthesis of high-
energy ATP molecules during OXPHOS. Located in all nucleated mammalian cells 
regardless of function, mitochondria form comprehensive dynamic networks, 
intricately maintained by the balance of mitochondrial fusion, fission, biogenesis and 
mitophagy pathways. Believed to be derived from eukaryotic progenitors following 
endosymbiotic engulfment or “symbiogenesis” with a α-proteobacterium, 
mitochondria form a bacterial-like organelle comprising a distinct outer and inner 
membrane that surround the intermembrane space, and a matrices compartment 
(figure 1-6A) (Wallin, 1926; Yang et al., 1985; Martin et al., 2015).  
 
It is hypothesised that the evolution of mitochondria arises by two proposed theories: 
(1) the serial endosymbiotic hypothesis and (2) the hydrogen hypothesis (Margulis, 
1971; Martin and Muller, 1998). Of the former and more classical model, 
mitochondrial formation is hypothesised to arise from successive symbiogenesis 
events in aerobically respiring eukaryotic cells. This follows thermoplastic 
archaebacteria nucleus formation, merging with spirochete-like eubacteria and finally 
the incorporation of photosynthetic bacteria (Margulis, 1971; Witzany, 2006). 
Meanwhile, the hydrogen hypothesis proposes mitochondrial formation to follow the 
uptake of hydrogen-producing eubacterium by hydrogen-dependent archaebacterium 
- resulting in the presence of both aerobic and anaerobic respiratory enzymes and 
clear gene classes within an eukaryotic cell (Martin and Muller, 1998). Over time, 
numerous studies seem to support the hydrogen hypotheses; however, despite the 
differences, both proposed hypotheses demonstrate a symbiotic relationship 
between the endosymbiotic transfer of mitochondria and its genes from eubacteria to 
mammalian cell (van der Giezen, 2011; Poole and Gribaldo, 2014).   
 
1.7.1 Mitochondrial Structure and Genome  
Termed initially as “sacrosomes”, the word ‘mitochondria’ was initially coined by 
Benda (1898) following observations of the organelle during spermatogenesis (van 
der Giezen, 2011). Subsequent electron microscopy studies depict mitochondria as 




elongated, rod or oval shaped structures (Palade, 1953). The size of which is 
dependent on the metabolic activity and function of the cell in which the mitochondria 
reside. The highest mitochondrial density occurs at the greatest sites of high energy 
consumption and correspondingly, ATP synthesis demand: for example, 
mitochondrial density index analysis shows cardiac tissue to have a higher 
mitochondrial concentration over a number of other tissues (Forner et al., 2006; Park 
et al., 2014). This variation in tissue-dependent density patterning is also seen in an 

































































































































































































































































































































































































































































1.7.1.1 Mitochondrial Structure 
As abovementioned, mitochondria (figure 1-6A) are structurally double-membraned, 
housing an internal matrix comprising metabolic enzymes, transcription and 
translational machinery and numerous copies of mtDNA (Palade, 1953). Of the 
outermost layer, the outer membrane (OM) encompasses a lipid bilayer spanned by 
transmembrane protein channels, known as porin, which allows two-way passage of 
small molecules between the cytoplasm and the intermembrane space (Alberts et al., 
2002). Such small molecules are largely impermeable to the subsequent inner 
mitochondrial membrane (IMM) lipid bilayer, with exception to H2O, hydrogen 
peroxide (H2O2), O2, CO2 and NH2 for example. The inner mitochondrial membrane 
(IMM) comprises a continuous closed membrane that protrudes into the 
mitochondrial matrix. Known as cristae, the IMM comprises two of main workings: (1) 
the inner boundary membrane and (2) the cristae membrane (CM) (which houses the 
majority of OXPHOS protein complexes) that interconnect by tubular cristae junctions 
(Frey and Mannella, 2000; Vogel et al., 2006). Inner foldings of the CM into the 
cristae allows increased surface area, which alongside the electrochemical insulating 
lipid components of the IMM, specialise the mitochondria (specifically the CM) for its 
respiratory function. By contrast, membrane-associated proteins of the IMM allow 
import of products such as intermediary metabolites and carrier molecules into the 
mitochondria for subsequent processing.  
 
1.7.1.2 Mitochondrial Genome  
MtDNA, is circular and double stranded in nature and is comprised of a guanine rich 
heavy strand and a cytosine rich light strand (figure 1-6B). It is estimated that with 
multiple mitochondria present in human somatic cells, the number of mtDNA copies 
lies somewhere between 103 and 104, although this may be higher in certain cell 
types, such as maternal germ cells in which mtDNA copies can increase to over a 
million during oocyte maturation (Lightowlers et al., 1997; Coller et al., 2001). The 
complete sequence of mtDNA was originally elucidated in 1981 by Anderson and 
colleagues (1981) and was subsequently reviewed in 1999 (Andrews et al., 1999). 
MtDNA comprises 16,596 base pairs (bp) that encode 37 genes in total (13 protein 
encoding mRNAs, 2 ribosomal RNAs (rRNAs) and 22 transfer RNAs (tRNAs)), as 
well as housing within the non-coding displacement loop (D-loop) cis-acting elements 




machinery (Anderson et al., 1981; Gustafsson et al., 2016). MtDNA also differs from 
nuclear DNA through the absence of introns and termination codons, the latter of 
which are alternatively created through post-transcriptional polyadenylation of 
mRNAs (Anderson et al., 1981). Therefore, the mitochondrial genome relies on a 
synergistic relationship with nuclear DNA to encode much of its inventory, including 
the other ~77 respiratory chain subunits that are transported into the mitochondria for 
subsequent assembly into macromolecular protein complexes (Neupert and 
Herrmann, 2007; Schmidt et al., 2010).  
 
Originally believed to be of their own free-floating genetic entities, current 
understanding reveals mtDNA molecules to be compacted into inner mitochondrial 
membrane-associated nucleoprotein complexes known as nucleoids (mt-nucleoids) 
(Gustafsson et al., 2016). Mt-nucleoids are thought to contain between 1-2 molecules 
of DNA, giving a ‘string on a bead’ like appearance; these can be visualised by 
various methods including immunocytochemical staining and GFP tagging as seen in 
human studies (Spelbrink et al., 2001). Super-resolution fluorescent imaging also 
reveals nucleoids to be ~100 nm, compared with ~200-300 nm in previous 
conventional microscopy studies; however, there is much debate whether nucleoids 
contain a single copy or ~6-10 copies of mtDNA (Kukat et al., 2011; Bogenhagen, 
2012; Kukat and Larsson, 2013). Meanwhile, the abundant mitochondrial 
transcription factor A (TFAM) protein is integral to the structural formation of mt-
nucleoids: wrapping mtDNA to their respective nucleoid in patches via cross-strand 
binding and loop formation with mtDNA as identified by electron microscopy (Kukat et 
al., 2015). Furthermore, mtDNA is shown to be fully coated with TFAM, consequently 
giving rise to the elongated but irregularly shaped mt-nucleoids as observed as 
observed by electron cryotomography within bovine mitochondria (Kukat et al., 
2015). The levels of TFAM appear correlated to mtDNA copy number, as seen in 
murine studies (Larsson et al., 1998). 
 
Finally, it is important to note that differences in mtDNA exist between organisms. 
Mouse mtDNA, for example, is thought principally homologous in terms of encoding 
gene location; however, is smaller than human mtDNA at 16,259 bp due to a smaller 
879 bp D-loop (Bibb et al., 1981). Promoter and stop codon sequences required for 




from those within the human D-loop (Bibb et al., 1981). When packaged into mt-
nucleoids, mouse somatic cells are shown to comprise of a single mtDNA copy per 
nucleoid (average ~1.1-1.5) that is packaged into a slightly more elongated nucleoid 
shape (Kukat et al., 2011). Increases in mtDNA copy numbers show unaltered 
nucleoid size and shape; however, resulted in more nucleoids per cell.   
 
1.7.2 MtDNA Transcription, Translation and Replication 
1.7.2.1 MtDNA Transcription 
Transcription of the mitochondrial genome occurs in a bidirectional manner and 
originates from three different promoter regions housed within the non-coding D loop: 
two heavy stand promoters (HSP1 and HSP2) and one light strand promoter (LSP) 
(Gustafsson et al., 2016). Transcription from these promoters results in the 
production of a single polycistronic precursor RNA transcripts, the length of which 
predominantly depending on the promoter. Transcripts emanating from HSP2 results 
in near genome length products, whilst transcribes originating at HSP1 contain the 2 
mitochondrial rRNAs and tRNAs, tRNAPhe and tRNAVal, and terminate at a specific 
site in the tRNALeu gene (Rebelo et al., 2011). Meanwhile, the remaining 8 tRNAs and 
mitochondrial ND6 gene are transcribed under the LSP promoter on the light strand. 
Resultant RNA transcripts are then processed into their constituent tRNAs, mRNAs 
and 12S and 16S rRNAs for subsequent  translation.  
 
Mammalian mtDNA transcription requires machinery distinct from that used by the 
nuclear genome, requiring the help of TFAM, mitochondrial RNA polymerase 
(POLRMT) and mitochondrial transcription factor B2 (TFB2M) and TFB2M1 proteins 
to initiate gene expression (Gustafsson et al., 2016). Utilising these, transcription 
starts 10-15 bp upstream of the starting origin, beginning with TFAM binding to 
unwind and relax the surrounding DNA region, as part of allosteric protein bubble 
coalescences with neighbouring TFAM monomers - in preparation for POLMRT-DNA 
binding at the transcriptional promoter (Traverso et al., 2015). Subsequently, TFAM 
can act as a regulator of POLRMT/TFB2M and POLMRT/TFB21 complexes 
(Falkenberg et al., 2002). TFB2M is primarily recruited to the transcription start site, 
allowing the fully assembled complex to induce structural changes at the promoter 
region and encourage initial phosphodiester bond formation during the transcription 




POLMRT is then able to follow and elongates transcription, requiring additional aid 
from the mitochondrial elongation factor (TEFM) to which POLMRT interacts via its 
catalytic C-terminus. Interestingly, in vitro depletion of TEFM is shown to impair 
elongation of the copied DNA transcript (Minczuk et al., 2011; Posse et al., 2015).  
 
1.7.2.2 MtDNA Transcription Termination 
Termination of mtDNA transcription involves a specific set of events mediated by the 
transcription termination factor (mTERF), a 39 kDA protein of which there are four 
types (Gustafsson et al., 2016). Amongst the best characterised is mTERF1, which 
through its three putative leucine-zipper motifs, terminates short HSP1-initated 
transcription at a 28 bp binding region located within the tRNALeu gene (Bonawitz et 
al., 2006). MTERF1 is believed to mediate mtDNA transcription termination through 
the physical modulation of the DNA duplex followed by stabilised binding of the 
termination factor by base flipping, such activity dependent, in vivo, on the trimeric 
conformation of mTERF and its post-translational phosphorylation (Asin-Cayuela et 
al., 2004; Prieto-Martin et al., 2004; Yakubovskaya et al., 2010). By contrast, less is 
known about the termination events that follow HSP2- and LSP-initiated transcription 
and the other homologues of mTERF, as such further studies are required to clarify 
function (Gustafsson et al., 2016). Once terminated, the resulting RNA transcripts are 
translated into corresponding proteins.  
 
1.7.2.3 MtDNA Translation 
Primary transcripts produced by mtDNA transcription are long and polycistronic in 
nature, requiring subsequent maturation processes prior to mtDNA translation. In 
general, maturation begins with excision of interspersed mitochondrial tRNA, in which 
tRNAs sequences are cut from mRNA and rRNA via endonucleolytic excision by 
RNase  Z – in a model described as ‘tRNA Punctuation’ (Anderson et al., 1981; Ojala 
et al., 1981). Here, excision by RNase P is thought to cleave the primary transcript at 
the 5’-end of pre-tRNAs, whilst the endonuclease ELAC2 is described to execute the 
maturation of the mtDNA transcript via cleavage at the 3’-end of tRNA (Brzezniak et 
al., 2011; Rossmanith, 2011). The absence of tRNA flanking of some mRNA regions, 
however, proposes use of alternate cleavage mechanisms, of which the role of 
serine/threonine kinase (FASTK) proteins has been recently proposed (Popow et al., 




and tRNAs undergo maturation and stability involving various post-transcriptional 
modifications that facilitate subsequent mtRNA translation (D'Souza and Minczuk, 
2018). 
 
Decoding of mitochondria mRNA is understood to utilise the 22 mitochondrially 
encoded tRNAs only, in which tRNAs undergo extensive post-transcriptional 
chemical modifications to facilitate translation of the mitochondrial genome 
(Anderson et al., 1981; Bibb et al., 1981; D'Souza and Minczuk, 2018). Amongst 
alterations is the introduction of chemical modifications at the ‘wobble’ base (position 
34) at the tRNA anticodon: in which the first position of the anticodon (corresponding 
to the third position of DNA) is altered to facilitate a larger repertoire of codon 
recognition during mitochondrial translation through non-Watson-Crick base pairing 
(Barrell et al., 1980). Alterations include introduction of 5-formylcytosine of 
mitochondrial tRNAMet (f5C34) by NSUN3 and ABH1, MTO1 and GTPBP3-mediated 
biogenesis of taurinomethyluridine and catalysis of 5-taurinomethylridine thiolation to 
allow for subsequent translation (Villarroya et al., 2008; Sasarman et al., 2011; Haag 
et al., 2016; Nakano et al., 2016; Wu et al., 2016; Van Haute et al., 2017).  
 
The subsequent translation of mammalian mitochondrial mRNAs comprises four 
stages: (1) initiation, (2) elongation, (3) termination and (4) recycling. Translation is 
carried out on the mitoribosome that structurally comprises a large 39S subunit and a 
smaller 28S subunit, as well as two matrix rRNAs (12A and 16S) (Sharma et al., 
2003; Greber et al., 2014; Kaushal et al., 2014; Greber et al., 2015). Due to the small 
number and content of rRNA components within the mitoribosome, 36 additional 
mitochondrial-specific proteins are recruited that together form a protein-protein 
network around a highly catalytic rRNA core (Amunts et al., 2015). Accordingly, 
nuclear-encoded regulatory proteins are required to facilitate each stage of mRNA 
translation into polypeptides: mitochondrial initiation factors (mtIF) 2 and mtIF3, for 
example, are shown to position AUG or AUA start codons at the 28S subunit, whilst 
TEFMs direct tRNAs to form base pairs with mRNA at the codon-anticodon site to 
mediate elongation of translation (Bhargava and Spremulli, 2005; Haque and 
Spremulli, 2008; D'Souza and Minczuk, 2018). Finally, mitochondrial translation is 




recognised by mtRF1a (mitochondrial termination factor 1a) (Barrell et al., 1980; 
Anderson et al., 1981).  
 
Shown to catalyse the hydrolysis of the peptidyl tRNA, MtRF1a is understood to be 
the only release factor able to terminate translation across 13 mtDNA-encoded 
polypeptides at UAA and UAG codons; the exceptions being the termination at Mt-
CO1 and ND6 open reading frames (Soleimanpour-Lichaei et al., 2007; Huynen et 
al., 2012; Lind et al., 2013). In this context, AGA and AGG are understood to encode 
the stop codon; yet, as these codons occur only once at each end of the ORF, it is 
proposed that termination of mtDNA translation occurs in a non-adherent manner to 
the genetic code: a -1 frameshift of the mitoribosome ensuring termination at these 
rarer codons (Temperley et al., 2010a; Temperley et al., 2010b). ICT1 is previously 
proposed to mediate this function via the hydrolysis of peptidyl tRNAs at stop codons; 
however, this role remains widely debated (Akabane et al., 2014). ICT1, for example, 
is unable to terminate translation in A-site extended RNA templates as in Mt-CO1 
and ND6 and as such, is therefore likely to utilise alternative termination release 
factors, at least in this context (Chrzanowska-Lightowlers et al., 2011; Chrzanowska-
Lightowlers and Lightowlers, 2015). Nonetheless, following termination at the stop 
codon, recycling factors mtRRF and EGF2 mediates the release of ribosomal 
subunits, tRNAs and mRNAs from the resultant polypeptide, allowing for quaternary 
folding and arrangement of mtDNA-encoded proteins (D'Souza and Minczuk, 2018).  
 
1.7.2.4 MtDNA Replication 
MtDNA replication occurs in a continuous and autonomous manner, independent of 
cell cycle and nuclear DNA replication (Bogenhagen and Clayton, 1977). Replication 
is thought to occur by either of the two main models proposed as: (1) the 
synchronous model and (2) the asynchronous (strand displacement) model (Clayton, 
1992; Holt et al., 2000).  
 
Asynchronous mtDNA replication occurs in a continuous manner, summarised by the 
interdependency of H strand synthesis on transcription initiation via the LSP 
promoter; the coordination of both heavy and light stands resulting in complementary 
DNA synthesis without the production of Okazaki fragments (Gustafsson et al., 




(OH), with first phase mtDNA replication occurring in a clockwise manner to produce 
a single H strand without complementary replication of the L strand. Synthesis of the 
heavy leading strand advances two-thirds of the way, subsequently allowing the light 
strand origin (OL) to be exposed for subsequent binding and complementary L strand 
synthesis to be initiated by an additional molecule of POLRMT in the opposite 
direction. In addition, random mtDNA transcription is also prevented here, by way of 
mitochondrial single stranded-binding protein (mtSSB) binding to the displaced 
parental H strand and preventing transcriptional assembly of POLRMT on ssDNA 
(Miralles Fusté et al., 2014). Interestingly, synthesis of the L strand is highly 
dependent on the POLRMT transcription enzyme: subsequent looping of the 
exposed L strand obstructs mtSSB binding, allowing POLRMT to transcribe primer 
sequences from a poly-T stretch to which the mitochondrial DNA polymerase γ (Polγ) 
subsequently binds and executes L strand DNA replication (Miralles Fusté et al., 
2014; Gustafsson et al., 2016). MtDNA daughter molecules are then ligated; forming 
closed circular molecules known as C mtDNA (Clayton, 1991). Supporting this notion 
of strand displacement are a number of studies, including notably the mapping of free 
‘5 ends of OH and OL by atomic force microscopy; replication by this, however, is 
thought to take approximately 1 hour – a slow rate for DNA replication (Brown et al., 
2005).  
 
By contrast, synchronous replication comprises synthesis of leading and lagging 
strands in a synchronous and symmetrical manner, allowing replication to occur 
bidirectionally (Gustaffson et al., 2016). This is seminally described in 2D gel 
electrophoresis work by Holt and colleagues (2000), in which replication is observed 
via production of two classes of mtDNA intermediates, differentially sensitive to 
single-strand nuclease digestion (Holt et al., 2000; Yasukawa et al., 2005). During 
the synchronous model, replication appears to predominantly initiate at the OH, 
however, work by Bowmaker and colleagues (2003) shows that replication also 
begins at multiple initiation zones spanning the broad zone (OriZ), namely at genes 
encoding ND5, ND6 and cytochrome b (Bowmaker et al., 2003). Intriguingly, 
subsequent revisions of this work by atomic force microscopy and 2D gel 
electrophoresis appear unable to confirm synchrony as a model of mtDNA 






Finally, two additional models for mtDNA replication have been recently suggested, 
based on mtDNA replication intermediates identified by 2D gel electrophoresis: (1) 
model of ribonucleotide incorporation throughout the lagging strand (RITOLS) and (2) 
the model of strand-coupled mtDNA replication (Holt et al., 2000; Gustafsson et al., 
2016). Initially thought that replication may occur via two parallel mechanisms, slow 
incorporation of DNA precursor labelling into intermediates argue against mtDNA 
maintenance via strand-coupled approaches in favour of RITOLs (Holt et al., 2000; 
Reyes et al., 2013). Correspondingly, RITOLS demonstrates similarity to strand 
displacement replication, albeit the circumvented role of mtSSB, thus allowing 
asynchronous POLRMT-mediated transcription of the lagging L strand for later DNA 
conversion (Yasukawa et al., 2006). Subsequently, RNA intermediates are 
successively threaded in a ‘bootlace’ manner onto a lagging-strand template as the 
replication fork advances until further DNA synthesis processing (Reyes et al., 2013). 
Unfortunately, enzymes required for the process are yet to be identified, thus a firm 
conclusion of the mtRNA replication mechanism remains undefined.  
 
1.7.2.5 MtDNA Mutagenesis 
The introduction of mutations into mtDNA is understood to be higher in frequency 
than nuclear DNA, at an around a 10-17 fold increase (Neckelmann et al., 1987; 
Wallace et al., 1987). This observation is made on the long-time basis of the 
mitochondrial genome’s close proximity to the electron transport chain (ETC) and its 
resultant oxidative by-products (section 1.5.4) (Yakes and Van Houten, 1997; 
Michikawa et al., 1999; Zinovkina, 2018). Both deletions and point mutations, as well 
as insertions and large-scale rearrangements are found in mtDNA: specifically, point 
mutations are found to occur at a ~6x10-8 frequency per bp per year, whilst deletions 
occur at ~6 x10-6 per mitochondrial genome replication (Shenkar et al., 1996; 
Marcelino and Thilly, 1999). This deterioration in the mtDNA is originally thought to 
be due to poor DNA repair mechanisms or a lack thereof, as well as a lack of 
protective histones (Richter et al., 1988; Zinovkina, 2018). It is now understood that 
the existence of DNA repair processes are beyond doubt, with many mechanisms 
shared with those for the nuclear DNA; however, these are much more diverse 




seen in the nuclear DNA (Liu and Demple, 2010; Zinovkina, 2018). 
 
Mitochondrial replication is a key process by which mutations are thought to be 
introduced into the mitochondrial genome. Of the 17 DNA polymerases, DNA 
polymerase gamma (Polγ) is the only replicative polymerase known to exist in 
mammalian mitochondria and is proposed to principally introduce replication errors 
through spontaneous misincorporation and miscopying (DeBalsi et al., 2017). This is 
despite a high fidelity that results in misinsertion only every 1 in 500,000 bp 
synthesised (Longley et al., 2001). Accordingly, studies showing recapitulation of in 
vivo mtDNA mutations by Polγ in vitro, appears to support the notion that 
endogenous errors mediated by Polγ during mtDNA replication constitutes the 
primary source of mtDNA point mutations (Zheng et al., 2006). Moreover, when 
mtDNA Polγ 3’ exonuclease activity is inactivated, this is shown to increase levels of 
mtDNA mutations, as well as the loss of mitochondria and onset of ageing (Zhang et 
al., 2000; Trifunovic et al., 2004). Meanwhile. mtDNA deletions are proposed to occur 
either by repair mechanism errors that follow the induction of double-strand DNA 
damage or slippage replication (Shoffner et al., 1989; Krishnan et al., 2008). 
 
1.7.2.6 MtDNA Repair Mechanisms 
Despite some protection from mtDNA-associated proteins, the mitochondrial genome 
is still susceptible to insult from mutagenic agents. As such, the mitochondria 
comprises a number of systems to mediate mtDNA repair; however, the precise 
molecular mechanisms by which are still poorly understood (Zinovkina, 2018). 
Amongst those more widely established is the single-patch base excision repair (SP-
BER) pathway, in which mutated regions are ‘marked’ by DNA glycosylases for 
cleavage from the DNA strand by apurinic/apyrimidinic (AP) endonuclease, followed 
by sealing of the mtDNA by Polγ lyase activity (Zinovkina, 2018). Onset of SP-BER is 
dependent on the lyase activity and the ability to remove the 5’ terminal group of the 
abasic site by Polγ: if not in this this instance, repair occurs via long patch base 
excision repair (LP-BER) (DeBalsi et al., 2017; Zinovkina, 2018). LP-BER typically 
proceeds when repair involves removal of several mtDNA-inserted nucleotides, 
resulting in the formation of a flap structure as mediated by DNA2 nuclease/helicase 
activity and EXOG1 (exo/endonuclease G) (Kroeger et al., 2003; Liu et al., 2008; 




involves the ligation of ends by DNA ligase 3 (Zinovkina, 2018). Meanwhile, repair of 
double-strand breaks and mismatches (mismatch repair; MMR) have been also 
described elsewhere in the removal of mis-incorporated and missense bases, of 
which the latter still remains in favour due to the presence of essential factors within 
the mitochondria, including MSH and YB-1 proteins (de Souza-Pinto et al., 2009; 
Kazak et al., 2012).  
 
Finally, recent literature exploring Cockayne syndrome (CS), a defective ageing 
disorder involving mutations in ERCC6 (CSB) and ERCC8 (CSA), appears to have 
invigorated the argument for nucleotide excision repair (NER) during mtDNA repair 
mechanisms, previously thought be absent from mitochondria. Follow mutagenic 
H2O2 pro-oxidant inducing injury, NER enzymes CSA and CSB increase in 
expression and interaction with BER-associated mitochondrial glycosylases to 
implement mtDNA repair (Kamenisch et al., 2010). Mutations in CSA and CSB 
proteins have indicated cellular sensitivity to the accumulation of damaged 
mitochondria and oxidative stress which promotes the ageing phenotype, of which 
rescue using serine protease inhibitors appears to reverse mitochondrial defects 
(Pascucci et al., 2012; Cleaver et al., 2014).  
 
1.7.3 Heteroplasmy and the Threshold Effect  
Heteroplasmy is described as a state in which a mixture of normal wild type (WT) 
mtDNA and mutated mtDNA can exist within an individual cell and is expressed as a 
percentage of total mtDNA genomes comprising mtDNA mutations (Larsson and 
Clayton, 1995). Cells may also exist as homoplasmic WT or homoplasmic mutant 
states, whereby all genomes are genetically or mutagenically identical (figure 1-7). 
Since mtDNA mutations are coupled to mtDNA copy numbers and are highly 
recessive, it is likely that individual cells can tolerate a level of mutation before a 
dysfunctional phenotype is observed (Sciacco et al., 1994). Consequently, once a 
threshold is reached that induces respiratory deficiency, mutation-harbouring cells 
can be identified by assaying complex IV and complex II activity by cytochrome c 
oxidase/ succinate dehydrogenase (COX/SDH) histochemistry. The threshold for 
mitochondrial heteroplasmy to induce such a phenotype is unclear; however, it is 
estimated to be around ~60-85% dependent on the mutation type (Boulet et al., 




less clear; however, it is thought that as mtDNA replicates independently of the cell 
cycle, and not all molecules are always replicated, mtDNA mutations can clonally 
expand within individual cells through the simple process of random genetic drift 
(figure 1-5) (Elson et al., 2001).  
  
Figure 1-7: Heteroplasmic cells harbouring mutant mtDNA and the onset of a mutant 
phenotype when a threshold is exceeded. Heteroplasmy is a state whereby a single cell harbours 
both normal and mutant mtDNA; cells may also exist as homoplasmic WTs (i.e. all normal mtDNA) or 
homoplasmic mutant states (all mutant mtDNA). Cells are able to tolerate the presence of mutant 
mtDNA until a certain threshold is reached (~60-85%), which in turn induces the onset of respiratory 
decline within the cell. Blue rings denote normal WT mtDNA; red rings denote mutant mtDNA. 




1.7.4 Mitochondrial Electron Transport Chain   
Dubbed as ‘cellular powerhouses of the cell’, mitochondria are important arbitrators 
of energy metabolism through their part in the generation of high-energy adenosine 
triphosphate (ATP) molecules. The process by which is largely driven by the electron 
transport chain’s (ETC) respiratory complexes (complexes I-IV) and ATP synthase 
(complex V) located on the IMM during the process of oxidative phosphorylation 
(OXPHOS) (figure 1-8). However, production begins prior within the cellular 
cytoplasm: glucose is catabolised in the presence of oxygen into pyruvate, the 
process of which leads to the generation of 2 ATP molecules and 2 electron carrier 
molecules nicotinamide adenine dinucleotide (NADH) that are subsequently 
transported into the mitochondrial matrix alongside pyruvate. Pyruvate is then 
converted to acetyl Coenzyme A (CoA) by decarboxylation, generating a further 
molecule of NADH and CO2. Accordingly, CoA is a key substrate for the tricarboxylic 
acid cycle (TCA) cycle that occurs within the mitochondrial matrix, undergoing 
oxidation to CO2, whilst coenzymes NAD+ and flavin adenine dinucleotide (FADH+) 
are reduced to functional carrier molecules NADH and FADH2 during the cyclical 
breakdown of citrate. The process of TCA generates 10 NADH and 2 FADH2 
molecules that are fed into the ETC for the process of OXPHOS.  
 
As previously highlighted, the OXPHOS system comprises five transmembrane 
protein complexes (complexes I-V) that form the ETC.  Electrons from NADH and 
FADH2 generated from glucose catabolism and the TCA cycle are transferred to 
oxygen at the ETC, initiating sequential reduction reactions at complexes I through to 
complex IV that result in proton (H+ ion) translocation from the mitochondrial matrix to 
intermembrane space.  This creates a ~150-180mV proton gradient membrane 
potential that encourages matrix proton flux via a hydrophilic passage across the 
IMM through complex V. Passage drives ATP synthesis, in which adenosine 
diphosphate (ADP) is phosphorylated to ATP, dependent on the bioavailability of 
ADP (Alberts et al., 2002). Accordingly, when ADP:ATP ratios are high within the 
mitochondrial matrix, oxygen is consumed to execute ATP synthesis whilst 
simultaneously restoring the electrochemical gradient in a state III respiration state 
due to H+ flux (Chance and Williams, 1955; Chance and Williams, 1956). Meanwhile 
low ADP:ATP is associated with low oxygen consumption and static H+ flow across 




regulated by state III and IV respiration and the control of mitochondrial membrane 
potential. One ATP molecule is synthesised for every 3 protons that pass complex V 























































































































































































































































































































































































































































































































































































































































































1.8 Mitochondria, Inflammation and Senescence in Ageing 
  
Chronic low-grade systemic inflammation is a pervasive feature of human ageing, 
thought to result in the cumulative damage to macromolecules - referred to frequently 
as “inflammageing” (Chung et al., 2009; Franceschi and Campisi, 2014). In the 
elderly, inflammageing is measured as a significant risk factor for morbidity and 
mortality, with several elevated markers of inflammation observed in age-associated 
pathologies (Saito and Papaconstantinou, 2001; Gomez et al., 2010; Kim et al., 
2011). Inflammageing occurs in a sterile manner: specifically, the increasing 
prolonged release of “normal” endogenous molecules during cellular injury, 
recognised as damage associated molecular patterns (DAMPs) by pattern 
recognition receptors (PRRs) that are typically expressed on innate immune cells. 
This is consistent with the idea that low-grade inflammation with age arises from 
chronic stimulation of the inflammatory programme: indeed, circulating endogenous 
mtDNA, for example, is shown to increase in individuals aged 50 years and older, 
with highest plasma mtDNA in individuals coinciding with the greatest amount of IL-6, 
TNFα and RANTES (Regulated on Activation Normal T Cell Expressed and 
Secreted) proinflammatory cytokines (Pinti et al., 2014). Similar exposure of these in 
vivo mtDNA concentrations to monocytes increases TNFα production, therefore 
suggesting unregulated mtDNA release with age may contribute to inflammageing 
(Pinti et al., 2014). 
 
1.8.1 Mitochondria and Inflammation 
1.8.1.1 Mitochondria and proinflammatory signalling 
Since mitochondria are known to be endosymbionts derived from bacteria, the 
release of mtDNA and other mitochondrial debris is unsurprisingly demonstrated to 
stimulate host inflammatory signalling. The cognate binding of mitochondrial-derived 
ligands to PRRs induces a wide variety of signalling pathways: for example, mtDNA 
is shown to bind to TLR9 and induce NF-κB signalling, of which proinflammatory 
cytokines form part of the downstream transcriptional programme (Bao et al., 2016). 
The induction largely ascribed to CpG DNA motifs housed within the mitochondrial 
genome that make mtDNA bacterially homologous.  Activation of other pathways are 
also noted, including the stimulation of the NOD-like receptor family pyrin domain-
containing 3 (NLRP3) inflammasome that results in IL-1β and caspase-3 expression 
(Gurung et al., 2015). Interestingly, NLRP3 activation is not solely limited to activation 
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via mito-DAMPs: extracellular ATP for example has been shown to activate the 
inflammasome and induce the proinflammatory response. ATP is subsequently 
implicated in previous studies of aberrant physiological inflammation as a key 
mechanism in initiating early innate immune responses (Bao et al., 2016; Amores-
Iniesta et al., 2017).  
 
Improper release of mtDNA and mito-DAMPs is thought to occur by increased cell 
death signalling (see section 1.7.2), with reported data showing induction of 
necroptotic cell death to activate the inflammasome and its downstream neutrophilic 
chemokine gradient following mitochondrial release of ATP (Iyer et al., 2009; 
McDonald et al., 2010). Similarly, the NLRP3 inflammasome is reported to be 
activated on apoptotic cell death by released oxidised mtDNA into the cytosol; in this 
respect, it is possible that increased mito-DAMP release may contribute to 
inflammageing (Shimada et al., 2012). Accordingly, several studies provide 
correlative evidence of age-related changes in cell death signalling that provide such 
an opportunity: activity of apoptotic executioner caspases -2, -3, -6, -7 and -9, for 
example, is shown to increase in aging rat liver, lung and spleen (24-26 months) 
when compared to young (6 months) and middle aged (12-14 months) controls, 
whilst in post-mitotic hippocampal tissues increased caspase activity is observed in 
older murine groups (Lynch and Lynch, 2002; Zhang et al., 2002). However, less is 
clear about necrotic cell death, although necroptosis activity of markers receptor-
interacting serine/threonine-protein kinase 3 (RIPK3) and mixed lineage kinase 
domain-like protein (MLKL) are demonstrated to increase with age, at least in 
adipose tissue (Deepa et al., 2018). It is therefore possible that in ageing, with 
increased cell death may come increased release of inflammatory inducing mito-
DAMPs.      
 
1.8.1.2 Mitochondria and redox signalling 
Mitochondria are implicated in the production of ROS and are subsequently proposed 
to be a critical mediator in redox-sensitive proinflammatory pathways. As such, 
increasing evidence supports the notion, with studies previously demonstrating 
inflammatory pathway activation in response to a variety of ROS-mediated activities, 
whether directly or indirectly. Amongst them, intermediate ROS signalling is shown to 
activate the NF-κB-COX2 axis, as well as TLR9 and NLRP3 inflammasome signalling 
on release, inducing a downstream transcriptional programme of proinflammatory 
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cytokines chemotactic for immune cells (Ichimura et al., 2003; Amma et al., 2005; 
Zhou et al., 2011; Jurk et al., 2014). Consequently, mitochondrial dysfunction may be 
implicated in the stimulation of immune cell recruitment, including macrophages and 
neutrophils of the innate immunity arm (Chen et al., 2018). Indeed, mtDNA induction 
of TLR9/NF-κB signalling, for example, is shown to induce apparent IL-6, IL-10 and 
TNFα cytokine release by activated macrophages, with an ensuing neutrophil 
infiltration thereafter within lung tissue during stimulation of a systemic inflammatory 
response (SIRS) (Zhang et al., 2010). This proinflammatory-mediatory role may be 
further delineated during inhibition of respiratory function via TNFα or 
pharmacological inhibitors antimycin A or oligomycin, in which experimental 
disruption of mitochondrial respiratory enzymes exacerbates O2* production and 
incites an observable tissue phenotype that includes oxidative tissue damage, 
immune cell recruitment and cytokine expression in both human and murine models 
(Schulze-Osthoff et al., 1993; Mariappan et al., 2009; Vaamonde-Garcia et al., 2012; 
Vaamonde-Garcia et al., 2017). Subsequent inhibition of pro-oxidant signalling 
appears to alter the proinflammatory-phenotype, thereby supporting the role of 
oxidant signalling as a critical driver of inflammation (Ishihara et al., 2015; Rehman et 
al., 2016).  
 
Of particular interest, mitochondrial dysfunction has also been shown to stimulate 
proinflammatory signalling as a consequence of augmented ROS generation and 
subsequent NF-ĸB induction. Earlier evidence appears to directly correlate ROS 
production to NF-κB activation, in which H2O2 is reported to activate IKK, as well as 
possibly promoting dimerisation of IKK with NEMO (Kamata et al., 2002; Herscovitch 
et al., 2008). Following inhibition of respiratory function by antimycin A, enhanced cell 
sensitivity to TNF-induced NF-κB cytotoxicity is also observed as a consequence of 
exacerbated ROS production (Schulze-Osthoff et al., 1993). In this context, 
mitochondrial dysfunction and ROS would appear important together in the 
exacerbation of NF-κB mediated immune responses, with downregulation of ROS 
synthesising complex III subunit UQCRC2 shown to increase epithelial 
hypersensitivity and immune cell infiltration as a result of redox imbalance, whilst 
pharmacological inhibition of complex I is also shown to elicit similar effects of 
exacerbated ROS production and concurrent inflammatory signalling (Turrens and 
Boveris, 1980; Chen et al., 2003; Aguilera-Aguirre et al., 2009; Fato et al., 2009). 
Conversely, such ROS NF-κB mediated inflammatory processes can be attenuated, 
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thereby supporting the role for mitochondrial dysfunction in redox proinflammatory 
signalling. For example, pharmacological inhibition of NF-κB with resveratrol and 
pyroolidinedithiocarbamate administration appears to reduce proinflammatory gene 
expression and monocyte adhesion in ageing rat blood vessels, in locations where 
both NF-κB and ROS levels were elevated significantly (Ungvari et al., 2007). 
Meanwhile, murine ablation of the NF-κB p50 subunit appears to accelerate chronic 
inflammation and ageing due to absent p50-dimer repression of inflammatory genes 
and is proposed to cause inflammatory-mediated activation of the NF-κB-COX2 
ROS-producing axis (Ungvari et al., 2007; Jurk et al., 2014).  
 
Converse to the role of mitochondria serving as important mediators of 
proinflammatory signalling, a number of cytokines and oxidant signalling 
intermediates like nitrous oxide (NO) and peroxynitrite are able to disrupt normal 
mitochondrial function (Maneiro et al., 2005). Amongst those discussed here are 
TNFα and IL-1β, which through binding to the complex I subunits is able to deplete 
ATP synthesis, as well as alter mitochondria membrane potential (Stadler et al., 
1992; Lopez-Armada et al., 2006; Mariappan et al., 2009). TNFα is also able to 
induce pronounced changes to mitochondrial morphology, including the loss of IMM 
cristae which arises from changes to mitochondrial dynamic mitofusion and 
mitofission proteins, at least in adipocytes (Chen et al., 2010). Although the precise 
molecular mechanisms are not fully clear, these changes propose a role for 
inflammation to augment ROS levels observed experimentally. It is therefore possible 
that in ageing, chronic inflammatory stimulus induces mitochondrial decline, which in 
a vicious cycle is able to promote inflammageing. The origins of the inciting 
inflammation, however, are unclear, although are suggested either to be microbial in 
the case of infection, or sterile – in which one mechanism implicated is the 
development of dysregulated apoptosis or a role for the accumulation of senescent 
cells (see section 1.5.3). 
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1.8.2 Apoptosis  
Programmed cell death or apoptosis is vital for organismal homeostasis and ensures 
the proper removal of damaged or dangerous cells from the body. Initially described 
by Kerr and colleagues (1972) in C. elegans, findings to date agree that apoptosis 
largely occurs in a caspase-mediated manner following their activation from their 
zymogen forms. As a result, apoptosis is characterised by a number of 
distinguishable morphological changes including chromatin condensation, cell 
shrinkage and ultimately the formation of apoptotic bodies for subsequent clearance 
(Elmore, 2007). The pro-apoptotic signalling process of which is understood to 
comprise two mechanistic parts: (1) extrinsic or death receptor-mediated apoptosis 
and (2) intrinsic apoptosis; carefully balanced by several pro- and anti-apoptotic 
factors to prevent improper induction or prevention of cell death.  
 
Signalling pathways leading to apoptosis involve the ligand binding to corresponding 
surface membrane receptors that activate extrinsic pathway mechanisms. For 
example, FasL or CD95, binds to Fas, a death receptor often highly expressed in 
hepatic cell types (Leithauser et al., 1993). Stimulation following ligand binding 
subsequently initiates a signalling cascade through activated membrane bound 
FADD and TRADD to induce recruitment of procaspase-8 and its downstream 
apoptotic effector caspase-3 (Hsu et al., 1995; Kischkel et al., 1995). In turn, extrinsic 
apoptosis appears to be regulated by cellular FLICE-inhibitory proteins (cFLIP), a 
caspase-8 homologous protein recruited to sequester the downstream signalling 
effects of caspase-8 (Scaffidi et al., 1999; Wang and El-Deiry, 2003).    
 
By contrast, mitochondria play an integral direct role in mediating the intrinsic 
pathway of apoptosis, through the release of several proapoptotic proteins from the 
intermembrane space. Amongst those is cytochrome c, with release occurring after 
permeabilisation of the mitochondrial outer membrane on inducible ligand binding or 
cellular stress (Kroemer et al., 2007). Mediating mitochondrial permeabilisation and 
cytochrome c release is the BH3-domain only protein, Bid, which following truncation, 
translocates to the mitochondria and oligomerizes with the pro-apoptotic channel 
forming Bcl-2 proteins, Bak and Bax (Shimizu et al., 1999). The resultant release of 
cytochrome c results in the activation and formation of the apoptosome comprising 
Apaf-1, cleaved apical procaspase-9 and cytochrome c proteins to induce cell death  




1.8.3 Mitochondrial Dysfunction and Senescence 
Seminally discovered in primary human cells undergoing limited rounds of cell 
division by Hayflick and Moorehead (1961), senescence is a cellular state of 
permanent proliferative arrest, recently linked to ageing and inflammageing (Childs et 
al., 2015). Senescent cells have multiple distinguishing characteristics from normal 
entities, including hypertrophy and telomere attrition, expression of cell cycle arrest 
proteins (p16INK4a,p21  and p53), increased lysosomal hydrolase enzyme senescent-
associated β-galactosidase activity (SA-β-Gal), and the upregulated expression of 
anti-apoptotic survival pathways (Dimri et al., 1995; Alcorta et al., 1996; Wong and 
Riabowol, 1996; Zindy et al., 1997; Chen et al., 2008). Moreover, senescent cells are 
associated with development of SASP, a senescent associated secretory phenotype 
comprising a transcriptional programme of growth factors, proteases and immune cell 
chemotactic factors, thought to have a limiting function via immune-cell mediated 
clearance of senescent cells within a variety of settings (Coppe et al., 2010; 
Hoenicke and Zender, 2012; Demaria et al., 2014). Predominantly activated by NF-
κB signalling and maintained in an autocrine fashion by IL-1α, increased SASP is 
observed in a number of age-related pathologies including diabetes, atherosclerosis 
and hepatic steatosis (Childs et al., 2016; Prattichizzo et al., 2016; Ogrodnik et al., 
2017). Therefore in ageing models of senescence, inflammageing and ageing are 
causally linked: with formative work involving the periodic clearance of p16INK4a -
positive senescent cells to coincide with prolonged life and health span, attenuated 
proinflammatory signalling in the kidney and heart, as well as the reversal of 
pathogenesis, for example, in steatosis of the liver (Baker et al., 2016; Ogrodnik et 
al., 2017).  
 
Cumulative evidence suggests that the induction of senescence and its secretory 
phenotype appears to be critically mediated by mitochondrial respiratory chain 
dysfunction. Indeed, senescent cells  feature mitochondrial alterations that include 
decreased mitochondrial membrane potential, increased ROS production and 
increased mitochondrial mass: the selective removal of mitochondria was shown to 
ameliorate the senescent phenotype including mitochondrial ROS production 
(Moiseeva et al., 2009; Correia-Melo et al., 2016; Chapman et al., 2019). In this 
context senescence is thought to be a downstream mechanistic effect of 
mitochondrial-induced oxidative stress and in which earlier steps to minimise ROS 
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species production delays cellular senescence (Packer and Fuehr, 1977; Chen et al., 
1995). Adding to this, ROS is shown to have a direct potentiating effect on senescent 
effector pathways including p16, p21 and p53 cell cycle mediators as a means to 
stabilise cell cycle arrest, with supporting evidence showing exacerbation of ROS 
following the stimulation of senescent cell cycle arrest (Macip et al., 2002; Macip et 
al., 2003; Takahashi et al., 2006). The literature therefore appears to support the 
notion that mitochondrial dysfunction mediates the induction of senescence through 
exacerbated ROS production, in turn inducing a senescent associated phenotype 
and further stabilising permanent arrest through pro-oxidant signalling as part of 








Chapter 2 | Aims and Objectives 
  
The principle aim of the project was to investigate the role of mitochondrial 
dysfunction and inflammation in ageing liver regeneration. Both mitochondrial 
dysfunction and chronic inflammation are key hallmarks in organismal decline: 
specifically, exacerbated inflammatory processes are implicated in hepatic 
pathophysiology, whilst the onset of mitochondrial dysfunction is noted to elicit a 
number of dysregulated physiological responses including stimulation of  pro-oxidant, 
apoptotic and immune cell signalling. However, limited evidence has specifically 
linked these biological observations within the context of liver regeneration, also 
widely accepted to decline with age. The present study therefore aims to delineate 
the mechanistic link between mitochondrial dysfunction and hepatic regenerative 
decline. 
 
Aim 1: To further validate the core role of mitochondrial dysfunction in liver 
physiology with age, utilising a global progeroid PolgA+/mut and PolgAmut/mut mouse 
model, with the aim to identify the basal contribution and mechanisms behind 
mitochondrial dysfunction during age-associated tissue decline, specifically within the 
liver. 
 
Aim 2: To determine the contribution of age-associated mitochondrial dysfunction in 
response to mechanical tissue injury and how this contributes to the liver’s 
regenerative processes. PolgA+/mut mice will be aged before undergoing partial 
hepatectomy and markers of regeneration will be accessed to understand how PolgA 
accumulation of mtDNA mutations and subsequent mitochondrial respiratory 
dysfunction affects liver regeneration.   
 
Aim 3: To investigate the relative contribution of oxidative stress during liver 
regeneration in the presence of mitochondrial dysfunction. Marks of cellular 
proliferation will be assessed in PolgA+/+ (PolgA WT) and PolgA mice, following acute 
exposure to oxidative-stress induced CCl4 toxic injury. By doing so, we hope to 
delineate the role of hypothesised mitochondrial reactive oxygen species in liver 




Aim 4: Investigate the relative contribution of mitochondrial dysfunction in 
inflammation and how this contributes to basal hepatocellular turnover and active 
liver regeneration. PolgA+/+,  PolgA+/mut and PolgAmut/mut mice will be assessed for 
inflammatory markers with age, as well as during regenerative models of injury.  
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Figure 3-1: Breeding strategy for PolgA+/+ (WT), PolgA+/mut and PolgAmut/mut mice (Taken from 
Baines, 2014). Initial establishment of colony required mating of Polgmut/mut male mice with a C57Bl/6J 
WT female to generate PolgA+/mut progeny. Mating of PolgA+/mut males and PolgA+/mut females enabled 
propagation and sustenance of PolgA+/+ (PolgA WT), PolgA+/mut and PolgAmut/mut mice. 
Chapter 3 | Materials and Methods 
  
  
3.1 Mice and Models of Injury 
  
3.1.1 Generation of PolgA mutator (PolgAmut/mut) mice 
Mitochondrial mutator mice (PolgAmut/mut) were generated by knock-in insertion of the 
missense mutation (D257A) that changes aspartic acid to alanine within the second 
endonuclease proofreading domain into the PolgA catalytic subunit of the mtDNA 
polymerase gamma (Trifunovic et al., 2004; Kujoth et al., 2005). Mutator mice 
colonies were initially established from PolgA+ /mut males (n=4) kindly donated by 
Tomas Prolla, Departments of Genetics and Medical Genetics, University of 
Wisconsin, Madison, USA and mated with C57Bl/6J female pure wild-type mice to 
generate PolgA+/mut female and PolgA+/mut male mice. Colonies were propagated and 
subsequently maintained in house to generate PolgA+/mut and PolgAmut/mut mice (figure 
3-1). Mice were housed in accordance with the UK Animals Scientific Procedures 
Act, 1986 with 12-hour light/dark cycles at 25oC. All injury models were performed 
under a UK Home Office licence on male C57BL/6J background (PolgA+/+; WT), 
PolgA+/mut and PolgAmut/mut mice and following approval from the Newcastle Ethical 




3.1.2 Isolation of genomic DNA for mouse genotyping 
Genotyping of PolgA WT, PolgA+/mut and PolgAmut/mut mice was carried out from 
amplified genomic DNA extracted from mouse ear biopsies. Ear punches were 
digested at 55oC overnight in digestion buffer comprising 50 mM KCl, 1 mM Tris-HCl 
(pH 9.0), 0.1% Triton X-100 and 0.4 mg/ml Proteinase K. Sample mixture was 
subsequently heated to denature the Proteinase K at 94oC and centrifuged at full 
speed for 15 minutes. Supernatant was subsequently used for PCR amplification of 
genomic DNA.  
 
3.1.3 PCR of genomic DNA 
Genotypes of PolgA WT, PolgA+/mut and PolgAmut/mut was determined by amplification 
of PolgA genomic DNA under specific primer sequences (table 3-1) by polymerase 
chain reaction (PCR) using Veriti Thermal Cycler (ThermoFisher Scientific). PCR 
reaction mixture comprising 2.5 µl EDTA-Tris Buffer, 2.5 µl dNTPs, 1 µl of each 10 
µM forward and reverse primer, 0.25 µl ExTaq (Takara) and nuclease free water to 
make a total volume of 23 µl. PCR amplification of genomic DNA was performed 
using the reaction template of 1 minute at 94oC for DNA polymerase activation within 
ExTaq solution followed by 35 cycles of the following: 94oC for 20 seconds, 
annealing at 64oC for 30 seconds and elongation at 72oC for 45 seconds. This was 
followed by a final elongation for 5 minutes at 72oC. Mouse genotyping bands were 
determined by visualising amplified polymerase chain reaction (PCR) products onto a 
2% agarose gel containing 0.01% ethidium bromide (appendix I). 
 
Table 3-1: Genotyping primer sequences for mice 
Primer Primer Sequence 
PolgA Forward 5’-GCCTCGTTTCTCCG-3’ 
PolgA Reverse 5’-GGATGTGGCCCAGGCTGTAACTCA-3’ 
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3.1.4 Partial hepatectomy  
Median laparotomy and resection of the left lateral and medial lobes (70%) were 
performed on WT, PolgA+/mut and PolgAmut/mut mice at 3 (n=≥3) and 6 (n=≥3) months 
of age following isofluorane anesthetisation. Excised lobes were weighed and 
subsequently processed for both RNA and protein extraction and 
immunohistochemical analysis by snap freezing and fixing tissue in 10% PBS 
buffered formalin (Sigma) respectively. Mice were monitored daily and kept in a 
heated cabinet at 27oC until harvest at 48 hour and 72 hour post-surgery. 2 hours 
prior to harvest, mice were singly injected with 5-chloro-2’-deoxyuridine thymidine-
labelling analogue at 100ug/g; mice were then humanely killed and blood samples 
collected. Liver tissues were harvested for subsequent RNA, Protein and 
immunohistochemical analysis. Naïve control groups received anaesthetisation and 
median laparotomy only.  
  
3.1.5 Acute carbon tetrachloride injection   
Mice were injected with a single dose of carbon tetrachloride (CCl4) intraperitoneally 
at 2 µl/g body weight (CCl4: olive oil at 1:1 [vol/vol] to induce acute liver injury. Mice 
were monitored daily and kept incubated at 27oC until harvest either 48 hours or 5 
days post-injection. Mice were subsequently humanely killed and liver tissues 
excised for fixing in 10% PBS buffered formalin for histology and snap freezing in 
liquid nitrogen for RNA and protein analysis. Control groups received olive oil as a 
vehicle control. 
  
3.2 Cell Culture 
  
3.2.1 Isolation of primary mouse hepatocytes 
Primary mouse hepatocytes were isolated as previously described in Gieling and 
colleagues (2010). Female WT, PolgA+/mut and PolgAmut/mut were administered 
ketamine/xylaxine overdose and livers perfused with Krebs-ringer bicarbonate buffer 
(Sigma) supplemented with 0.1 mM EDTA. Livers were digested in situ with Krebs-
ringer bicarbonate buffer (Sigma) supplemented with 50 mg/ml Clostridium 
histolyticum collagenase (Sigma) and 0.15 mM CaCl2 and subsequently excised into 
EDTA-supplemented Krebs-ringer buffer. The bile duct was separated from liver and 
the liver capsule ruptured to allow hepatocytes to disperse. Cells were filtered, 
washed twice in Krebs-ringer bicarbonate buffer and resuspended into William’s 
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medium E culture media (WME; Gibco) via centrifugation at 500rpm for 2.5 minutes. 
WME: William’s media E (Gibco), 10% FCS, 100 U/ml penicillin (Lonza), 100 µg/ml 
streptomycin (Lonza), 2 mM glutamine, 2 mM pyruvate (Lonza). Hepatocytes were 
plated into 6 and 96-well tissue culture plates (Greiner) pre-coated with rat tail 
collagen (50 µg/ml 0.02 M acetic acid, 1 hour, RT; ThermoFisher Scientific) and 
incubated at 37oC, 5% CO2 for 4 hours to allow cells to adhere. Following incubation, 
cells were washed in 1 x DPBS (Lonza) and serum starved overnight: WME was 
replaced with low serum WME supplemented with 0.5% FCS and incubated for 16 
hours at 37oC, 5% CO2 for subsequent analysis.   
  
3.2.2 Isolation of primary mouse hepatic stellate cells  
Primary mouse hepatic stellate cells (HSCs) were isolated from excised livers of 
female WT, PolgA+/mut and PolgAmut/mut  mice, perfused in vivo with HBSS+ (with Ca2+ 
and Mg2+). In sterile conditions, livers were homogenised in HBSS+ (Lonza) 
supplemented with 10 mg/ml pronase I (Roche), 3 mg/ml collagenase B (Roche) and 
washed with 10 mg/ml DNase (Roche) in HBSS+ via a 125 µm nybolt mesh. Flow 
through was suspended in HBSS+, centrifuged at 1800 rpm for 7 minutes and 
resultant cell pellet resuspended in DNase-HBSS+ media for further centrifugation. 
Final pellet was resuspended in 11.5% Optiprep-HBSS+ mixture and HSCs isolated 
by density gradient centrifugation at 1500 g for 23 minutes (acceleration 7, 
deceleration 2). A resultant cell layer containing HSCs was carefully collected, 
resuspended in DNase-HBSS+ media and centrifuged at 1800 rpm, 7 minutes. 
Pelleted cells were resuspended in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 16% fetal calf serum (Biosera), 100 U/ml penicillin (Lonza), 
100g/ml streptomycin (Lonza), 2 mM glutamine and 1 mM pyruvate and seeded onto 
a T75 flask (Greiner Bio-One) for 20 minutes incubation at 37oC, 5% CO2 to allow 
separation of Kupffer cells. Flasks were washed to remove non-adherent HSCs and 
re-seeded onto fresh T75 flasks. HSCs were maintained at 37oC, 5% CO2 overnight 
and medias changed the following morning to remove cell debris; culture media was 
subsequently replaced every 2-3 days. Day 0 freshly isolated HSCs were considered 
quiescent and maintained until harvest approximately 7-10 days post-isolation - at 
which point they were considered activated.  
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3.2.3 Isolation of liver neutrophils 
WT, PolgA+/mut and PolgAmut/mut mice were humanely killed and livers removed. Livers 
were then placed into a 10cm cell culture dish (Greiner) containing HBSS+ (with Ca2+ 
and Mg2+) supplemented with 3 mg/ml Collagenase (Roche) and 10 mg/ml DNase 
(Roche) and mechanically disrupted. Cells were filtered through a 40 µM cell strainer 
and centrifuged at 800g for 5 minutes, 4oC. Liver neutrophils were isolated by percoll 
gradient (33% vol/vol), centrifuged 800g for 30 minutes, RT and supernatant 
collected. Cells were washed and resuspended in 500 µl FACs buffer (1 x PBS 
supplemented with 5% serum) and purity established by Ly6G, CD11b and CD45B 
(BD Biosciences) flow cytometry (BD FACScantoII). 
 
3.2.4 Isolation of bone marrow neutrophils 
Bone marrow was extracted from femurs and tibias taken from WT, PolgA+/mut and 
PolgAmut/mut mice and flushed with 1x HBSS-Prep. Briefly, 8 x HBSS-Prep: 10 x PBS 
(without Ca2+ and Mg2+), 2M HEPES (appendix II) buffer supplemented with 0.5% 
FCS, diluted from 8x to 1x using sterile distilled water. Extracted marrow was pelleted 
at 400g, 5 minute RT and red blood cells lysed in 0.2% and 1.6% saline gradients 
respectively. Cells were filtered through a 70 µM cell strainer and suspension 
centrifuged at 400g, for 5 minutes at RT. Supernatant was collected and neutrophils 
isolated by percoll gradient (62%). Isolated neutrophils were washed and 
resuspended in assay medium of choice for subsequent analysis.  
 
3.3 Liver Culture Assays 
 
3.3.1 Hepatocyte BrdU proliferation assay 
Primary hepatocytes were seeded in 96 well plates (Greiner) at a density of 1 x 104 
cells/well in WME supplemented with 10% FCS and incubated for 4 hours at 37oC, 
5% CO2 to allow cells to adhere. Cells were washed in 1 x DPBS (Lonza) and serum 
starved for 16 hours as above. Concentrations of epithelial growth factor (EGF; 
Sigma) treatments at 5, 50 and 250 ng/ml were added to hepatocytes and cells 
allowed to incubate at 37oC, 5% CO2 for a further 1 hour. BrdU labelling solution 10 
µM (BrdU colorimetric assay, Roche) was added to hepatocytes and incubated for 24 
hours at 37oC, 5% CO2. Hepatocytes were subsequently fixed in 200 µl FixDenat 
solution for 30 minutes RT and anti-BrdU-POD working solution diluted 1:100 added. 
Cells were washed twice in 1 x PBS and colorimetrically detected at 450nm 
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spectrophotometrically following addition of 100 µl substrate solution and 1 M H2SO4 
to hepatocytes.  
 
3.3.2 Hepatocyte Alamar Blue assay 
Cell viability and cytotoxicity was determined by the reduction of oxidised redox 
indicator resazurin (Sigma) to resorufin via Alamar Blue assays (White et al., 1996; 
Vega-Avila and Pugsley, 2011; Rampersad, 2012). Primary hepatocytes were 
seeded in 96 well plates (Greiner) at a density of 1 x 104 cells/well, allowed to adhere 
for 4 hours, washed in 1 x DPBS (Lonza) and serum starved 16 hours overnight in 
0.5% FCS supplemented WME as above. Cells were treated with EGF (Sigma) at 5, 
50 and 250 ng/ml for a further 24 hours and media replaced with 100 µl/well warmed 
Resazurin solution diluted 1:100 in low serum culture media. Briefly, Resazurin salt 
(Sigma) stock was dissolved in PBS and sodium hydroxide at pH 7.4 and sterile 
filtered at a concentration of 880 mM. Hepatocytes were incubated for a further 3 
hours, 37oC, 5% CO2 and kept out of direct light. Supernatants were harvested in 
duplicate and transferred to a black 96 well plate (Corning) for spectrophotometric 
measurement at 535/595 nm and analysed with SoftMax® Pro software. 
  
3.3.3 LDH cytotoxicity assay 
Aliquots of culture media were transferred (~50 µl) into 96 well plate (Greiner) during 
each media change; culture media was centrifuged at 400g for 3 minutes and 
supernatants harvested. Harvested aliquots were transferred to a flat bottomed 96-
well plate (Corning) for enzymatic analysis. Lactate dehydrogenase 
(ThermoScientific) was performed on cell supernatants: assay reaction mixture was 
prepared by mixing LDH assay buffer (0.6ml) with substrate mix (11.4 ml) and kept 
out of direct light. Assay mixture was added in equal amount to supernatants (25 µl 
LDH mix to 25 µl sample) and incubated at 30 minutes RT in the dark. The assay 
was terminated by adding 25 µl stop solution and the absorbance at 490 nm was 
measured spectrophotometrically. Background absorbance was measured at 690 nm 




3.4 RNA and Protein Lysis 
  
3.4.1 Cell lysis 
Primary cells were washed twice in 1 x DPBS (Lonza) and lysed for RNA extraction 
in vitro on addition of 350 µl RLT Buffer (Qiagen) supplemented with 1% 2-β-
mercaptoethanol (Sigma). Culture plates were agitated by plate rocker and allowed 
to lyse for 5 minutes. An equal volume of 70% ethanol was added to plates and RNA 
isolated from lysed cells using the RNeasy Plus Mini Kit (Qiagen) as per 
manufacturer’s instructions. Resulting RNA was eluted into Rnase-free water and 
quantified using a Nanodrop 2000c spectrophotometer. RNA samples were stored at 
-80oC.   
 
For protein, primary cells were washed twice in 1 x DPBS (Lonza) and 300 µl RIPA 
lysis buffer (appendix III) containing protease inhibitors (Roche) was added to culture 
plates. Cells were mechanically disrupted by cell scraper and lifted cells transferred 
to 1.5 ml Eppendorfs (Starlab). Homogenate was sonicated for 20 minutes and 
subsequently pelleted by cold centrifugation, 10 minutes 10,000rpm. Supernatant 
was harvested for further protein analysis. 
  
3.4.2 RNA isolation from frozen liver tissue 
In round bottomed Eppendorfs containing a single 7 mm stainless steel bead, frozen 
liver samples was added to 350 µl RLT Buffer (Qiagen) supplemented with 1% 2-β-
mercaptoethanol (Sigma) and homogenised using a Qiagen TissueLyser II, 20.0 1/S 
frequency, 2 x 2 minutes. Tissue lysate was transferred through Qiashredder 
columns for homogenisation at ≥ 8000 x g for 15 seconds; RNA was subsequently 
isolated using the RNeasy Plus Mini Kit (Qiagen) as per manufacturer’s instructions. 
Briefly, liver homogenate was transferred to RNeasy spin columns and centrifuged at 
≥ 8000 x g for 15 seconds. Flow through was discarded and sample washed further 
with buffer RW1 at ≥ 8000 x g for 15 seconds and then buffer RPE twice at ≥ 8000 x 
g for 2 minutes, discarding flow through each time. Column was dried to remove 
remaining ethanol contaminates at full speed for 1 minute. RNA was eluted into fresh 
collection tube from column by adding directly to membrane 30-50 µl RNase-free 
water and spun ≥ 8000 x g for 1 minute. Extracted RNA was quantified using a 




3.4.3 RNA quantification by Nanodrop 
Isolated RNA was quantified and purity assessed spectrophotometrically using a 
nanodrop 2000 spectrophotometer at 260 nm and 280 nm wavelength; nanodrop 
was blanked with a loaded 1 µl RNase free water sample prior to measurement. 
Acceptable purity of RNA samples was indicated as an A260/A280 ratio greater than 
1.8. 
 
3.4.4 Protein extraction from frozen liver tissue 
In round bottomed Eppendorfs containing a single 7 mm stainless steel bead, frozen 
liver samples were lysed in 500 µl RIPA lysis buffer, homogenised via a Qiagen 
TissueLyser II, 20.0 1/S frequency, 2 x 2 minutes and followed by sonication for 20 
minutes. Tissue homogenate was pelleted by cold centrifugation, 10 minutes at 
10,000 rpm and supernatant collected for protein analysis. 
  
3.4.5 Protein quantification for protein-based assay 
Protein concentration was quantified using the BioRad Protein Assay Kit as per 
manufacturer’s instructions and measured spectrophotometrically at 750 nm 
wavelength. Briefly, 2 µl of protein sample or control buffer sample was diluted 1:10 
in distilled water and added to 100 µl of mixture comprising 98 µl buffer A and 2 µl 
buffer S. 800 µl of buffer B was added and samples incubated at room temperature 
for 20 minutes to allow for colour change. Protein concentration was determined at 
750 nm by spectrophotometry and absorbance value divided by coefficient 0.0157 
and then 2 to determine concentration in µg/µl.  
 
3.5 Western Blotting 
  
Protein samples for western blot were prepared as follows: 20 µg of protein lysate 
was diluted in 1 x Laemelli buffer (2% SDS, 0.06 M Tris-HCl 5% β-mercaptoethanol, 
10% glycerol and bromophenol blue) denatured at 95oC for 5 minutes. Protein was 
then fractionated by 12% SDS-PAGE and blotted onto nitrocellular membranes. 
Membranes were blocked for 1 hour with 5% milk powder in TBS-Tween and 
incubated with primary antibodies (table 3-2), 4oC overnight. Membranes were 
subsequently washed in TBS-T, incubated for 1 hour with HRP-conjugated 
secondary antibodies (table 3-2) and washed again; specific antigens were detected 
on addition of enhanced-chemiluminescence (ECL; Amersham Biosciences). 
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3.6 cDNA synthesis and standard PCR gel electrophoresis 
  
cDNA synthesis was carried out by Promega Reverse Transcription System: 1 µl of 
DNase was added to 500-1000 ng of RNA in a 1:1 ratio with DNase buffer, incubated 
at 37oC, 30 minutes and DNase activity terminated on incubation with 1 µl stop 
solution and for 2 minutes, RT. Per every 1000 ng RNA extracted, 1 µl random 
hexamer primers (Promega) was added and incubated for 5 minutes, 70oC and 
transferred immediately to ice. Intermediary products were subsequently added to a 
6.5 µl real-time (RT) mix comprising 4 µl MMLV RT buffer, 1 µl Moloney Murine 
Leukaemia Virus Reverse Transcriptase (MMLV), 0.5 µl RNasin, 1 µl dNTPs (all 
reagents Promega) and incubated for 1 hour at 42oC. Synthesised cDNA was stored 
at -80oC. 
 
Selective nucleotide sequence amplification was carried out by PCR using a 2720 
Geneamp thermal cycler (Applied Biosystems). PCR amplification was facilitated by 
DreamTaq master mix comprising DNA polymerase, MgCl2, dNTPs and optimised 
buffer.  A total volume reaction for PCR of 25 µl was mixed: comprising 2 µl of 10 
ng/µl cDNA, 12.5 µl X2 Dreamtaq master mix (ThermoFisher), 1 µl of corresponding 
10 µM forward and reverse primer and nuclease water. PCR amplification of 
sequences was carried out at varying annealing temperatures 55-60oC, with 
thermocycling reaction template comprising the following steps: 5 minute polymerase 
activation step at 95oC, followed by 28 cycles of 30 second denaturation of cDNA at 
95oC, annealing for 45 seconds and extension at 72oC for 60 seconds, followed by a 
final 10 minutes at 72oC. Amplified PCR products were visualised by gel 
electrophoresis, in which samples were diluted 1:6 and mixed with 6 x Blue/Orange 
Loading Dye (Promega). Samples were loaded onto a 2% agarose gel and ran at 
100 V for approximately 30 minutes. Nucleotide products were visualised by UV 





Table 3-2: Antibodies for western blot 
Primary  Antibodies  
Antigen   Antibody   Company   Source   Dilution   Code  
GAPDH   Polyclonal   Abcam   Rabbit   1:2000   ab22555  
β-­‐actin   Polyclonal   Sigma   Mouse   1:1000   A2228  
NDUFB8   Monoclonal   Abcam   Mouse   1:2000   ab110242  
SDHB   Monoclonal   Abcam   Mouse   1:200   ab14714  
ATPB   Monoclonal   Abcam   Mouse   1:2000   ab14730  
UQCRC2   Monoclonal   Abcam   Mouse   1:1000   ab14745  
Mt-­‐CO1   Monoclonal   Abcam   Mouse   1:2000   ab14705  
Cytochrome  P450  2E1   Polyclonal   Abcam   Rabbit   1:5000   ab28146  
αSMA   Monoclonal   Sigma   Mouse   1:1000   A2547  
CDKN2A/p16   Polyclonal   BioRad   Rabbit   1:500   AHP1488  
4HNE   Monoclonal   JaICA   Mouse   1:500   MHN-­‐020P  
Cyclin  A2   Monoclonal   Cell  Signalling   Mouse   1:1000   4656  
Cyclin  B1   Polyclonal   Cell  Signalling   Rabbit   1:1000   4138  
Cyclin  D1   Monoclonal   Cell  Signalling   Rabbit   1:1000   2978  
Cyclin  D2   Monoclonal   Cell  Signalling   Rabbit   1:1000   3741  
Cyclin  D3     Monoclonal   Cell  Signalling   Mouse   1:1000   2936  
Cyclin  E1   Monoclonal   4129   Mouse   1:1000   4129  
Cyclin  E2   Polyclonal   4132   Rabbit   1:1000   4132  
Cyclin  H   Polyclonal   2927   Rabbit   1:1000   2927  
Secondary  Antibodies  
Primary  Mouse  Ab   Anti-­‐mouse  HRP   Sigma   Goat   1:2000   A4416  







Oligonucleotide primers were designed using Primer Blast analysis software for exon 
coding regions of nuclear-encoded genes (table 3-3). Qualitative PCR tested primer 
specificity at 10 µM concentration. For quantitative real time PCR (qRT-PCR), cDNA 
samples were diluted to 10 ng/µl and added to 0.5 µM forward and reverse primer, 
6.5 µl SyBR Green Jumpstart (Sigma) and nuclease-free water. Quantitative analysis 
for each gene primer was carried out on an Applied Biosystems 7500 Fast Real-time 
PCR machine at various annealing temperatures 53-60oC. The reaction template 
comprised a 10 second polymerase activation step at 95oC followed by a 95oC 
denaturation step, 5 seconds, annealing for 1 minute and extension at 72oC. For 
mitochondrial-encoded genes (table 3-4), qRT-PCR was performed on an Applied 
Biosystems StepOne Real-time PCR machine and analysed by means of the 
TaqMan Gene Expression Assay (Applied Biosystems). 25 ng cDNA was added to a 
20 µl reaction comprising, 10 µl 2 x TaqMan Gene Expression Mastermix No 
AmpErase UNG, RNase-free water and Taqman probes for mitochondrial genes 
(table 3-4). Reaction was run as 10 minutes 95oC activation step, 40 cycles of 15 
seconds cDNA denaturation and 20 second 60oC step to allow for the annealing of 
TaqMan probes. Template temperatures of 95oC 15 seconds, 60oC 1 minute and 
95oC 15 seconds calculated a dissociation curve from which relative expressions 
were analysed by means of the 2-ΔCT method. CT values for the gene of interest were 
normalised to the reference housekeeping genes by calculating ΔCT(gene of interest – 
housekeeping gene). Mean changes in experimental groups were adjusted to the PolgA WT 





Table 3-3: Validated qRT-PCR mouse primer sequences 
Gene   Forward  Sequence   Reverse  Sequence   Annealing  
Temperature  
(OC)  
GAPDH   CACAGTCAAGGCCGAGAAT   GCCTTCTCCATGGTGGTGAA   57  
KC  /  CXCL1   CTGGGATTCACCTCAAGAACATC   CAGGGTCAAGGCAAGCCTC   60  
MIP2a  /  CXCL2   CCAACCACCAGGCTACAGG   GCGTCACACTCAAGCTCTG   60  
TNFα   GACCAGGCTGTCGCTACATCA   CGTAGGCGATTACAGTCACGG   57  
IL-­‐6   ACCAGAGGAAATTTTCAATAGGC   TGATGCACTTGCAGAAAACA   58  
S100A9   CACCCTGAGCAAGAAGGAAT   TGTCATTTATGAGGGCTTCATTT   55  
MCP1   AGGTCCCTGTCATGCTTCTG   TCTGGACCCATTCCTTCTTG   55  
RANTES   TGCTGCTTTGCCTACCTCTCC   TGGCACACACTTGGCGGTTCC   55  
αSMA   TCAGCGCCTCCAGTTCCT   AAAAAAAACCACGAGTAACAATCAA   60  
COL1A1   TTCACCTACAGCACGCTTGTG   GATGACTGTCTTGCCCCAAGTT   57  
TIMP1   GCAACTCGGACCTGGTCATAA   CGGCCCGTGATGAGAAACT   57  
TGFβ   CTCCCGTGGCTTCTAGTGC   GCCTTAGTTTGGACAGGATCTG   57  
SOD1   GAGACCTGGGCAATGTGACT   GTTTACTGCGCAATCCCAAT   60  
SOD2   CCGAGGAGAAGTACCACGAG   CCGAGGAGAAGTACCACGAG   60  
GSS   GCCTCCTACATCCTCATGGA   CCACATGCTTGTTCATCACC   60  
GPX   ACTACACCGAGATGAACGA   GACGTACTTGAGGGAATTCAG   57  
  
Table 3-4: qRT-PCR Taqman probes for mitochondrial genes 
Gene   Company   Code   Annealing  
Temperature  (OC)  
beta-­‐2-­‐globulin   ThermoFisher  Scientific   Mm00437762_m1   60  
ND1   ThermoFisher  Scientific   Mm04225274_s1   60  
ND4   ThermoFisher  Scientific   Mm04225294_s1   60  
COX1   ThermoFisher  Scientific   Mm04225243_g1   60  
COX3   ThermoFisher  Scientific   Mm04225261_g1   60  
ATP6   ThermoFisher  Scientific   Mm03649417_g1   60  
TOMM20   ThermoFisher  Scientific   Mm01609022_g1   60  




3.8 Serum aminotransferase assays 
  
Blood samples were collected from sacrificed WT, PolgA+/mut and PolgAmut/mut mice 
and incubated at room temperature for 20 minutes to allow for blood clotting. 
Samples were centrifuged at 8000g for 15 minute, room temperature and 
supernatant serum collected; samples were stored at -80oC. For analysis, alanine 
aminotransferase activity assays (AST Assay; Sigma) were kindly performed by Ms. 
Hannah Paish. Serum samples were diluted 1:8 and added to 25 µl of reaction mix 
per well of a 96 well plate comprising: 20 µl AST assay buffer, 0.5 µl AST enzyme 
mix, 2 µl AST developer and 2.5 µl AST substrate. Assay plate was mixed, incubated 
in dark at 37oC for 3 minutes and initial absorbance determined at 450 nm 
((A450)Initial). Final absorbance ((A450)Final) was measured following 15 minutes further 
incubation, in dark at 37oC and difference from (A450) initial calculated. Standards for 
assay were generated as follows from manufacturer’s glutamate standard solutions 
as follows (table 3-5): 
 Table 3-5: Standards for serum AST assay 
Standard   mM      Assay  Buffer  
1   1   5μl  Std  solution   495μl  
2   0.8   400μl  of  1mM   100μl  
3   0.6   375μl  of  0.8mM   125μl  
4   0.4   333μl  of  0.6mM   167μl  
5   0.2   250μl  of  0.4mM   250μl  
6  (Blank)   0   0   500μl  
 
 
Concentration of serum AST was determined from equation: 
[AST = B x sample dilution factor/ reaction time x V], where B denotes amount of 
glutamate generated between initial and final A450; reaction time is time of assay 






3.9.1 Haematoxylin and Eosin (H&E) staining 
Formalin fixed tissue was paraffin-embedded and cut via a microtome onto slides at 
4 µm at least 2 hours prior to staining. Slides were deparaffinised; 2 x 5 minutes in 
clearene, 5 minutes in 100% ethanol, 5 minutes in 70% ethanol, and placed into tap 
water. Sections were incubated for 2-5 minutes in Mayer’s haematoxylin (Sigma) 
followed by 30 seconds in Scotts water. Slides were counterstained 2-3 minutes in 
eosin and washed in tap water. Slides were briefly dehydrated in increasing alcohol 
grades and mounted in Pertex (Histolab).  
 
3.9.2 Dual Cytochrome c Oxidase (COX) / Succinate Dehydrogenase 
(SDH) Histochemistry 
Frozen liver (µm) tissue sections were cryosectioned onto glass slides and dried for 
at least 1 hour, RT prior to staining. Sections were incubated in 50 µl COX medium at 
37oC for 8 minutes; stock media comprising 500 µM cytochrome c 0.2 M phosphate 
buffer pH 7.0, diluted 1 in 5 with 3,3’ diaminobenzidine tetrahydrochloride (DAB; 5 
mM DAB in 0.2 M phosphate buffer pH 7.0) and supplemented with 20 µg/ml 
catalase (Sigma). Sections were washed 2 x 5 minutes in 3 x PBS and 50 µl SDH 
medium added to sections. SDH medium: 800 µl NitroBlue tetrazolium (NBT; 1.5 mM 
NBT in 0.2 phosphate buffer pH 7.0), 100 µl phenazine methosulphate (PMS; 2 mM 
PMS in 0.2 phosphate buffer pH 7.0), 100 µl sodium succinate (1.3 M sodium 
succinate in phosphate buffer pH 7.0) and 10 µl sodium azide (100 mM sodium azine 
in 0.2 phosphate buffer pH 7.0). SDH media was removed from section by washes 3 
x 5 minutes in 1 x PBS and dehydrated via increasing alcohol gradient and two 
concentrations of Histoclear (National Diagnostics, Atlanta, USA). Slides were 
mounted in DPX. 
 
3.9.3 Immunohistochemistry 
Formalin fixed tissue was paraffin-embedded and cut onto slides at 4 µm by 
microtome at least 2 hours prior to staining. Slides were deparaffinised and 
rehydrated in clearene and graded alcohols as above before incubating in 3% 
hydrogen peroxidase (Sigma)/methanol, 15 minutes RT. Antigens specific to each 
antibody (table 3-6) were retrieved by various methods. Briefly, slides requiring a 
0.01% pronase (BioScientific) were incubated for 20 minutes at 37oC whilst sections 
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requiring antigen retrieval in Vector Unmasking solution (Vector Laboratories), 10 
mM Sodium Citrate Buffer pH 6 or 1 mM EDTA pH 8 were heated in a microwave for 
15-25 minutes at 600W (table 3-6). Slides were allowed to cool and blocked for 20 
minutes, RT with avidin/biotin (Vector Laboratories), washing slides in 1 x PBS 
between each step. Sections were blocked with either 20% swine serum or 1 x 
casein for 45 minutes prior to 4oC overnight incubation with primary antibody (table 3-
6). Slides were washed in 1 x PBS and incubated 1-2 hours, RT with a biotinylated 
secondary antibody. Positively detected antigens were amplified for detection by 
ABC R.T.U Vectorstain kit (Vector Laboratories), incubated 1 hour RT and presence 
detected by 3,3-diaminobenzidine tetrahydrochloride (DAB; Vector Laboratories and 
Sigma). Tissue nuclei were counterstained 2-5 minutes using Mayer’s haematoxylin 
and slides dehydrated in graded alcohols and clearene. Stained sections were 




Table 3-6: Antibodies and retrieval methods for immunohistochemistry 
Antigen   Antigen  Retrieval   Primary  Antibody   Secondary  
Antibody  
PCNA   Citric  saline  (pH  6.0)    
Microwave  20  minutes  






CD3   1  mM  EDTA  (pH  9.0)  
Microwave  15  minutes  






CD68   Citric  saline  (pH  6.0)    
Microwave  20  minutes  






CD45R   Citric  saline  (pH  6.0)    
Microwave  20  minutes  






NIMP   Pronase  0.01%    
Microwave  20  minutes  






αSMA   Citric  saline  (pH  6.0)  
Microwave  20  minutes  
Mouse  mAb  to  αSMA  FITC  






Caspase  3   10  mM  Sodium  Citrate  (pH  
6.0)  
Rb  mAb  to  cleaved  caspase  3  






Microwave  25  minutes   1:200  dilution  
Secondary  Antibodies  




Anti-­‐mouse  HRP   Goat   Sigma  (A4416)  
Primary  Rabbit  Ab   Anti-­‐rabbit  HRP   Swine   DAKO  (E0353)  






Goat   Dako  (V0403)  
 
 
3.9.4 cIdU Immunofluorescence  
Formalin fixed tissue was paraffin-embedded and cut by microtome to 4 µM 
thickness onto slides. Sections were deparaffinised and rehydrated in clearene and 
graded alcohols as above and rinsed in distilled water. Sections were subjected to 
antigen retrieval in 10 mM citrate buffer pH 6 in a pressurised cooker for ~20 minutes 
and blocked in 10% normal donkey serum, 1 hour RT. Washing slides in 1 x TBST 
between each step, sections were blocked with avidin/biotin (Vector Laboratories) for 
20 minutes each, incubated overnight with primary rat anti-cldU antibody (Novus 
Biologicals) and cIdU detected for with secondary antibody donkey anti-rat IgG (H 
&L) Cy5 647 (Jackson ImmunoResearch) incubated at RT for 2 hours. Sections were 
washed in 1 X TBST and nuclei counterstained for with Hoescht (Life Technologies) 
diluted 1:1200 in TBST for 15 minutes. Stained sections were mounted with Prolong 




3.9.5 Image analysis of staining 
Representative photomicrographs of stained sections were taken using a Nikon 
Eclipse Ni-U upright microscope for bright field images or Zeiss AxioImager Z2 for 
cldU immunofluorescent images. Positively stained cells and areas were analysed in 
20 high power fields (HPF) and analysed using NIS-Elements BR Analysis (Nikon).  
  
3.10 MSD V-PLEX proinflammatory panel 1 mouse assay 
  
3.10.1 Principle of Meso Scale Discovery cytokine assay 
Meso Scale Discovery (MSD) V-Plex Cytokine assays allows rapid detection of 
soluble cytokine proteins by method of sandwich immunoassay. This involves the 
addition of samples to plates with a working electrode surface pre-coated with 
capture antibodies. Sample analytes are captured by immobilising capture antibodies 
and detected by the addition of solution containing cytokine detection antibodies 
conjugated with electrochemiluminescent (ECL) labels (MSD SULFO-TAG) to 
complete the sandwich. Buffer is added to maintain ECL signals and plate is loaded 
onto an MSD instrument for voltage application. Subsequent emission of light is 
detected and emission is measured quantitatively for intensity proportional to amount 
of cytokine present in sample.  
 
3.10.2 Detection of cytokines in mouse sera 
Inflammatory cytokines IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, KC/GRO, IL-10, IL-12p70 
and TNFα were detected and measured by V-Plex Proinflammatory panel 1 mouse 
Assay (MSD) in female mouse sera taken from ageing PolgA WT, PolgA+/mut and 
PolgAmut/mut mice as per manufacturer’s instructions. Briefly, calibrator stock 
standards were prepared by reconstitution in 1000 µl of diluent 41 and diluted serially 
4-fold to generate a further 7 standard calibrators. The 8th calibrator comprised of 
diluent 41 only. Subsequently, serum samples were diluted 2-fold in diluent 41 for 
assay detection and 50 µl added to a pre-washed plate, washed with 150 µl of 1 X 
Wash Buffer. 50 µl of calibrator standards and controls were also added to 
corresponding wells.  Plates were sealed, allowed to incubate at room temperature 
for 2 hours and washed again 3 times with Wash Buffer. To detect cytokines, 25 µl of 
detection antibody solution was added; prior to use X50 stock detection antibody 
solution comprising cytokine-specific antibodies conjugated with SULFO-TAG was 
prepared as a 1X working solution. Plate was then sealed and further incubated at 
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room temperature for 2 hours. To measure detected antibodies, plate was washed 3 
times with Wash Buffer and 150 µl of 2X Read Buffer T added to each well. Plate 
was analysed on a MSD instrument and concentration of cytokine present measured 
proportional to intensity of light emitted from assay.  
 
3.11 Neutrophil Assays 
  
3.11.1 Neutrophil functional chemotaxis assay 
Chemotaxic migration was assessed as previously established by Newcastle 
University’s Simpson Lab. Briefly in each half of slide, three 2.5 mm circular 
chambers, separated by 2.5 mm were inserted into a gel comprising 2% agarose 
prepared in HBSS- (Sigma) and supplemented with 25% bovine serum albumin 
(BSA; Sigma), 2% gelatin solution (Sigma) and Iscove’s Modified Dulbecco’s Medium 
(IMDM), 5 x 105 neutrophils in 10 µl of 1% autologous serum supplemented IMDM 
was added to central chamber whilst autologous serum supplemented IMDM and 10 
mM of chemoattractant N-Formyl-Met-Leu-Phe (fMLP; Sigma) was added to the 
other two wells; slides were incubated at 37oC, 5% CO2 for 2 hours and then fixed in 
2.5% paraformaldehyde overnight. To measure migration of neutrophils, slides were 
stained with Giema solution diluted 1:10 in PBS-Tween and analysed using a Zeiss 
Axio Observer Inverted microscope.  
 
3.11.2 Neutrophil functional phagocytosis assay 
Bone marrow derived neutrophils were isolated from PolgA WT, PolgA+/mut and 
PolgAmut/mut mice as previously described above and seeded into a 24 well plate at 1 
x 105 in 400 µl. Phagocytosis was assessed via addition of 40 µl Zymosan A: heat or 
chemically inactivated, fluorescin-labelled bacterial bioparticles derived from 
Saccharomyces cerevisiae (Invitrogen) and incubated for 2 hours at 37oC, 5% CO2.  
Plates containing neutrophils and zymosan particles were PBS washed, fixed in 4% 
formaldehyde for 10 minutes and subsequently analysed for phagocytosis by Zeiss 
Axio Observer Inverted microscope. Neutrophil phagocytosis was assessed by the 
presence of two or more phagocytosed zymosan particles within the cell and 






3.11.3 Isolation of blood neutrophils 
Blood samples were collected from sacrificed 3-6 and 9-12 month old WT, PolgA+/mut 
and PolgAmut/mut mice and incubated at room temperature for 20 minutes to allow for 
blood clotting. Samples were subsequently diluted 1:2.5 in 200 µl calcium-free 1 x 
PBS prior to staining with fluorescent antibodies for flow cytometry analysis. 
 
3.12 Flow Cytometry 
  
3.12.1 Principle of flow cytometry 
Flow cytometry permits the multi-parameter characterisation of single cells in an 
otherwise ‘impure’ heterogenous cell population by laser-based technologies. 
Parameters such as cell size, cell surface expression markers, intracellular 
molecules and intracellular signalling are characteristics frequently used. The 
technology involves the passing of a cell suspension containing cells of interest 
through small opening to allow single passage only via a laser light. Forward 
scattering of light (light in front of laser beam) and sideward scattering of light 
induced by the cell is collected by detectors and converted to electrical current with 
voltage proportional to amount of light.  
 
Cell characteristics may also be observed by fluorescently labelling them via 
fluorochrome conjugated antibodies binding to cell specific markers. Light can be 
emitted and detected from antibody-bound cells when excited by an appropriate 
excitation wavelength; this can be separated from forward and side scatter 
parameters using combinations of mirrors and filters to allow separation of light into 
defined wavelengths. Such specific wavelength parameters are detected by a 
photomultiplier tube sensor. When using multi-parameter fluorescent detection it is 
imperative to minimise spectral overlap between different wavelengths: applying 
electronic compensation to avoid false positive detection of fluorescently labelled 
cells as well as the appropriate use of several controls including: stained and 
unstained cells, compensation controls and fluorescence minus one controls (FMO). 
 
3.12.2 Fluorescent cell viability staining of neutrophils 
Neutrophils were checked for cell viability before fluorescent labelling with conjugated 
antibodies. Neutrophils were added to a 96 well plate and centrifuged at 400 x g for 4 
minutes, supernatant discarded and pelleted cells resuspended in 30 µl of Live/Dead 
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viability dye (ThermoFisher Scientific) at 1:120 in PBS for subsequent incubation at 
4oC for 15 minutes. Live/Dead cells were washed in FACs buffer (PBS supplemented 
with 1% FCS; Lonza and BioSera respectively) to quench unbound dye and 
resuspended in 30 µl of 1:30 FACs buffer diluted Fc block to prevent further non-
specific binding. Cells were washed again in FACs buffer.  
 
3.12.3 Staining, induction of ROS production and acquiring of 
fluorescently labelled neutrophils 
Fluorescent labelling of neutrophils was undertaken to determine reactive oxygen 
species (ROS) release during respiratory burst in response to stimulatory factors. As 
above, neutrophils from blood and liver neutrophils were isolated into a final volume 
of 500 µl FACs buffer (1 x PBS supplemented with 5% FCS) and subsequently 
stained with fluorescent antibodies Ly6G, CD45R and CD11b (table 3-7) added at 
1:50 dilution. Neutrophils were fluorogenically labelled with 1 µM Dihydrorhodamine 
123 (DHR; ThermoFisher Scientific) ROS probe, prior prepared in FACs buffer and 
incubated for 10 minutes in the dark at 37oC. Neutrophils were then either primed 
through the addition of 100 mM platelet activating factor (PAF; Sigma) or primed and 
stimulated through addition of PAF plus 1:1000 diluted fMLP (Sigma) to give the 
following flow cytometry assay controls: DHR only; DHR plus PAF; and DHR plus 
PAF and fMLP. Between the addition of each stimulatory factor, neutrophils were 
incubated at 37oC in the dark for 10 minutes.  
 
Prior to analysis, blood neutrophils were lysed with 1 X ACK (Ammonium-Chloride-
Potassium) lysis buffer (ThermoFisher Scientific) and incubated for 10 minutes at 
37oC in the dark. All neutrophil isolates were spun at 500 x g for 5 minutes, 
supernatant removed and resuspended into 500 µl of FACs buffer. Neutrophils were 
then spun a further time at 500 x g for 5 minutes and remaining cell pellet 
resuspended in a total final volume of 100 µl for data acquisition by flow cytometry. 
All flow cytometry was performed on either a FACSCanto II or BD FACSDIVA v8, 
acquiring sufficient number of events for subsequent export and analysis. 
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3.12.4 Analysis of flow cytometry data 
Raw flow cytometry data was analysed with software FlowJo v8 (BD Biosciences). 
Subsequent workflow of analysis followed plotting forward scatter height (FSC-H) 
versus side scatter area (SSC-A) for exclusion of contaminating red blood cells and 
cellular debris within cell isolate. FSC-H against FSC-A removed doublet cells and 
remaining cell population positively gated within the 405-450 nm channel to select for 
cells with area proportional to height and to remove permeable dead and necrotic 
cells with increased uptake of Live/Dead dye. Neutrophil populations were then 
characterized and analysed according to expression of their fluorescently labelled 
intracellular and extracellular markers.  
Table 3-7: Flow cytometry antibodies 
Antigen   Fluorophore   Vendor   Dilution  
Live/Dead   BV241   Life  Technologies   1:100  
CD45R  (for  liver  
neutrophils  only)  
BV510   Biolegend   1:50  
CD11b   PerCP-­‐Cy5.5   Biolegend   1:50  
LY6G   APC   Biolegend   1:50  
  
3.13 NAD+/NADH GloTM Assay 
  
Levels of NAD+ and NADH were measured from frozen liver samples taken from 
aged PolgA WT, PolgA+/mut and PolgAmut/mut mice. Samples were cut and sliced to 20 
mg and homogenised at room temperature in PBS-bicarbonate supplemented with 
0.5% dodecyltrimethylammonium bromide. Samples were diluted 2-fold and 50 µl 
transferred into a 96 well plate. Standards of NAD+ and NADH were prepared from a 
500 nM working solution of NAD+ and NADH diluted in PBS (table 3-8).  
As per manufacturer’s instructions for the NAD+/NADH GloTM Assay (Promega) to 
corresponding wells, 25 µl of 0.4N HCl was added, plate covered and incubated for 
15 minutes at 60-65oC. Plate was cooled for 10 minutes at room temperature and 25 
µl 0.5 M Trizma base added to neutralise HCl.  In a 1:1 mixture add 50 µl of 0.4 N 
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HCl to 0.5 M Trizma base.  To measure NADH and NAD+, 20 µl of samples were 
transferred into a 96 well white assay plate and spectrophotometrically measured at 
647 nm.  
 
Table 3-8: Standards for NAD+ and NADH measurement 
NAD+    and  NADH  Standard  Dilutons  
Standard   nM   Working  Solut ion  
(μl)   
Bicarb  Assay  Buffer  (μl)  
1   200   40   60  
2   100   20     80  
3   50   10   90  
4   25   5   95  
5   12.5   2.5   97.5  
6   6.25   1.25   98.75  
7  (Blank)   0   0   0  
 
3.14 Statistical Analysis 
  
Statistical analysis was performed using GraphPad Prism 7 for Windows (GraphPad) 
for ageing cohorts and in vivo damage models of PolgA WT, PolgA+/mut and 
PolgAmut/mut mice. Prior, data were checked prior for skewness and normality using 
Shapiro-Wilk and Kolmogorov-Smirnov tests. Data was reported and plotted 
graphically as means +/- standard error of mean (SEM); statistical analysis was 
performed using analysis of variance (ANOVA) test. Due to presence of multiple 
experimental groups and multiple time points, statistical analysis for ageing and in 
vivo models comprised two-way ANOVA with Bonferroni post-hoc test for multiple 
comparisons. Given values of P = ≤0.05 were accepted as *, P = ≤0.01 **, P = 












Chapter 4 | Phenotypic Characterisation of Polgmut/mut Ageing Livers Compared 
with Wild-Type Mice 
 
4.1 Introduction 
The accumulation of somatic mtDNA mutations and resulting respiratory dysfunction 
is implicated in the inexorable homeostatic decline of an organism and has been 
examined in the literature in a variety of mitotic and post-mitotic tissues (Zhang et al., 
1997; Cottrell et al., 2001; McDonald et al., 2008; Gutierrez-Gonzalez et al., 2009). In 
the human liver, clonal expansion of COX-deficient hepatocytes has been observed 
with increasing occurrence during human ageing (Fellous et al., 2009). The functional 
relevance of these clonally deficient populations remains unclear, in part, due to the 
difficulty in performing representative studies within static mitotic tissues samples, 
such as the liver. More significantly, there is an accompanied decline in hepatic 
regeneration with age, despite the organ’s renowned unique capacity to fully recover 
lost cellular mass and function in response to injury. Most studies have focused on 
models of regeneration and utilised injurious interventions, such as two-thirds partial 
hepatectomy (PHx). Such studies have demonstrated that following PHx, survival is 
reduced by 40% in aged mice and in humans fatality increased by 15% in the elderly, 
perhaps owing to increased apoptosis, lower hepatocyte response to proliferative 
signals and halted progression of hepatocytes through the cell cycle with age (Huh et 
al., 2004; Enkhbold et al., 2015). Alterations are also accompanied by a number of 
mitochondrial changes including modification to the ultrastructure, a decrease in 
mitochondrial number and membrane potential, and an increase in peroxide reactive 
oxygen species (ROS) generation (Tauchi and Sato, 1968; Sastre et al., 1996). 
Elsewhere, in mitotic aged human colonic crypts, clonally expanded respiratory chain 
deficiency is found to be associated with decreased cell proliferation and 
accompanied by increased apoptosis of deficient crypt cells (Taylor et al., 2003; 
Nooteboom et al., 2010; Baines et al., 2014). Subsequently the biological contribution 
of age-accumulated mtDNA mutations and ensuing mitochondrial dysfunction in 
relation to liver ageing and regulation of hepatocellular proliferation was investigated 
in the present study. 
 
The PolgAmut/mut mtDNA mutator mouse expresses a proof-reading deficient version 
of the mitochondrial DNA polymerase gamma (γ) which stochastically accumulates 
mtDNA mutations with time, providing experimental support that respiratory chain 
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dysfunction can promote an accelerated ageing phenotype (Trifunovic et al., 2004; 
Kujoth et al., 2005). Such studies on the PolgAmut/mut mouse have shown that 
premature ageing arises from mtDNA point mutations accumulating within tissues, 
including the liver, at a rate 3-5 fold faster per mtDNA molecule than wild type (WT) 
mice. Unlike age-associated mtDNA mutations in human tissues that occur 
sporadically and heterogeneously, PolgAmut/mut mutagenesis occurs during 
embryogenesis and expands clonally across all tissues (Khrapko et al., 2006). 
Propagation of the ageing phenotype within these mice was originally proposed to 
occur in the absence of oxidative stress and attributed to the increasing loss of vital 
cells with respiratory chain dysfunction by apoptosis (Trifunovic et al., 2004; Kujoth et 
al., 2005; Hiona et al., 2010). However, technological advances have more recently 
shown that mitochondrial ROS may contribute to PolgAmut/mut ageing by 
demonstrating the increasing in vivo detection of hydrogen peroxide with age and the 
extension of lifespan following antioxidant intervention (Dai et al., 2010; Ahlqvist et 
al., 2012; Logan et al., 2014). Homeostatic decline observed in these mice has also 
been shown to be attributed to the early onset of stem cell dysfunction in which 
PolgAmut/mut progeny develop abnormal lineage differentiation and altered numbers 
and proliferative capacity of stem cells (Norddahl et al., 2011; Ahlqvist et al., 2012).  
 
Since normal ageing WT mice accumulate low levels of mtDNA point mutations and 
demonstrate lower mtDNA mutation frequencies in the aged liver than the mutator 
mouse, PolgAmut/mut were used to investigate the role of mitochondrial respiratory 
dysfunction on the ageing regenerative liver (Vermulst et al., 2007; Ameur et al., 
2011). In addition and more representative of the multi-factorial ageing process in 
humans, the present study included use of PolgA+/mut heterozygous mice; these mice 
also accumulate mtDNA mutations but at a lower rate of ~4  point mutations per 
mtDNA molecule and without the premature progeroid ageing phenotype (Kraytsberg 
et al., 2009).  Studies have also shown that within tissues such as the brain, heart 
and intestinal duodenum, respiratory deficiency occurs: quantified at ~20% in 
duodenal cells that correlates to the 100-fold increase in mtDNA mutations over WT 





The aim of this chapter was to phenotypically characterise the effects of 
mitochondrial respiratory chain function in the PolgA+/mut and PolgAmut/mut liver in 
relation to basal hepatocellular regeneration with age. 
 
4.3 Histology and ageing phenotype of WT and PolgA liver tissues 
Concomitant with increased age-related incidence of liver pathologies, morphological 
changes are increasingly recognised within the hepatic sinusoid with age. As well as 
evidence suggesting a link to the ageing process, evidence shows morphological 
changes to mitochondria ultrastructure as well as elevated mtDNA mutational load 
observed within the ageing liver. As such, liver tissues were analysed within 
PolgA+/mut and PolgAmut/mut mice to determine if mtDNA mutations induced 
histological perturbations that could underlie age-related changes to normal hepatic 
functions, including the possible reduction in liver regeneration. Tissues from WT, 
PolgA+/mut and PolgAmut/mut were characterised by H&E staining from 3, 6, 9 and 12 
month old mice; however, no obvious changes to the hepatic ultrastructure was 
observed with age, despite an obvious ageing phenotype and increases in liver to 
body weight ratios in both PolgAmut/mut mice age groups (p<0.05, n=5) and across the 





Figure 4-1: Histological 









photomicrographs of H&E 






at ages 3, 6, 9 and 12 months. 
Bars 100 µm; x20 magnification. 
(B) Liver to body weight ratios of 
WT, PolgA+/mut and PolgAmut/mut 
at 3 and 12 months. *p=0.05, 
****p=0.0001. N=3-7 for WTs, 
n=5 for PolgA+/mut and n=3-7 





4.4 Mitochondrial OXPHOS deficiency in PolgAmut/mut livers 
  
4.4.1 COX/SDH staining analysis of livers 
PolgAmut/mut mice are characterised by an accelerated ageing phenotype due to tissue 
accumulation of mtDNA mutations, exhibited by symptoms such as thymic involution, 
loss of bone mass, reduced subcutaneous fat and cardiomyocyte respiratory 
dysfunction (Trifunovic et al., 2004; Kujoth et al., 2005). In PolgA+/mut mice, no 
accelerated ageing is documented, however, mitochondrial respiratory deficiency is 
observed in mitotic colon crypts, which accumulate with age (Baines et al., 2014). 
Interestingly for PolgAmut/mut mice, progressive deterioration of respiratory chain 
function is observed from 12 weeks and symptomatic onset within 6-8 months of age 
– a reflection of augmented mutational loads in PolgAmut/mut mice. To therefore 
determine if the liver also harnesses respiratory deficiency with age, frozen sections 
(15 µm) were subjected to dual COX/SDH staining from 3 month and 12-month WT 
(n=5, n=5) and PolgAmut/mut (n=3) mice. The subsequent colouration from the assay 
resulting from respiratory enzyme activity of nuclear encoded complex II succinate 
dehydrogenase (SDH) and mitochondrially encoded complex IV cytochrome c 
oxidase (COX). Accordingly, cells with normally functioning COX activity saturate 
with brown coloured reduced 3,3’-diaminobenzidine (DAB), whilst blue colouration 
occurs due to complex IV deficiency, as detected by the reduction of nitroblue 
tetrazolium (NBT) by SDH, in the absence of cellular saturation with reduced DAB 
product (Ross, 2011). Utilising this assay, mitochondrial deficiency was therefore 
calculated in WT and PolgAmut/mut livers as a percentage of the total tissue area via 
microscopy thresholding (figure 4-2A-B).  
 
Even at 3 months of age, PolgAmut/mut mice displayed trends of elevated COX 
deficiency compared to WT controls (figure 4-2, C). Deficiency appeared visibly 
mosaic-like with possible respiratory dysfunction emanating from the hepatic 
periportal regions - given the greater COX deficient density observed closer to the 
portal vein (figure 4-2, C). In 12-month livers, deficiency was significantly elevated in 
these PolgAmut/mut mice (p<0.01) (figure 4-2, C); periportal staining appeared to 
extend towards the pericentral zones, coinciding with similar lineage tracing studies 
in the human liver (Fellous et al., 2009). However, COX deficiency was not 
statistically different between 3 and 12-month PolgAmut/mut mice nor between all WT 
ages. Whereas some evidence of COX negativity was observed in 12-month WT 
90  
  
mice and similarly located in the periportal regions, this was less detectable by 
microscopic threshold analysis (figure 4-2, B, C). PolgAmut/mut mice livers 
unsurprisingly showed augmented levels of hepatic COX deficiency when compared 
to age-matched WTs and were considered similarly COX deficient between 3 and 12 













Figure 4-2: Histological analysis of basal mitochondrial function in young (3 month) and old (12 
month) WT and PolgAmut/mut mice. 
 
(A) Representative photomicrographs of COX/SDH staining in WT and PolgAmut/mut mice livers at 3 and 12 
months. Outset images taken at x10 magnification, Bars 100 µm; inset images taken at x20 magnification (B) 
Representative photomicrographs of thresholds analysing COX/SDH staining in young and old WT and 
PolgAmut/mut livers. Area of liver tissue shown to be COX deficient is shown in yellow; total tissue area is 
highlighted in purple. Bars 500 µm. (C) Mitochondrial dysfunction shown by COX/SDH staining calculated as a 
percentage of total tissue area.  
PolgAmut/mut 
PolgAmut/mut 
3m PolgAmut/mut WT 12m PolgAmut/mut 
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4.4.2 Respiratory chain deficiency in PolgAmut /mut livers 
The utility of COX/SDH tissue staining in locating mitochondrial dysfunction is 
attributable to the reduction of electron acceptor nitroblue tetrazolium (NBT) in the 
absence of COX functionality. Yet, a caveat of COX/SDH staining is the limited 
detection of respiratory deficiencies for other specific ETC complexes. For example, 
complex I deficiency is readily detected in musculoskeletal tissues in the presence of 
COX negativity - identified only by specific immunofluorescent labelling for complex I 
(Rocha et al., 2015).  Ageing liver tissues from WT, PolgA+/mut and PolgAmut/mut mice 
were therefore tested for specific ETC complex deficiencies; however, due to the 
liver’s auto-fluorescent nature, possible tissue deficiencies were alternatively 
detected by western blot (Croce et al., 2010).  
 
Protein expression of complexes I (NDUFB8), complex II (SDHB), complex III 
(UQCRC2), complex IV (Mt-CO1) and complex V (ATPB), determined via western 
blot, confirmed respiratory deficiency. Interestingly, no observable differences in Mt-
CO1 expression could be detected in the liver from all aged genotypes, despite 
previous complex IV (COX) deficient staining (figure 4-3). Instead, reduced 
expression was observed in whole livers for NDUFB8 in PolgAmut/mut mice at 3, 6 and 
12-month, deducing a complex I deficiency. In addition, NDUFB8 in PolgA+/mut whole 
livers was also found to observe reduced protein expression at 12 months of age but 






Figure 4-3: Western blot detection of mitochondrial respiratory complex enzyme proteins complex I 
(NDUFB8), complex II (SDHB), complex III (UQCRC2), complex IV (Mt-CO1) and complex V (ATPB) 
 
Western blot detection of NDUFB8, SDHB, UQCRC2, Mt-CO1 and ATPB in (A) 3 month WT, PolgA+/mut and 
PolgAmut/mut mice livers, (B) in 6 month WT, PolgA+/mut and PolgAmut/mut mice livers and (C) in 12 month WT, 






4.5  Basal proliferation and apoptosis in the ageing liver cohort  
  
4.5.1 MtDNA mutations reduce basal hepatocyte proliferation in the  
ageing liver 
Indications of reduced hepatocellular regeneration is previously outlined in the 
literature, describing diminished post-PHx survival in aged cohorts, as well as 
increased elderly incidence of liver pathologies (Enkhbold et al., 2015; Kim et al., 
2015). With somatic mtDNA mutations highly implicated in the ageing process, it was 
hypothesised that the presence of mtDNA mutations would have an aberrant effect 
on hepatocyte proliferation. Liver sections dissected from aged WT, PolgA+/mut and 
PolgAmut/mut mice were therefore immunohistochemically labelled for proliferating cell 
nuclear antigen (PCNA), an auxiliary protein of DNA polymerase δ and a marker of 
cell proliferation (figure 4-4, A). The analysis of PCNA positive hepatocytes revealed 
hepatocellular proliferation in WT mice to remain relatively constant between the 
ages of 3 and 12 months, yet as PolgA+/mut and PolgAmut/mut mice aged to 9 and 12 
months, this capacity compared with WTs was significantly reduced (p<0.001) (figure 
4-4, B). Though trending, the effect at these ages did not appear to be significantly 
gene dose dependent when comparing PolgA+/mut and PolgAmut/mut mice, thus 
suggesting accumulation of mtDNA mutations has an effect in some part to reduce 











 mice by 
immunohistological analysis. 
 
(A) Representative photomicrographs of 





 mice. Arrow depicts 
positively stained hepatocytes. Bars 100 
µm. (B) Positively stained hepatocytes is 







= 0.05). Positive 
cells were counted in 15 high power 
fields at x20 magnification. All P values 
calculated using a two-way ANOVA. 
*p=0.05, ***p=0.001. n=3-7 for WTs, n=5 
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4.5.2 Increased apoptosis is observed in PolgAmut /mut mice 
As well as hepatocellular proliferation, liver homeostasis requires the additional 
regulation of hepatic apoptosis for maintenance, in which termination of parenchymal 
regeneration, for example, requires small wave apoptosis to correct excess 
hepatocytes produced during restoration (Sakamoto et al., 1999). Disrupted balance 
can lead to either hyperplasia and tumour development, or where there is increased 
apoptosis, hepatocyte cell loss and liver damage. Induction requires the functional 
role of mitochondria to execute programmed cell death following the cytosolic release 
of intramembrane space proteins such as cytochrome c. In the presence of 
accumulated mtDNA mutations, correlative links to increased apoptotic levels and 
subsequent mammalian ageing is derived from early work undertaken on PolgAmut/mut 
mice (Kujoth et al., 2005). Here, similar effects can be observed in the present study, 
whereby immunohistological analysis for executor caspase 3 in liver sections shows 
significantly increased levels of caspase 3 positive hepatocytes in PolgAmut/mut mice 
at 6 months (p<0.05) and 9-12 months (p<0.001), when compared PolgA+/mut and 
WTs (figure 4-5, A,B). Indeed, in previous studies elevated caspases are observed in 
a number of tissues; our findings across 6-12 months coincide with increased liver 
apoptosis in PolgAmut/mut mice, however, at 3 months of age no significance is seen 
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(A) Representative photomicrographs 






Arrows depict caspase-3 positive 
stained cells. Bars 100 µm.  
(B) Quantification of caspase-3 
positive hepatocytes. Stained 
hepatocytes were counted in 15 high 
power fields at x20 magnification. All 
P values calculated using a two-way 
ANOVA. *p=0.05, ***p=0.001. n=3-7 
for WTs, n=5 for PolgA
+/mut


























4.6 Respiratory dysfunction and oxidant enzyme expression with age  
Numerous studies on propagation of the ageing phenotype in mutator mice 
predominantly report negligible increases in oxidative damage and stress signals 
(Trifunovic et al., 2004; Kujoth et al., 2005; Edgar and Trifunovic, 2009; Hiona et al., 
2010), whilst other studies report in vivo detected levels of peroxide ROS markers 
and the delay in the onset of ageing following anti-oxidant intervention (Dai et al., 
2010; Ahlqvist et al., 2012; Logan et al., 2014). These differences in the literature, 
however, are most likely attributed to the greater sensitivity of ROS detection 
methods in later papers over initial PolgAmut/mut observational studies. To test whether 
reduced respiratory capacity was caused by mtDNA mutations that had an effect on 
oxidative signalling, gene expression for oxidant enzymes were measured in whole 
liver tissue in 3, 6 and 12 month WT, PolgA+/mut and PolgAmut/mut mice. Quantification 
of mRNA levels for glutathione synthase (GSS), glutathione peroxidase (GPx) and 
superoxide dismutases SOD1 and SOD2 were inconclusive across all age groups 
and genotypes (figure 4-6, A-D); however, SOD2 expression did show possible 
indications of increased levels in 12 month PolgAmut/mut livers when compared to WT 
and PolgA+/mut mice (figure 4-6, D) but failed to reach significance. This could be 
explained as SOD2 is an isoform of superoxide dismutase specifically localised at the 
site of ROS production with the inner mitochondrial matrix. Interestingly, these trends 
coincided with significant increases in PGC1α (figure 4-7), a transcriptional cofactor, 
intimately linked to regulation of energy metabolism, including mitochondrial 
biogenesis and the detoxification of ROS (St-Pierre et al., 2002; St-Pierre et al., 
2003; Valle et al., 2005). In 12-month PolgAmut/mut mice, PGC1α was shown to be 
significant when compared to age matched WT and PolgA+/mut mice and 3-6 month 







































































































 mice expressed as relative level of transcriptional 
difference (RLTD) expressed as a mean fold change ± SEM.  
 
 (A) mRNA gene expression levels of glutathione synthase (GSS) (B) mRNA gene expression 
levels of glutathione peroxidase (GPX) (C) mRNA gene expression levels of superoxide 





 mice.  
Figure 4-7 (right): mRNA 
















4.7 Measurement of NAD+/NADH by luciferase reporter 
Previous findings indicate that elevated levels of NADH (nicotinamide adenine 
dinucleotide) and thus augmented NAD+/NADH ratios can delay the proliferative cell 
cycle and induce senescence (Wiley et al., 2016). Given the catalytic oxidoreductase 
function of complex I in reducing NADH, NAD+ and NADH levels were measured via 
using the NAD-NADH-GloTM luciferase reporter assay kit (Promega) to determine if 
respiratory deficiency in PolgAmut/mut mouse liver altered these levels when compared 
to WTs (figure 4-8). No differences were detected in individual NAD+ and NADH 
levels between both compared genotypes and ages in whole liver tissues (figure 4-8, 
A,B). Similarly, when comparing NAD+/NADH ratios levels between WTs and 
PolgAmut/mut livers, no age-associated alterations were observed (figure 4-8, C). 
Surprisingly, reductions in basal hepatocellular turnover were not associated with 
NAD+/NADH control of cell cycle.  
  
Figure 4-8: NAD+ and NADH 
levels measured in young (3 






(A) NAD+ and (B) NADH whole 
liver levels  determined from 
standard by NAD/NADH luciferase 
reporter assay kit. (C) NAD/NADH+ 
ratios  determined from WT and 
PolgA
mut/mut
 livers. n=3-4 for WT 
and PolgAmut/mut mice.  
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4.8 Characterisation of the effect of the PolgA mutation in hepatocytes 
  
4.8.1 Characterisation of primary hepatocyte proliferation 
The liver parenchyma is principally composed of hepatocytes, in addition to bile 
conduits and biliary epithelial cells, whereby hepatocellular proliferation is proposed 
to undergo a combination of hypertrophy and hyperplasia to maintain cellular mass - 
dependent on the mode of injury. To test whether basal age-associated proliferative 
defects observed in whole liver tissues was a hepatocyte defect, hepatocytes were 
isolated from young (3-4 month) and old (9-12 month) WT, PolgA+/mut and 
PolgAmut/mut livers. Once isolated, primary hepatocytes were allowed to adhere to 
plastic before phenotypic characterisation was analysed in response to proliferative 
signals. The proliferation of cultured hepatocytes was analysed by BrdU assay: 
normalised to total protein content and assessed as a fold change compared to WT 
controls. In response to increasing concentrations of mitogenic factor EGF, old 
PolgAmut/mut mice showed trending reductions in proliferative response when 
compared to WT and PolgA+/mut counterparts; in young hepatocytes across all 
genotypes, no differences were observed (figure 4-9, B-C). To ensure these 
observations were not due to altered or decreased viability a resazurin-based alamar 
Blue assay was used; no differences were detected between WT, PolgA+/mut and 
PolgAmut/mut hepatocytes at young and old ages (figure 4-9, D-E). No differences were 
also observed in levels of cell death marker lactate dehydrogenase (LDH), following 
initial LDH release due to stresses of hepatocyte isolation methods (figure 4-9, E-F). 
Instead, observations of photomicrographs show that at both 3-4 and 9-12 months of 
age, PolgAmut/mut hepatocytes show a reduced ability to adhere to the culture flask 
surface (figure 4-9, A), with 9-12 month PolgAmut/mut hepatocytes looking increasingly 
stressed under culture conditions at 24 hours. Hepatocytes isolated from WT, 
PolgA+/mut and PolgAmut/mut mice exhibited comparable levels of viability once they 
have adhered to plastic at both 3 months and 12 months; however, PolgAmut/mut 
hepatocytes failed to initially adhere and thrive - perhaps due to the greater presence 
of mitochondrial respiratory deficiency in these mice.  
 
Subsequently, to further characterise and confirm respiratory deficiency within the 
liver and specifically hepatocytes, protein expression was also analysed in isolated 
primary hepatocytes via western blot. Direct comparisons were made between young 
and old hepatocytes across all genotypes and found NDUFB8 to have reduced 
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expression in both PolgA mice groups (figure 4-10). Coinciding with whole liver tissue 
analysis, our results show reduced hepatocellular proliferation specifically coincided 
with complex I mitochondrial deficiency. Reduced NDUFB8 expression was also 
observed in 9-12 month old PolgAmut/mut hepatocytes. No differences by western blot 
were observed for other ETC complexes, between genotypes and between ages.  
  
     
Figure 4-9A: Representative photomicrographs of hepatocytes isolated from PolgA WT, PolgA+/mut and 
PolgAmut/mut mice. 
 
(A) Representative photomicrographs of cultured hepatocytes isolated from 3-4 month and 9-12 month WT 
and PolgA mice. Hepatocytes were allowed to adhere for 6 hours, washed and then left for a further 24 hours 
untreated or stimulated with varying concentrations of epithelial growth factor (EGF) to measure proliferation. 
N=4 per genotype.  
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Figures 4-9B to 4-9E: Proliferative and viability assays in isolated hepatocytes from WT, PolgA+/mut 
and PolgAmut/mut mice. 
 
Isolated PolgA WT, PolgA+/mut and PolgAmut/mut hepatocytes were allowed to adhere for 6 hours, washed 
and then left for a further 24 hours untreated or stimulated with varying concentrations of epithelial growth 
factor (EGF) to measure proliferation via (B-C) BrdU proliferation assay. Cell viability and death of 
hepatocytes were confirmed via (D-E) Alamar Blue and (F-G) lactate dehydrogenase; LDH assay. N=4 for 
WTs, PolgA+/mut and PolgAmut/mut mice.  
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Figure 4-10: Western blot detection of complex I (NDUFB8), complex II (SDHB), complex III (UQCRC2), 
complex IV (Mt-CO1) and complex V (ATPB) in hepatocytes isolated from young (3 month) and old (12 
month) WT, PolgA+/mut and PolgAmut/mut mice livers. 






































4.8.2 Characterisation of primary hepatocyte apoptosis  
In the presence of increased levels of mtDNA mutations, the inability for cultured 
primary hepatocytes to survive and proliferate could be due to an increase in 
apoptotic signalling. Mitochondria are known to have an integral role in arbitrating 
apoptosis, with the presence of mtDNA mutations thought to increase cell death via 
reduced mitochondrial membrane potential that induces dysfunctional release of 
proapoptotic intermembrane space proteins (Hiona et al., 2010). To characterise 
whether hepatic mtDNA mutations skew signalling towards a proapoptotic phenotype 
and consequently diminish hepatocellular survival and proliferation, mRNA 
expression levels of apoptotic proteins were measured in freshly isolated (T0) 
primary hepatocytes.  Quantification of mRNA gene expression levels show specific 
trends of augmented proapoptotic Bax protein in both PolgAmut/mut and PolgA+/mut 
mice (figure 4-11, C). Comparisons made between genotypes revealed trends of 
increased levels in old hepatocytes, specifically with greatest expression observed in 
hepatocytes from old PolgAmut/mut mice. Anti-apoptotic protein BclXL by contrast is 
significantly reduced in the presence of mtDNA mutations and specifically in old 
hepatocytes (figure 4-11, A). Similar trends were observed for anti-apoptotic Bcl-2, 
but was only significant when comparing young WT and PolgAmut/mut hepatocyte 
mRNA expression (figure 3-11B). Coinciding with this, no obvious changes were 
shown in proapoptotic Bid gene expression, in which its truncation is shown to play 




Figure 4-11 mRNA expression of pro- and anti-apoptotic genes in freshly isolated (T0) hepatocytes. 
 
(A-B) Anti-apoptotic genes BCLxL and BCL-2 expression in young (3-4 month) and old (9-12) month 
hepatocytes isolated from WT, PolgA+/mut and PolgAmut/mut mice livers, as well as quantification of gene 
expression for (C) proapoptotic BAX and (D) Bid genes in the presence of mitochondrial dysfunction. All P 





4.9 Characterisation of inflammation in PolgA aged livers 
A pervasive feature of normal ageing is inflammageing, a term coined to reflect age-
related inflammation, typically encompassing chronic and dysfunctional immune cell 
signalling. Mitochondria are recognised to play a proinflammatory role that ranges 
from the activation of the NLRP3 inflammasomes and proinflammatory pathway by 
mitochondrially-derived DAMPs to intermediary ROS signalling. Mitochondria are a 
major source of ROS, implicated in ageing as well as a secondary messenger in 
inflammatory signalling and the subsequent expression of proinflammatory cytokines 
largely by augmented NF-κB signalling (Ichimura et al., 2003; Amma et al., 2005; 
Zhou et al., 2011; Jurk et al., 2014). The observed basal proliferative defects and 
increased apoptosis in PolgAmut/mut hepatocytes could therefore be a consequence of 
ROS and oxidative stress, with ROS implicated in the suppression of cell cycle entry 
following checkpoints (Shackelford et al., 2000). The increase in in vivo mitochondrial 
ROS within PolgAmut/mut  is also notably implicated in the activation of 
proinflammatory and apoptotic signalling pathways (Dai et al., 2010; Logan et al., 
2014). Accordingly, exposure of cells to hydrogen peroxide (H2O2) has been linked to 
the cell cycle arrest via cyclin D1 targeting (Burch and Heintz, 2005; Pyo et al., 
2013).  
 
Taken together, previous work could collectively hypothesise the presence of 
mitochondrial respiratory function to diminish cell proliferation via oxidative signalling. 
The aim of the following section is to therefore determine if the presence of mtDNA 
mutations alters proinflammatory signalling and ROS, and reduces PolgA 
hepatocytes capacity for hepatocellular proliferation. 
  
4.9.1 MtDNA mutations cause increased lymphopenia in ageing PolgA 
livers   
Common to the feature of ageing are alterations to inflammatory signalling, in which 
chronic low-grade systemic inflammageing is observed. To test whether the presence 
of mtDNA mutations altered inflammatory infiltration in the ageing liver, tissue 
sections were stained for inflammatory markers. Staining with CD45R and CD3 found 
inflammatory infiltrate of respective B and T cell lymphocytes to be significantly 
reduced  in PolgAmut/mut mice at 9 months (p<0.001) and 12 months of age (p<0.001) 
(figure 4-12, figure 4-13). Diminished T cell levels were also observed in PolgAmut/mut 
at 6 months (p<0.001), though this followed a significant initial increase when 
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compared to WTs at 3 months of age (p<0.001). Similar significance was observed 
for CD45R stained B cells, whereby elevations in 3 and 6-month PolgAmut/mut mice 
were subsequently followed by T cell lymphopenia (figure 4-13). A stain for monocyte 
and macrophages marker CD68 showed levels to increase at older age in WT mice; 
however, such significant increases were not observed in older PolgA+/mut and 
PolgAmut/mut livers (figure 4-14). Interestingly, analysis of CD68 staining in PolgA mice 
demonstrates highly significant increases in monocyte/macrophage infiltration at 
younger ages when compared to WTs – remaining relatively constant at old age.  
 
4.9.2 MtDNA mutations cause increased neutrophilia in PolgAmut/mut 
livers  
Livers of PolgAmut/mut mice had considerable immune cell infiltration, with tissue 
staining demonstrating the infiltrate to be predominantly neutrophils, found within the 
liver in greater numbers than WT and PolgA+/mut mice (figure 4-15). Indeed, in 
manifestations of liver disease, inappropriate activation and homing of neutrophils to 
the liver is observed, secondary to altered wound healing processes (Theilgaard-
Monch et al., 2004). Therefore to understand whether mtDNA mutations promote 
proinflammatory signalling, quantification of cytokine mRNA expression was 
undertaken in homogenised whole liver tissue (figure 4-15) from all groups for 
cytokines CXCL2, TNFα and IL-6: proinflammatory signals known to be chemotactic 





Figure 4-12: Analysis of CD3 
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 mice livers at 3, 6, 9 and 
12 months of age. Positive cells 
were counted in 15 fields at x20 
magnification. All p values 
calculated using a two-way ANOVA. 
*p=0.05, *** p-0.001. n=3-7 for WTs, 












































       
Figure 4-13: Analysis of 
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 mice. Bars 100 µm. 
(B) Quantification of CD45R 
positively stained in WT, 
PolgA+/mut and PolgAmut/mut mice  
livers. Positive cells were 
counted in 15 fields at x20 
magnification. All p values 
calculated using a two-way 
ANOVA., *** p=0.001. n=3-7 for 
WTs, n=5 for PolgA+/mut and n=3-




Figure 4-14: Analysis of CD68 
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livers at 3, 6, 9 and 12 months of 
age. Positive cells were counted 
in 15 fields at x20 magnification. 
All p values calculated using a 
two-way ANOVA. **p=0.01, *** 
p=0.001. n=3-7 for WTs, n=5 for 





Figure 4-15: Analysis of 
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Figure 4-16: Analysis of mRNA gene 
expression for proinflammatory 







mRNA expression of (A) calmodulin S100A9 
(B) TNFα; (C) CXCL2; (D) IL-6 and (E) 
MCP-1 in PolgA WT, PolgA+/mut and 
PolgAmut/mut mice livers. All p values 
calculated using a two-way ANOVA *p=0.05, 
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4.9.3 Serum detection of proinflammatory cytokines 
Inflammatory homing to the liver was additionally investigated using MSD multiplex 
ELISA to detect serum chemotactic factors in WT, PolgA+/mut and PolgAmut/mut female 
mice. Coinciding with mRNA expression trends, sera assayed from 3 and 12-month 
mice found significantly elevated levels of TNFα in older PolgAmut/mut mice (n=4) when 
compared to WTs (p<0.05, n=5) and PolgA+/mut mice (p<0.05, n=4) (figure 4-17, A). A 
similar finding was observed for IL-6 (figure 4-17, B), with the greatest increase in IL-
6 concentration demonstrated between older WT and PolgAmut/mut mice (p<0.001), in 
addition to differences noted between sera of 12-month PolgA+/mut and PolgAmut/mut 
groups (p<0.01). Interestingly, despite previous low levels of CD3 and CD45R 
staining, increased protein concentrations for lymphocyte chemotactic factor IL-2, 
were also found in older PolgAmut/mut mice (figure 4-17, C). Further examination of 
cytokine protein levels between ageing cohorts, additionally demonstrated increased 
levels for IL-6 and IL-2 in both PolgAmut/mut groups, which taken together, may 
indicate presence and accumulation of mtDNA mutations with age to skew 
inflammatory signalling. No differences were observed for chemokines KC, IL-1β, 







Figure 4-17: Analysis of proinflammatory cytokine 
protein levels in serum taken from  young (3-4 







Protein concentrations of proinflammatory cytokines (A) 
TNFα; (B) IL-6; (C) IFNγ; (D) IL-2 (E) IL-1β; (F) KC-
GROα; (G) IL-4; (H) IL-; (H) IL-5; (I) IL-10; and (J) IL-
12p70. All p values were calculated using a two-way 
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4.10.1 Phenotypic characterisation of neutrophils 
The liver harbours a diverse range of immune cells that play an integral role in 
mediating tolerance to self-antigens, as well as typical host defence mechanisms 
against invading pathogens. Within the steady state liver, neutrophils have relatively 
low abundance, participating in the clearance of cell debris and initiation of tissue 
repair/wound healing processes during sterile tissue injury. Interestingly, following the 
experimental depletion of neutrophils, diminished post-PHx parenchymal restoration 
is seen as a result of reduced ICAM-1-dependent activation of Kupffer macrophages 
(Selzner et al., 2003). Therefore, to test whether increased homing of neutrophils to 
the PolgAmut/mut liver was a cell inherent defect, neutrophils from young murine bone 
marrow were isolated and phenotypically characterised. Responding to chemotactic 
factors platelet activating factor (PAF) and N-formylmethionyl-leucyl-phenylalanine 
(FMLP), neutrophils from PolgAmut/mut mice were found to have trends of increased 
chemotaxis over other control groups (figure 4-18, A), though this failed to reach 
significance. Therefore, no firm conclusion can be made with regards to augmented 
chemotactic function in the presence of mtDNA mutations. However, isolated 
PolgAmut/mut neutrophils did observe significantly greater uptake of zymogen particles 
when analysing phagocytic function in relation to the clearance of tissue debris 














(A) Distance travelled (µM) by bone marrow isolated neutrophils in response to FMLP and PAF stimulation. 




 mice. Uptake 
of two or more zymogen particles was considered positive for neutrophil phagocytosis neutrophils, arrows 
show examples of phagocytosed zymogens. Positive cells were counted in 10 fields at x10 magnification 





 mice in all functional assays. 
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4.10.2 Quantification of neutrophil reactive oxygen species 
Sterile inflammageing and age-related chronic pathologies are characterised by the 
dysfunctional and low-grade excess release of ROS and proinflammatory cytokines, 
of which neutrophils are amongst suggested key effectors (Ogawa et al., 2008). 
Indeed, an inherent neutrophil function is the production of superoxide and other 
ROS following NAPDH oxidase (NOX2)-dependent phagocytosis, as well neutrophil 
extracellular traps (NETs) production. NETs are an extrusion of DNA and granular 
proteins that induce proinflammatory clearance of pathogens and potential self-
antigens, and for which ROS and oxidised mtDNA are important mediators (Zhang et 
al., 2015; Wang, 2018). Consequently, with age, it suggested that neutrophils may 
contribute to the inflammageing phenotype with failure to clear aged neutrophils 
resulting in increased NET and ROS production from such cells (Zhang et al., 2015). 
It was therefore hypothesised that irregular presence and increased numbers of 
neutrophils in PolgAmut/mut livers may contribute to hepatocellular ageing and 
proinflammatory phenotype through increased ROS production. To test this, 
neutrophils from young (3-4 month) and old (11-12 month) WT, PolgA+/mut and 
PolgAmut/mut mice were isolated from blood and livers and stained fluorogenically for 
ROS during basal and activated states. Of the 100,000 events measured by flow 
cytometry, it was found that in 3-4 month blood, fewer neutrophils were present 
basally in PolgAmut/mut and PolgA+/mut mice when compared to WT controls and 
comprised relatively similar levels of ROS - an observation more pronounced with 
age but failing to reach significance (figure 4-19, A-C). Counts of unstimulated 
neutrophils and their ROS content were also increased in 11-12 month PolgAmut/mut 
livers when compared to WT controls (figure 4-20, A-C). When activated with PAF 
and FMLP, hepatic neutrophil counts increased and induced a greater release of 
ROS in PolgAmut/mut livers at 11-12 months of age (figure 4-20, A-C), a change not 
observed in 3-4 month livers. Similarly, greater ROS levels were detected on 
activation in blood PolgAmut/mut neutrophils (figure 4-19, B, C). Between the aged 
cohorts, notable increases in 3-4 month PolgAmut/mut counts coincided lower levels of 
ROS, whereas lesser PolgAmut/mut blood neutrophils at 11-12 months released a 
greater amount of ROS when compared to WTs. For PolgA+/mut neutrophils in both 
tissues and age groups a gene-dose effect was observed; however, when analysing 
DHR staining, ROS levels were often detected to be higher than that released from 
PolgAmut/mut mice.   
119  
  
   




 neutrophils isolated 
from blood.  





 mice blood. (B-C) Measurement of ROS release from blood isolated 
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neutrophils via detection of DHR expressed as median fluorescent intensity. All p values calculated 









The presence of somatic mtDNA mutations appears to have correlative links to 
cellular proliferation within the liver. Both PolgA+/mut and PolgAmut/mut mice displayed 
significant gene-dose reductions in PCNA between 9 and 12 months when compared 
to WTs, an observed trend also seen in PolgAmut/mut mice hepatocytes during EGF 
stimulation causing DNA synthesis. Although PolgA+/mut and PolgAmut/mut livers 
appeared histologically normal, trends of increased mitochondrial respiratory 
deficiency observed by COX/SDH staining was demonstrated in PolgAmut/mut mice 
and was significant at older age. It would also appear that qualitatively, deficiency 
occurs in normal WT ageing, though this was not statistically significant. Further 
qualitative examination found deficiency to predominantly occur around the portal 
vein and to extend with age towards the pericentral zones, which may be due to 
clonal expansion of mtDNA mutations. Previous work investigating normal human 
hepatic homeostasis displays clonal populations originating periportally, which then 
undergo unidirectional flux in a hypothesised ‘streaming liver’ manner (Fellous et al., 
2009). Here deficient hepatocytes were found to increase in frequency with age, in 
line with previous PolgA mice studies (Trifunovic et al., 2004; Kujoth et al., 2005). 
However, no differences were observed in the levels of COX deficiency between 
young and old PolgAmut/mut mice: perhaps ascribed to possibility that the level of 
respiratory deficient hepatic cells is within the tolerance level and does not 
demonstrate an observable phenotype in PolgAmut/mut mice. Subsequently, onset may 
be ascribed to accumulation and the exacerbation of inflammation and apoptosis that 
in turn results in an observable reduction in hepatocellular turnover within the ageing 
liver.  
 
Analysis of ETC complexes confirmed mitochondrial respiratory dysfunction. 
However, although staining was indicative of mitochondrial COX dysfunction, 
complex IV (Mt-CO1) protein expression was not downregulated in liver and 
hepatocytes. Whilst these results cannot exclude the possibility of complex IV loss of 
protein functionality, instead analysis of specific ETC complexes found that in 
PolgAmut/mut mice deficiencies observed were specific for complex I (NDUFB8) across 
all ages in both hepatocytes and whole liver, indicating a possible link between 
complex I respiratory dysfunction and reduced hepatocellular turnover. Indeed, in 
other work, reduction of complex I by pharmacological inhibition is found to halt cell 
proliferation via induction of G2/M cell cycle arrest as well as provoke apoptosis 
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(Srivastava and Panda, 2007). Similarly, it was found that hepatocyte cell death was 
markedly increased in PolgAmut/mut mice when compared to other groups and 
previous findings (Kujoth et al., 2005). In spite of the altered complex I expression, it 
was found that reduced basal hepatocellular turnover in PolgAmut/mut mice was not 
linked to altered NAD+/NADH ratios, at least utilising the assays available to do so. 
Despite this, alterations in PGC1α within aged PolgAmut/mut mice was observed, in 
which changes to the redox balance of NAD+/NADH is noted to regulate its 
transcriptional activity via metabolic sensor SIRT1. Although extensively described as 
a master regulator of mitochondrial biogenesis, the present data cannot conclusively 
correlate increased PGC1α gene expression with such a role due to the absence of 
upregulated protein expression of mitochondrial complexes during western blot. Such 
observations, however, may be ascribed to additional transcriptional and post-
translational targets of PCG1α, including the regulation of ROS-detoxifying enzymes 
(St-Pierre et al., 2002; St-Pierre et al., 2003; Valle et al., 2005). Indeed, the present 
study shows increased mRNA expression of ROS scavenger SOD2 with age as well 
as reductions in anti-oxidants GSS and GPx. In turn, PGC1α is shown to be induced 
by oxidative stress.  It is therefore possible that respiratory-associated reductions in 
cellular proliferation and redox alterations could be allied to mitochondrially-driven 
oxidative stress, though further work such quantifying ROS within the liver and 
determining cell cycle markers would be required to confirm and elucidate this. 
Although interesting, the mutation load of mtDNA in liver was not investigated further 
to determine thresholds required for the observed phenotypes.   
 
Analysis of neutrophils confirmed greater numbers within the PolgAmut/mut liver at old 
age when compared to WT controls, both basally and when activated, which may be 
in part due to increased neutrophil priming, recruitment and sensitivity to activation. 
Although failing to reach significance, functional analysis of PolgAmut/mut neutrophils 
show amplified ability for chemotaxis, which was not further explored in older ages. 
The role of oxidative stress and signalling is also unclear, with isolated aged liver 
PolgAmut/mut neutrophils showing increased basal levels of ROS, thus raising the 
question as to whether neutrophils are initially recruited due to excess ROS signalling 
by liver resident immune cells and/or recruited neutrophils are the source of excess 
oxidative stress signalling. Both would appear plausible, with initial increases in 
CD68 positive monocytes and macrophages seen at 3 to 6 months PolgAmut/mut mice, 
whilst higher basal PolgAmut/mut neutrophil ROS levels further augment on activation. 
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Taken together, these observations suggest the presence of mitochondrial 
dysfunction promotes the proinflammatory recruitment of neutrophils to the liver. 
These neutrophils are basally more primed for recruitment and galvanisation than 
WTs and release more ROS when stimulated. Heightened activation may also 
explain the increased gene-dose dependent phagocytic activity observed in PolgA 
mice. Indeed, it is understood that in the presence of sterile tissue injury, sustained 
neutrophil recruitment and activation can lead to chronic inflammation and impaired 
tissue recovery, as well as have some clinical relevance to inflammation in normally 
aged subjects (Meyer et al., 1998; Ogawa et al., 2008; de Oliveira et al., 2016).  
Recruitment could be alluded to the dysregulated stimulation of immune cell 
signalling due to mitochondrial dysfunction, in which downstream production of 
cytokines are chemotactic for neutrophils. Specifically, in relation to PolgAmut/mut mice, 
it has been previously shown that significant increases in in vivo ROS due to age-
accumulated mitochondrial dysfunction induces activation of pro-apoptotic and 
proinflammatory pathways (Logan et al., 2014). Therefore, taken together with the 
present changes in SOD2, it is therefore likely that the observable proinflammatory 
phenotype in aged PolgAmut/mut mice is ascribed to accumulation of mitochondrial 
dysfunction and resultant exacerbated ROS. In turn, inciting via oxidant-inflammatory 
signalling pathways, neutrophil recruitment. 
 
With previous work noting the importance of immune cells in liver homeostasis, it is 
also possible that altered inflammatory signalling in the presence of mitochondrial 
dysfunction could contribute to the basal proliferative phenotype within the liver 
(Moiseeva et al., 2009; Jiang and Torok, 2013; Jiang et al., 2013). However, with 
aged hepatocytes showing trends of reduced proliferative response in culture, any 
contribution of immune cells in reducing hepatocellular turnover is likely to be 
secondary. Alternatively, it is possible that inflammation could be an inducer of 
mitochondrial dysfunction, though this avenue was not explored. Consequently, 
further work to explore whether the presence of complex I deficiency affects 
hepatocyte proliferation using models of regeneration in subsequent chapters, will be 








































































































































4.13 Chapter 4 Key Summary Points 
  
• COX/SDH staining and reduced protein expression of complex I NDUFB8 
indicates mitochondrial respiratory dysfunction to increase with age in 
PolgAmut/mut mice, which in turn may be correlated with reduced PolgAmut/mut 
hepatocyte proliferative capacity and basal hepatocellular turnover.  
  
• Decreased GSS and GPX, as well as increases in SOD2 expression was 
observed in ageing PolgAmut/mut mice, in which loss of hepatocellular turnover 
may be ascribed to exacerbated ROS signalling and possible subsequent 
oxidative damage to the liver tissue. 
 
• PolgAmut/mut mice demonstrate changes in immune cell homeostasis with age. 
Mitochondrial respiratory dysfunction appears to induce a neutrophilic pro-
inflammatory environment as seen via increased NIMP positive neutrophils 
and increased detection of cytokines chemotactic for neutrophils. 
  
• Previous studies show ROS to be a potent activator of the innate immune 
response, whilst exacerbated neutrophil recruitment hinders tissue recovery. 
Increased mitochondrial respiratory dysfunction may therefore increase ROS-
induced neutrophil activation, which in turn may reduce hepatocellular 
proliferation in ageing PolgAmut/mut mice. Aged neutrophils appear to be basally 
‘more primed’ for activation, releasing more ROS basally and are functionally 
more active, as indicated by greater phagocytosis.  
 
• Caspase-3 positive hepatocytes and reduced expression of anti-apoptotic 
genes suggests that the presence of mitochondrial dysfunction also induces 
greater apoptosis with age. 
 
• Absence of reduced hepatocellular turnover in 3-month PolgAmut/mut and 
PolgA+/mut mice, despite some mitochondrial respiratory dysfunction, may be 
due to the ability for these hepatocytes to tolerate the level of mitochondrial 
respiratory dysfunction present. Onset of reduced basal hepatocellular 
turnover may be therefore ascribed to much greater levels of mtDNA 
mutations with age and the exacerbation of aberrant inflammatory, ROS and 






Chapter 5 | Investigating the Role of Mitochondrial Dysfunction and 
Ageing on Liver Regeneration 
 
5.1 Introduction  
To further assess the implications of defective basal hepatocellular proliferation 
within ageing respiratory chain deficient PolgAmut/mut mice, the surgical model 
incorporating two-thirds (70%) partial hepatectomy (PHx) was undertaken. As 
proliferation of existing hepatocytes is key to hyperplasic and hypertrophic 
regenerative mechanisms and since the progeroid ageing phenotype in PolgAmut/mut 
mice is correlated with accumulated mitochondrial respiratory chain dysfunction over 
time, partial hepatectomy (PHx) studies were carried out on aged WT and 
PolgAmut/mut mice to assess the role of mitochondrial respiratory chain dysfunction on 
‘ageing’ liver regeneration. Aberrant hepatocellular proliferation is also associated 
with ageing, with age-associated changes including a basal reduction in liver volume, 
decreased hepatocyte cell numbers and increased hypertrophy and more 
specifically, diminished hepatic mitochondrial density and alterations to the 
mitochondrial ultrastructure observed (Tauchi and Sato, 1968; Ferri et al., 2005; Frith 
et al., 2008). Diminished liver function as measured by liver clearance and phase I 
pharmakokinetics is additionally noted in the ageing liver; however, is often less well 
documented, due to compensatory mechanisms of the liver that include regeneration 
(Schmucker, 2005; Schmucker and Sanchez, 2011). More clinically relevant is the 
significant decline in hepatocyte survival following PHx intervention, ascribed to 
reduced capacity in hepatocellular proliferative mechanisms: including reduction in 
hepatocyte cell cycle entry, reduced expression of hepatocellular proliferative factors 
and diminished regenerative signalling (Bucher and Swaffield, 1964; Stocker and 
Heine, 1971; Miyaoka and Miyajima, 2013; Enkhbold et al., 2015) . In the previous 
chapter, hepatoproliferative defects observed in the aged PolgAmut/mut mice were due 
to an age-associated accumulation of mitochondrial respiratory dysfunction. 
Therefore, to assess active liver regeneration with age, PHx surgery removing 70% 
of the liver mass was performed in PolgA+/mut and PolgAmut/mut mice at 3 and 6 
months of age. 
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5.2  Aims 
To further assess the implications of mitochondrial dysfunction within PolgA+/mut 
heterozygous and PolgAmut/mut mice, in the context of ageing liver regeneration, 
parenchymal recovery was assessed using the classical 70% PHx model. 
Characterisation of hepatocellular regeneration in the presence of mitochondrial 
respiratory chain deficiency was undertaken in the present study to:  
 
1. Determine if the presence of mitochondrial respiratory chain dysfunction in the 
PolgA+/mut and PolgAmut/mut mice alters hepatocellular regeneration post-PHx in 
both young (3 month) and aged (6 month) mice. 
 
2. Assess whether age-associated accumulations of mitochondrial respiratory 
chain dysfunction diminishes post-surgical parenchymal recovery in 6 month 
old PolgA+/mut and PolgAmut/mut mice when compared to 3 month controls. 
 
5.3  Partial hepatectomy 
Resection of the liver or “partial hepatectomy” is understood to be the most classical 
model of synchronous liver regeneration involving surgical removal of the liver’s 
medial and left lateral lobes that equates to 70% of liver mass (Higgins, 1931). Here, 
removal of liver tissue gives rise to parenchymal recovery of the liver, predominantly 
by means of hepatocellular hypertrophic and hyperplasic mechanisms that 
compensate for the loss of hepatocyte cell numbers and function - the process of 
which involves a complex plethora of growth factors and inflammatory cytokines 
acting in concert across priming, proliferation and termination of regenerative phases 
to regulate cellular regrowth and liver size post-injury. Primed by cytokines and 
complement factors secreted by activated inflammatory cells like Kupffer cells, post-
PHx liver regeneration begins with rapid entry of quiescent G0 hepatocytes into the 
G1 phase of cell cycle and by ~24 hours post-surgery, the ‘S phase’ peak in DNA 
synthesis occurs (Michalopoulos and DeFrances, 1997; Miyaoka et al., 2012; 
Miyaoka and Miyajima, 2013). By ~3 days, the majority of hepatocellular proliferation 
and parenchymal hyperplasia by means of G1 phase transition into mitotic division 
occurs, carefully mediated by mitogenic factors such as hepatocyte growth factor 
(HGF) and epithelial growth factor (EGF). Finally, once 2.5 times the normal liver to 
body weight ratio is restored, entry into the termination phase of liver regeneration 
occurs, with induction of growth arrest regulated predominantly by tumour necrosis 
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factor (TGF)β and interleukin 1β (IL-1β) signalling (Tao et al., 2017). Within 5-7 days 
parenchymal recovery of mass is largely completed, closely followed by a wave of 
regeneration from non-parenchymal cells; 7-10 days post-PHx, the majority of lost 
cellular mass (93%) is recovered and by 20 days, liver volume pre-PHx is fully 
regained (Michalopoulos and DeFrances, 1997; Miyaoka et al., 2012). By contrast, 
30% PHx induces hepatic tissue recovery chiefly by sole means of hepatocellular 
hypertrophy (Miyaoka et al., 2012). The present study was therefore undertaken to 
determine if age-associated accumulation of mitochondrial respiratory chain 
dysfunction in PolgA+/mut and PolgAmut/mut mice alters hepatocellular regeneration 
following 70% partial liver resection.  
 
5.4 Regenerative response in WT, PolgA+/mut and PolgAmut/mut mice following  
partial hepatectomy 
  
5.4.1 Presence of mitochondrial respiratory dysfunction reduces 
survival following partial liver resection in aged PolgAmut/mut mice 
Presence of complex I respiratory deficiency, as demonstrated in PolgAmut/mut mice, 
appears to be correlated with defective hepatocellular proliferation and survival both 
basally with age and when hepatocytes are stimulated for DNA synthesis. It was 
therefore hypothesised that ageing PolgAmut/mut mice would have aberrant liver 
regeneration. Utilising PHx in WT, PolgA+/mut and PolgAmut/mut mice at 3 and 6 months 
of age to determine this effect, mice were initially grouped into post-operative 
survivors and non-survivors. PHx survivors were determined as post-surgical mice at 
48 or 72 hours (time points were determined by peak regenerative markers 
measured following PHx in 8-week WT mice; appendix IV), whilst non-survivors 
determined as those sacrificed ahead of the set timepoints due to welfare concerns. 
Here it was found that following surgery at 3 months, all genotypes thrived till their 
given time points, achieving 100% survival; yet when aged to 6 months, survival in 
PolgA+/mut PHx mice was lowered to 90.1% and in PolgAmut/mut mice 70% (figure 5-1, 
table 5-1). 100% survival was also observed in 6-month WTs, therefore indicating 
that age-associated presence of mitochondrial dysfunction seen in 6-month 

















     
Figure 5-1: Survival following partial hepatectomy (PHx); Table 5-1: Surviving and non-surviving 6-
month WT, PolgA+/mut and PolgAmut/mut mice following PHx.  
 




 mice, expressed as a percentage of 
total PHx surgeries undertaken. 3-month WT (n=10), PolgA
+/mut
 (n=10) and PolgA
mut/mut
 (n=8) observed 100% 
survival whilst the percentage survival was reduced to ~91% and 70% in 6-month PolgA
+/mut
 (n=11) and 
PolgA
mut/mut
 (n=10). Dichotomy of 6-month data into number of survivors and non-survivors for each genotype 
is shown in table 5-1 (above).   
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5.4.2 Regenerative capacity of the liver is reduced in the presence of 
mitochondrial respiratory dysfunction and with age 
It is established that following two-thirds liver resection, recovery of lost liver cell 
mass by means of hyperplasic and hypertrophic mechanisms occurs from pre-
existing hepatocytes, subsequently returning to homeostatic levels over time by 
apoptotic removal of generated excess cells (Miyaoka et al., 2012). As such, when 
testing by means of liver to body weight ratios whether the presence of mitochondrial 
respiratory dysfunction affects parenchymal recovery post-PHx, no significant 
difference between WT, PolgA+/mut and PolgAmut/mut mice in naïve (median 
laparotomy only) and hepatectomised groups at 3 months of age was observed 
(figure 5-2, A). Similarly, in 6-month WT and PolgA+/mut mice, liver to body weight 
ratios of the liver remnant increased with time – reaching statistical significance in 72-
hour post-PHx WT mice when compared to naïve laparotomy only controls (figure 5-
2, B). No changes were observed in 6-month PolgAmut/mut mice, perhaps ascribed to 
much lower body weights (figure 5-2, C-D), however they did appear to have initially 
larger livers than other naïve groups. Alternative measures by means of total liver 
weights were otherwise assessed, noting no significant changes between genotypes 
in 3-month mice (figure 5-3, A). However, when comparing each 3-month genotype 
to their naïve controls, significantly increased liver weights were observed post-PHx 
at 48 hours post-PHx in PolgAmut/mut mice, as well as at 72 hours in both PolgA+/mut 
and PolgAmut/mut cohorts. Corresponding to liver to body weight ratios, 6-month naïve 
PolgAmut/mut liver weights were also significantly elevated in comparison to WT and 
PolgA+/mut mice - these findings indicating initial hepatic enlargement (figure 5-3, B). 
Subsequently, PHx surgery was shown to increase liver mass in WT and PolgA+/mut 
mice, reaching significance at 72 hours post-PHx; yet, by contrast in PolgAmut/mut 
livers, hepatic mass was shown to significantly reduce 48-72 hours post-surgery. 















































































































































Figure 5-2: Liver to body weight ratios in WT and in the presence of mitochondrial respiratory 
dysfunction following partial hepatectomy (PHx). 
 
(A-B) Liver to body weight ratios taken from naïve (median laparotomy only) and 70% PHx WT, PolgA+/mut and 
PolgAmut/mut mice at 3 and 6 months of age. Ratios expressed as a proportion of total liver weight at 48 and 72 
hours post-PHx to body weight at surgery. N=5 per WT and PolgA+/mut naïve and PHx groups, n=3 per 
PolgAmut/mut naïve and PHx groups. All p values were calculated using a two-way ANOVA *p=0.05, *** 






















































 mice.  
 
 (A) Total liver weights are shown for 3-month WT, PolgA+/mut and PolgAmut/mut naïve and PHx mice. a denotes 
p<0.05 between naïve and 48 hour post-PHx PolgAmut/mut mice; b denotes p<0.05 between naïve and 72 hour 
post-PHx heterozygous PolgA+/mut mice; c denotes p<0.01 between naïve and 72 hour post-PHx PolgAmut/mut 
mice. N=5 per WT and PolgA+/mut naïve and PHx groups, n=3 per PolgAmut/mut naïve and PHx groups. 
 
(B) Total liver weights are shown for 6-month WT, PolgA+/mut and PolgAmut/mut naïve and PHx mice. a denotes 
p<0.001 between naïve WT and PolgA+/mut to PolgAmut/mut mice; b denotes p<0.05 between naïve and 48 hour 
post-PHx PolgAmut/mut mice; c denotes p<0.01 between naïve and 72 hour post-PHx WT mice; d denotes 
p<0.01 between naïve and 72 hour post-PHx PolgA+/mut mice; e denotes p<0.05 reduction between naïve and 
72 hour PolgAmut/mut mice; f denotes p<0.01 between 72 hour post-PHx WT and PolgA+/mut to 72 hour 





Although no differences in liver to body weight ratios were noted across genotypes in 
PHx groups, total PolgAmut/mut liver weights appeared to correspond to diminished 
parenchymal regeneration as observed by H&E and PCNA immunohistochemical 
(IHC) analyses. Measurement of hepatocyte proliferative markers across WT, 
PolgA+/mut and PolgAmut/mut livers revealed that PHx in 3-month mice induced a 
significant elevation in hepatocyte mitotic bodies (MB) and the DNA synthesis marker 
PCNA when compared to T0 liver tissue. PCNA and MB peak at 48 hours post-PHX 
and then fall towards baseline levels at 72 hours (figure 5-4, A, B). However, in the 
PolgA+/mut and PolgAmut/mut, the magnitude of this increase in MBs was significantly 
less than in WT mice in a gene-dose dependent manner, reaching statistical 
significance at 72 hours. A similar trend was observed in the PCNA IHC, with 3-
month PCNA-positive hepatocytes, also displaying a gene-dose dependent reduction 
in positively stained cells at 48 hours post-PHx in PolgA+/mut and PolgAmut/mut livers, 
when compared to T0 liver tissue (figure 5-5, A-B). Interestingly, whilst reductions in 
PCNA were additionally observed in PolgA+/mut at 72 hours; this was not observed in 
PolgAmut/mut mice – instead, the data trended towards an increase of PCNA positive 
hepatocytes, possibly indicative of impaired delayed regenerative response in the 
presence of mitochondrial respiratory dysfunction.  
 
Surgical intervention by PHx in 6-month mice appeared to induce hepatocellular 
proliferation in a similar manner to the 3-month cohort. However, as with previous 
studies performed in WT mice, assessment of ageing post-PHx parenchymal 
recovery in the present study revealed reductions in mitotic and PCNA indices in 6-
month mice compared to 3-month PHx mice, indicating that hepatocellular 
regenerative capacity declines with normal ageing (figure 5-8) (Bucher and Swaffield, 
1964; Enkhbold et al., 2015). In 48-hour post-PHx, 6 month WT mice saw a ~3 and 
~1.5-fold significant reduction in MBs and PCNA respectively compared to 3-month 
PHx mice, whilst at 72 hours a ~2-fold reduction in MBs was recognised. Decline in 
hepatocyte proliferation appeared to be exacerbated by the presence of 
mitochondrial respiratory dysfunction: 6-month PolgA+/mut and PolgAmut/mut mice 
demonstrated reduced MB at 48 hours post-PHx when compared to WTs in a gene-
dose dependent manner, as well as at 72 hours (figure 5-6, A-B). By contrast, no 
reductions in PCNA were seen particularly within 6-month PolgA+/mut and PolgAmut/mut 
livers when compared to 3-month cohorts, although at 72 hours post-PHx 




       
Figure 5-4: Analysis of regenerative mitotic 





 mice.   
 
(A) Representative photomicrographs of H&E 
staining from 3-month old male WT, PolgA+/mut 
and PolgAmut/mut PHx mice. Bars 100 µm. (B) 
Quantification of mitotic bodies in T0, 48 hour 
and 72 hour post-PHx mice. n=5 per group for 
WT and PolgA+/mut PHx mice; n=3 per group for 
PolgAmut/mut PHx mice. All P values were 









































































































       
PolgA+/mut PolgAmut/mut 
Figure 5-5: Regenerative analysis of 






PHx mice.   
 
(A) Representative photomicrographs of 
PCNA staining from 3-month old male WT, 
PolgA+/mut and PolgAmut/mut PHx mice. Bars 
100 µm. (B) Quantification of PCNA 
positive hepatocytes in T0, 48 hour and 72 
hour post-PHx mice. n=5 per group for WT 
and PolgA+/mut PHx mice; n=3 per group for 
PolgAmut/mut PHx mice. All P values were 
calculated using a two-way ANOVA 



















































































Figure 5-6: Analysis of regenerative 






mice.   
 
(A) Representative photomicrographs of 
H&E staining from 6-month old male WT, 
PolgA+/mut and PolgAmut/mut PHx mice. 
Bars 100 μm. (B) Quantification of mitotic 
bodies in T0, 48 hour and 72 hour post-
PHx mice. n=5 per group for WT and 
PolgA+/mut PHx mice; n=3 per group for 
PolgAmut/mut PHx mice. All P values were 
calculated using a two-way ANOVA 





























































Figure 5-7: Regenerative analysis of 






PHx mice.   
 
(A) Representative photomicrographs of 
PCNA staining from 6-month old male WT, 
PolgA+/mut and PolgAmut/mut PHx mice. Bars 
100 μm. (B) Quantification of PCNA positive 
hepatocytes in T0, 48 hour and 72 hour 
post-PHx mice. n=5 per group for WT and 
PolgA+/mut PHx mice; n=3 per group for 
PolgAmut/mut PHx mice. All P values were 




Figure 5-8: Regenerative markers in naïve (median laparotomy only) and partial 
hepatectomised young (3-month) and aged (6-month) in WT, PolgA+/mut and PolgAmut/mut mice 
for direct comparison only. 
 
(A-B) Quantification of mitotic bodies in T0, 48 hour and 72 hours 3-month and 6-month mice (B-C) 
Quantification of PCNA positive hepatocytes in T0, 48 hour and 72 hour 3-month and 6-month old 
post-PHx mice. n=5 per group for WT and PolgA+/mut PHx mice; n=3 per group for PolgAmut/mut PHx 
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5.4.3 Hepatoproliferative and growth termination factors following 
partial liver resection 
Parenchymal restoration during liver regeneration is a process mediated by the 
coordinated pleiotropic effects of priming proinflammatory cytokines, mitogenic and 
mito-inhibitory factors. Therefore, when assessing gene expression of proliferation-
associated proinflammatory cytokines during post-PHx recovery, the present study 
unsurprisingly observed alterations to hepatoproliferative factors. Such changes were 
predominantly observed in 6-month cohorts, in which PolgAmut/mut T0 livers 
demonstrates significantly elevated levels of proliferative proinflammatory cytokine 
TNFα (tumour necrosis factor factor-α) compared with T0 WTs; followed by a 
significantly marked downregulation at 48-72 hours in response to PHx when 
compared to WT and PolgA+/mut PHx livers (figure 5-9, C). Such findings would 
appear to correlate with reduced 6-month hepatocellular proliferation markers and 
inability to recover liver mass post-PHx in these mice. By contrast, WT and PolgA+/mut 
mice demonstrated trends of elevated TNFα expression at 72 hours post-PHx. In 
addition, 3-month mice did not observe any differences between genotypes, rather 
TNFα was shown to be significantly upregulated in PolgAmut/mut mice at 48 hours in 
response to PHx and reduced to baseline levels by 72 hours (figure 5-9, A).   
 
By contrast, the termination of liver regeneration is less well investigated, however 
factors such as transforming growth factor (TGFβ) are well known to be anti-
proliferative: mediating apoptotic signalling to correct for excess parenchymal 
recovery (Sakamoto et al., 1999). Consequently, whilst the mediated effects are 
noted as only transient, TGFβ receptor II deficient mice are shown to have enhanced 
hepatocellular proliferation (Oe et al., 2004). Assessing TGFβ in the present study, 
gene expression was shown to have no obvious changes across all genotypes in 3-
month PHx mice, despite the reductions in regenerative markers 48-72 hours post-
PHx in PolgA+/mut and PolgAmut/mut livers (figure 5-9, A). 3-month WT mice appeared 
to demonstrate downregulated expression of hepatic TGFβ mRNA at 72 hours post-
PHx, whilst no obvious changes were observed in corresponding PolgA+/mut and 
PolgAmut/mut livers: perhaps reflecting reduced hepatocellular proliferation in these 
groups. More interestingly, however, in 6-month mice significant upregulation of 
TGFβ was observed in PolgAmut/mut mice at 48-72 hours post-PHx in comparison to 
corresponding WT and PolgA+/mut groups – perhaps causative in the diminution of 









 T0 and PHx livers.  
 
Hepatoproliferative proinflammatory cytokine tumour necrosis factor-α (TNFα) gene expression was 
quantified in (A) 3 month and (C) 6 month in T0, 48 and 72 hours post-PHx mice. Mito-inhibitory factor 
transforming growth factor-β (TGFβ) mRNA levels were quantified in (B) 3 month and (D) 6-month mice. 
N=5 per group for WT and PolgA+/mut PHx mice; n=3 per group for PolgAmut/mut PHx mice at both ages. 























































































































5.5  Mitochondrial function WT, PolgA+/mut and PolgAmut/mut mice following 
partial hepatectomy  
 
 
5.5.1 Partial hepatectomy induces changes in mitochondrial 
respiratory function 
Energetic demand is well understood to increase following PHx in order to meet 
metabolic needs for cellular biosynthesis as the liver regenerates cellular mass and 
function following loss. Since under homeostatic conditions cellular energy is 
predominantly provided by the mitochondrial oxidative phosphorylation (OXPHOS) 
system, liver parenchymal recovery appears to be closely dependent on 
mitochondrial respiratory function. Increased respiratory and phosphorylation rates, 
changes in oxidant/redox state and altered activities of respiratory chain complexes 
have all been shown to occur during liver regeneration (Kamiyama et al., 1976; 
Inomoto et al., 1994; Hernandez-Munoz et al., 2003). Therefore, since PolgAmut/mut 
mice basal hepatocellular proliferation has been shown in the previous chapter to be 
defective, it was hypothesised that the presence of age-accumulated mitochondrial 
respiratory chain dysfunction would result in aberrant active hepatocellular 
regeneration processes, as tested by PHx in 3 and 6-month WT, PolgA+/mut and 
PolgAmut/mut livers. 
 
Mitochondrial respiratory function via COX/SDH staining was examined in T0 and 
post-PHx livers at 3 and 6 months, revealing presence and changes in cytochrome c 
oxidase (COX) deficiency post-PHx to predominantly occur in previously noted active 
proliferating periportal regions of the liver (Ferri et al., 2005). At 3 months, 
photomicrographic indications of possible basal COX deficiency was observed in T0 
PolgA+/mut and PolgAmut/mut livers, though COX/SDH staining was unable to be 
quantified across the study due to induction of hepatic steatosis on PHx. 
Parenchymal regeneration at 48 hours post-PHx, coincided with increased COX 
deficient staining, signifying PHx induces mitochondrial respiratory dysfunction that 
subsequently returns to approximate T0 levels by 72 hours post-PHx (figure 5-10, A). 
Interestingly, the presence of mitochondrial respiratory dysfunction in 3-month 
PolgA+/mut and PolgAmut/mut appeared to demonstrate the ability to return to T0 levels, 
although showing some areas of COX deficient staining to remain in a gene-dose 
dependent manner. These findings were certainly more marked when assessing 6-
month mice, with similar inductions of mitochondrial dysfunction on PHx at 48 hours 
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and in particular, reduced ability to resolve COX deficiency within PolgA+/mut and 
PolgAmut/mut mice (figure 5-11, A). Of note, photomicrographs also demonstrated that 
within 6-month mice, basal T0 levels showed greater COX deficiency than 3 month 
mice – indicating cumulative mitochondrial respiratory dysfunction with age.  
 
5.5.2 Partial hepatectomy induces protein expression changes in  
respiratory complexes 
The abovementioned changes appeared to reflect alterations in mitochondrial 
respiratory complexes: specifically, whole liver protein expression of complex I 
(NDUFB8) and complex IV (Mt-CO1) observed in PolgA+/mut and PolgAmut/mut mice at 
3 and 6 months. Whilst no 3-month changes were observed for complex II (SDHB), 
complex III (UQCRC2) and complex V (ATPB), diminished NDUFB8 protein 
expression was observed 48-72 hours in PolgA+/mut PHx mice, as well as 
downregulation of Mt-CO1 expression observed 48-72 hours and at 48 hours in 
PolgA+/mut and PolgAmut/mut mice respectively (figure 5-10, B-D). Upregulation of 
NDUFB8 was also observed 48 hours post-PHx in WTs, demonstrating a seemingly 
greater upregulation of WT NDUFB8 at this timepoint when compared with 3-month 
PolgA+/mut and PolgAmut/mut livers. Testing for respiratory complex proteins in 6-month 
mice, similar increases in NDUFB8 expression at 48 hours post-PHx was also 
observed but in WT and PolgA+/mut livers only (figure 5-11, B-D) rather PolgAmut/mut 
failed to upregulate NDUFB8 expression following resection – perhaps ascribed to 
initial complex I deficiencies seen within T0 and basal livers (see chapter 4). In 
addition, Mt-CO1 also appeared to be decreased post-PHx in 6-month PolgAmut/mut 
livers but not in PolgA+/mut mice. No observable changes were observed for SDHB, 































Figure 5-10: Analysis of mitochondrial 
respiratory function and respiratory complex 
protein expression in 3-month WT, PolgA+/mut 
and PolgAmut/mut T0 and PHx livers. 
 
(A) Representative photomicrographs of COX/SDH 
staining for mitochondrial function from 3-month old 
male WT, PolgA+/mut and PolgAmut/mut T0 and PHx 
mice. Bars 100 μm. (B-D) Western blots of 
mitochondrial respiratory complex subunits protein 
expression for complex I (NDUFB8), complex II 
(SDHB), complex III (UQCRC2), complex IV (Mt-
CO1) and complex V (ATPB) in 3-month WT, 
PolgA+/mut and PolgAmut/mut T0, 48 and 72 hours 
post-PHx mice livers. 
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Figure 5-11: Analysis of mitochondrial respiratory 
function and respiratory complex protein 
expression in 6 month WT, PolgA+/mut and 
PolgAmut/mut T0 and PHx livers. 
 
(A) Representative photomicrographs of COX/SDH 
staining for mitochondrial function from 6-month old 
male WT, PolgA+/mut and PolgAmut/mut T0 and PHx 
mice. Bars 100 µm. (B-D) Western blots of 
mitochondrial respiratory complex subunits protein 
expression for complex I (NDUFB8), complex II 
(SDHB), complex III (UQCRC2), complex IV (Mt-CO1) 
and complex V (ATPB) in 6-month WT, PolgA+/mut and 






5.5.3 Mitochondrial biogenesis during ageing liver regeneration 
The co-transcriptional regulatory factor PGC1α (peroxisome proliferator activated 
receptor gamma coactivator 1-alpha) is integral to the transcriptional control of 
mitochondrial biogenesis and respiratory chain function (Austin et al., 2012). PGC1α 
gene expression did not show marked changes in expression in 3-month mice (figure 
5-12, A). However, following PHx in 6-month aged WT mice, PGC1α gene 
expression was elevated at 48 hours, but subsequently returned to approximate 
baseline T0 levels by 72 hours. These changes in PGC1α, were not statistically 
significant (figure 5-12, B). Upregulation of PGC1α levels at 48 hours, on the other 
hand, was significantly raised in WT mice when compared to PolgA+/mut and 
Polgmut/mut groups.  
  
Figure 5-12: Gene expression of mitochondrial biogenesis co-transcriptional regulatory factor PGC1α.  
 
Gene expression for co-transcriptional regulatory factor for mitochondrial biogenesis, PGC1α (peroxisome 
proliferator activated receptor gamma coactivator 1-alpha), quantified in (A) 3 month and (B) 6-month WT, 
PolgA+/mut and PolgAmut/mut mice at T0, 48 and 72 hours post-PHx.  N=5 per group for WT and PolgA+/mut PHx 




5.5.4 Partial hepatectomy and alterations in anti-oxidant enzymes in 
PolgA 
The formation of reactive oxygen by-products has been reported to increase 
following PHx as a result of increased OXPHOS energetic demands (Yang et al., 
2004), in which detrimental excess reactive oxygen species (ROS) levels are 
detoxified by anti-oxidant scavenging activity. Amongst observations noted is 
augmented levels of glutathione (GSH) 24-72 hours after initial decreases (≈24 
hours) post-surgery (Huang et al., 1998), yet when assessing mRNA expression of 
corresponding GSH synthesising enzyme GSS (glutathione synthetase) in the 
present study, significantly decreased levels were observed at 48-72 hours post-PHx 
in 3 month mice, when compared to T0 WT tissues (figure 5-13, A). Similar 
observations were also observed for PolgA+/mut mice, but failed to reach statistical 
significance. Conversely, PolgAmut/mut mice showed failure to differentially regulate 
GSS across all given time points. In addition and also in accordance with previous 
studies, glutathione peroxidase (GPX) gene expression was also decreased in 
response to PHx, 48-72 hours in 3-month mice (figure 5-13, B); however, such 
findings are inconclusive with statistical analysis failing to reach significance (Huang 
et al., 1998; Yang et al., 2004). Moreover, no significant differences in mRNA levels 
were demonstrated for superoxide dismutase 1 (SOD1) across all genotypes when 
compared to T0 controls (figure 5-13, C)  
 
With murine ageing, comparable trends in antioxidant gene expression were 
observed at 6 months of age when normalised to 6-month T0 WT livers. 
Quantification of GSS mRNA levels revealed gene-dose dependent increases in 
baseline T0 PolgA+/mut and PolgAmut/mut livers, which was significant in the latter. 
Similar to 3-month PHx mice, GSS mRNA levels were markedly reduced in 6-month 
mice at 48-72 hours post hepatectomy (figure 5-14, A). Similar findings to 3-month 
mice were also observed for GPX, in which mRNA levels remained relatively 
unaltered following surgical resection of the liver in the presence of mitochondrial 
respiratory chain dysfunction, as in PolgA+/mut and PolgAmut/mut mice (figure 5-14, B). 
PHx also appeared to induce SOD1 gene expression at 48 hours post-PHx in 6-
month aged WT livers, however, SOD1 expression subsequently returned to T0 
levels by 72 hours. Such observations showed significantly reduced expression when 
compared to PolgAmut/mut mice, which on PHx, showed significantly increased SOD1 


















































































observed amongst 6-month PolgA+/mut groups across all antioxidant gene 
measurements taken. 
  
Figure 5-13: Analysis of anti-oxidant enzyme expression in 3-month WT, PolgA+/mut and PolgAmut/mut 
PHx mice.  
 
(A) Quantification of glutathione synthetase (GSS), (B) glutathione peroxidase (GPX) and (C) superoxide 
dismutase 1 (SOD1) gene transcription was analysed in 3-month WT, PolgA+/mut and PolgAmut/mut livers at T0, 
48 and 72 hours post-PHx. N=5 per group for WT and PolgA+/mut PHx mice; n=3 per group for PolgAmut/mut PHx 
mice. Two-way ANOVA was used to calculate P values, *p<0.05, **p<0.01. 
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Figure 5-14: Analysis of anti-oxidant enzyme expression in 6-month WT, PolgA+/mut and PolgAmut/mut 
PHx mice.  
 
(A) Quantification of glutathione synthetase (GSS), (B) glutathione peroxidase (GPX) and (C) superoxide 
dismutase 1 (SOD1) gene transcription was analysed in 6-month WT, PolgA+/mut and PolgAmut/mut livers at T0, 
48 and 72 hours post-PHx. N=5 per group for WT and PolgA+/mut PHx mice; n=3 per group for PolgAmut/mut PHx 


















































































5.6  Conclusion 
  
Despite basal age-associated reductions in hepatocellular proliferation and 
hepatocyte survival associated with complex I respiratory deficiency (see chapter 4), 
PolgAmut/mut mice respond to regenerative stressors from PHx with varying degrees. 
Whilst 3-month mice trended towards normal post-PHx recovery recognised by 
pronounced liver to body weight increases and similar liver weights to WT and 
PolgA+/mut mice, diminished post-surgical recovery was an effect more marked in the 
presence of age-accumulated mitochondrial respiratory chain dysfunction. As a 
consequence, 100% post-PHx survival across all 3-month genotypes was reduced in 
a gene-dose dependent manner to ~91% and 70% in 6-month PolgA+/mut and 
PolgAmut/mut mice respectively, and coincided with a significant decline in liver mass 
post-PHx in PolgAmut/mut mice - despite initial enlargement observed in naïve 
PolgAmut/mut livers. Such decreases in the presence of respiratory chain dysfunction 
could be ascribed to reductions in hepatocellular regenerative markers PCNA and 
mitotic indices; however, in 3-month PolgA+/mut and PolgAmut/mut mice and 6-month 
PolgA+/mut livers, ability to recover liver mass was not impaired, showing similar 
recuperation to aged matched WTs. It is therefore possible that where no diminution 
in hepatic regrowth is observed, the threshold of mtDNA mutations required to induce 
an aberrant effect on post-PHx recovery is unlikely to have been exceeded. At 3 
months of age, it is likely that normal mitochondrial function remains within remaining 
cells to compensate for respiratory defunct cells, whilst greater mitochondrial 
dysfunction in 6-month PolgAmut/mut induces diminished parenchymal recovery. 
Certainly, initial studies show that PolgAmut/mut mice accumulate mtDNA mutations a 
rate 3-5 fold greater than WTs within tissues including the liver, whilst further 
comparisons with PolgA+/mut groups show mtDNA mutations in ageing mitotic tissues 
to accumulate at an accelerated rate in PolgAmut/mut tissues only (Trifunovic et al., 
2004; Kujoth et al., 2005; Vermulst et al., 2008). 
 
Diminished liver regeneration is present in the ageing liver, with previous WT murine 
studies showing reduced survival following partial liver resection in older cohorts; this 
is likely associated with aberrant changes to hepatoproliferative signalling, as well as 
changes in hepatic ultrastructures (Guerrieri et al., 2002; Ferri et al., 2005; Enkhbold 
et al., 2015). Whilst no losses in hepatic liver mass and regenerative markers are 
observed in 3-month WT mice, levels of hepatocyte proliferative indicators are noted 
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to decrease within the 6-month cohort, exacerbated by the presence of respiratory 
chain dysfunction. Therefore it was hypothesised that PolgAmut/mut mice would show 
cumulative aberrant effects in regenerative signalling associated with age-
accumulated mitochondrial dysfunction and the onset of a progeroid ageing 
phenotype. Certainly at 3 months of age, PolgA+/mut and PolgAmut/mut hepatocytes are 
still able to proliferate to recover lost cell mass, albeit to varying extents when 
compared to WT livers - ascribed to significant gene-dose reductions at 48 hours 
post-PHx in DNA synthesis marker PCNA and corresponding mitotic indices in 
PolgA+/mut and PolgAmut/mut mice. Such changes appeared to extend to 72 hours post-
PHx within PolgAmut/mut: interestingly denoting increased counts in PCNA positive 
hepatocytes when compared to T0 control groups. Whether this is indicative of a 
delayed regenerative response is unclear due to contrasts with corresponding MB 
counts and no differences in 3 month post-surgical liver mass; however, DNA 
synthesis during the cell cycle prior to mitosis is understood to be tightly controlled – 
halted at the G2/M checkpoint in the presence of DNA damage and incomplete DNA 
replication via predominantly cyclin B-CDK1 mediated mechanisms (Fisher et al., 
2012). As such, increased DNA synthesis-associated PCNA levels could be 
suggestive of halted or delayed entry of PolgAmut/mut hepatocytes into mitotic division 
during liver regeneration. Further work to determine this would no doubt require 
assessment of cell cycle proteins, as well as the inclusion of additional time points to 
oversee a delayed regenerated response. Moreover, where age-associated 
mitochondrial dysfunction is present in 6-month PolgA+/mut mice and reduced 
regenerative markers are observed in the absence of reduced liver mass recovery, 
other regenerative mechanisms may be sufficient to compensate for proliferative 
defects. Unfortunately, this avenue was not further investigated; however, further 
work could be conducted in the future to address such possibilities including, for 
example exploration of hepatocyte hypertrophy and autophagic regenerative 
mechanisms.  
 
With reductions in hepatocyte mitosis and PCNA expression present in the post-PHx 
liver, it was alluded that observed post-surgical hepatocellular changes at both 3 and 
6 months may be in part due to changes in hepatoproliferative and mito-inhibitory 
factors. Carefully orchestrated in concert with other hepatocyte proliferative factors, 
the proinflammatory cytokine TNFα is a priming factor understood to diminish hepatic 
regenerative processes, as explored during genetic ablation or inhibition of the 
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corresponding TNFα receptor (Akerman et al., 1992; Yamada et al., 1997). Despite 
undergoing reduced hepatocyte mitosis, 3-month PolgAmut/mut livers were able to 
recover mass: showing similar abilities to WT and PolgA+/mut mice to upregulate 
TNFα gene expression 48 hours post-PHx. Whilst previous studies have 
demonstrated a double-edged sword role for TNFα in cellular apoptosis and survival, 
in the context of post-PHx recovery, TNFα is shown to a have a hepatoprotective role 
against Fas-mediated apoptosis following surgery (Takehara et al., 1998; Flusberg 
and Sorger, 2015). It is therefore possible that in order to achieve liver homeostasis 
post-PHx in 3-month PolgAmut/mut mice, greater upregulation of TNFα may be 
required to ensure survival of remaining compensatory hepatocytes in the presence 
of diminished post-surgical hepatocellular proliferation. On the contrary, PHx appears 
to downregulate TNFα at 48-72 hours in 6-month PolgAmut/mut mice when compared 
to T0 controls and other murine groups, resulting in possible diminished TNFα-
mediated hepatoprotection against apoptotic signalling and which may manifest in 
post-PHx reductions in liver cell mass and survival. Unfortunately, apoptotic 
signalling was not further explored with PHx; however, accelerated ageing in 
PolgAmut/mut mice ascribed to increased apoptosis observed in the present study 
(chapter 4) may provide some explanation for greater TNFα expression in 6-month 
PolgAmut/mut T0 livers. Moreover, despite reduced regenerative indicators and smaller 
decreases in post-surgical survival, TNFα expression in 6-month PHx PolgA+/mut mice 
showed similarities to WTs, further advocating for additional compensatory 
mechanisms against proliferative defects to ensure recuperation of liver mass 
following PHx.   
 
Interestingly, a decrease in hepatocellular proliferative response within 3-month PHx 
PolgA+/mut and PolgAmut/mut mice did not appear to significantly correlate with the 
premature termination of liver regeneration, with no overall significant differences 
observed in TGFβ mRNA levels. Yet, in 6-month PolgAmut/mut mice, expression is 
significantly upregulated over 48-72 hours post-PHx when compared to 
corresponding WT and PolgA+/mut mice. Anti-proliferative effects of TGFβ signalling 
are transient: demonstrated in previous studies to increase gene expression within 3-
4 hours of PHx and peaking at 48 hours; ensuing mito-inhibition occurs in a paracrine 
manner via suppression of DNA synthesis which is then shown to reduce by 72 hours 
alongside a decreased sensitivity of hepatocytes to TGFβ signalling (Nishikawa et al., 
1998). As such, significantly increased TGFβ expression in 72 hour, 6-month 
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PolgAmut/mut mice may be allied to observed reductions in hepatocyte PCNA and 
mitosis markers and reductions in liver regeneration via mito-inhibitory signalling. 
Despite a lack of significance, observed trends of gradual downregulated TGFβ 
expression between T0 and 72 hours post-PHx in both 3 month and 6 month WT and 
PolgA+/mut mice may also be of interest: in that gradual periportal-to-pericentral loss of 
TGFβ is noted in earlier studies to proceed hepatocyte mitotic division and thus its 
removal from the hepatic environment is required for completion of normal liver 
regeneration, as in WTs and PolgA+/mut mice (Braun et al., 1988; Jirtle et al., 1991). 
However, this conflict between results in PolgA+/mut and PolgAmut/mut mice, together 
with indices of hepatocellular proliferation and liver mass recovery, means findings 
remain inconclusive. As such, further work should be carried out to fully complement 
the current findings, including the characterisation of other priming and mitogenic 
factors such as IL-6, epidermal growth factor (EGF), hepatocyte growth factor (HGF) 
and TGF-α, as well as known anti-proliferative factors like activin A and bone 
morphogenic proteins (BMP). 
 
In previous studies, increases in mitochondrial activated respiration (state 3), 
respiratory and ATP phosphorylation activities have been observed and as such, it 
was hypothesised that PolgAmut/mut mice have a defective regenerative response, due 
to additional stress on mitochondrial respiratory capacity as energetic demands and 
OXPHOS metabolism increase (Hernandez-Munoz et al., 2003; Yang et al., 2004). 
Following PHx, induction of mitochondrial respiratory chain dysfunction across all 
genotypes at 48 hours post-PHx, and as seen by COX/SDH staining, occurred 
around the hepatic periportal areas in 3- and 6-month mice as previously shown 
(Ferri et al., 2005). These changes were further exacerbated in PolgA+/mut and 
PolgAmut/mut mice in a gene-dose dependent manner, with enhanced induction of 
COX deficiency ascribed to greater baseline presence of mitochondrial respiratory 
dysfunction within T0 tissues. Subsequently, enhancement appears correlated with 
observed reduced ability to fully resolve COX deficiency by 72 hour post-PHx to a 
lesser and gene-dose extent. Taken together these data suggest that the presence of 
basal mitochondrial respiratory dysfunction may exacerbate any mitochondrial 
respiratory stresses induced by PHx. Indeed in PolgA, enhanced COX deficiency 
may be ascribed to alterations to respiratory chain complex protein expression 
following resection, most notably complex I and complex IV, with failure at 3 months 
to express NDUFB8 and Mt-CO1 in PolgA+/mut and PolgAmut/mut mice across 48-72 
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hours post-PHx. Yet, with intact capacity to regenerate liver mass in these mice it is 
also possible that the threshold amount of respiratory chain deficient cells required to 
induce a tissue-level phenotype may have not have been exceeded due to 
respiratory proficient cells able to compensate for changes in mitochondrial complex 
expression post-PHx. Moreover, where reduced recovery of liver mass is seen in 6- 
month PolgAmut/mut mice, inability to upregulate complex I and IV are similarly 
observed. In chapter 4, demonstrated changes in respiratory function imply 
mitochondrial dysfunction increases with time, ascribed by previous studies on the 
clonal expansion of these respiratory deficient cells, which in turn could impact on 
basal hepatocellular turnover (Baines et al., 2014; Ma et al., 2018). Loss of 
hepatocellular proliferation is therefore likely to be linked to the inability to upregulate 
expression of mitochondrial complex proteins, in particular complex I (NDUFB8) 
and/or in combination with Mt-CO1 deficiency. The latter of which demonstrates 
some variability across age groups and genotypes in this study. Methods utilised for 
observing mitochondrial function were largely qualitative, therefore if permitted more 
time, quantifiable approaches such as assessing mitochondrial complex gene 
expression, respiratory control ratios and OXPHOS metabolism would be used to 
determine a more conclusive mechanism as to how the presence of mitochondrial 
respiratory dysfunction alters ageing hepatocellular regeneration. This could be 
achieved by a range of methods, including the use of precision cut liver slices which 
maintain a liver microenvironment in murine and human models, to address inability 
of PolgAmut/mut hepatocytes to survive ex vivo  (Olinga and Schuppan, 2013; Koch et 
al., 2014; Paish et al., 2019).   
 
Oxidative phosphorylation is known to significantly increase in response to PHx to 
meet the energetic demands of liver regeneration: with elevated ATP production 
coupled to increased OXPHOS enzyme activity and mitochondrial DNA content due 
to increases in mitochondrial biogenesis (Nagino et al., 1989; Yang et al., 2004). 
Whilst variable and inconclusive changes were found in 3-month PHx mice, 6-month 
WT livers observed significantly higher PGC1α gene expression levels at 48 hours 
than PolgA mice, indicating upregulated PGC1α-mediated activities 0-48 hours post-
PHx, including possible stimulated mitochondrial biogenesis as previously reported 
by Nagino and colleagues (1989). However, no observed upregulation was seen in 
the expression profile of mitochondrial protein complexes - postulating changes in 
PGC1α gene expression could be upstream of alternative transcriptionally targeted 
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pathways (Lupez-Loch et al., 2009). No significant upregulation of PGC1α gene 
expression was observed in PolgAmut/mut mice, possibly resulting in failure to meet the 
energetic demands of post-PHx regeneration, exacerbation of mitochondrial COX 
deficiency and ultimately failure to recover lost cellular mass. Interestingly, within 6-
month PolgA+/mut mice, increases in PGC1α were also absent despite relatively 
normal capacity for parenchymal regeneration. This may be ascribed to the use of 
PGC1α as a marker in the present study, since mitochondrial biogenesis has also 
been shown to also occur in a PGC1α-independent manner (Wilson et al., 2007). To 
further ascertain the role of PGC1α in the present study, including mitochondrial 
biogenesis, would no doubt require additional work, including assessing additional 
biogenesis markers like nuclear respiratory factor (NRF), TFAM and COX, as well as 
other PGC1α targets through additional assays.  
 
Alterations to anti-oxidant enzyme gene expression were found in the presence of 
mitochondrial respiratory dysfunction. Reactive oxygen species (ROS) are a by-
product of OXPHOS that are subsequently scavenged to maintain tissue 
homeostasis, therefore it was hypothesised that exacerbation of existing 
mitochondrial respiratory dysfunction in PolgA mice following PHx was a result of 
damaging excess ROS and leakage into the surrounding cellular environment. 
Despite being a first line defence against ensuing superoxide radicals, SOD1 
expression in WT, PolgA+/mut and PolgAmut/mut livers showed no significant difference 
at 3 months of age. Yet in 6-month mice, resection appeared to exacerbate SOD1 
gene expression in WTs and PolgAmut/mut livers - indicating a possible upregulation in 
response to OXPHOS, which may increase ROS production. Interestingly, SOD1 
expression remained constitutively and significantly upregulated in PolgAmut/mut mice 
when compared to WTs and PolgA+/mut livers, which may be suggestive of greater 
ROS generation or insufficient ROS scavenging. Indeed, gene expression levels of 
other anti-oxidant glutathione synthesising and rate-limiting GSS enzyme appears to 
complement this: increasing in a gene-dose dependent manner within T0 livers at 6 
months. Taken together these data suggest that following PHx, surgical intervention 
enhances respiratory chain dysfunction in PolgAmut/mut mice and thus excess ROS 
levels as a consequence of age-accumulated mtDNA mutations. Interestingly, 
increased GSS activity is observed prior to DNA synthesis (~12 hours) and 
diminishes by 24 hours post-PHx (Huang et al., 1998). Therefore, such changes in 




Due to the breeding strategy and reduced survival observed following PHx in 
PolgAmut/mut mice, the present study was limited to a small number of mice in each 
group. If allowed more time, more PolgAmut/mut mice would be included in the study to 
reduce variability and increase statistical power. Nonetheless, this chapter’s findings 
suggest PHx induces transient mitochondrial dysfunction and changes to 
mitochondrial complex protein activity and anti-oxidant expression, which in the 
presence of basal mitochondrial respiratory chain dysfunction in heterozygous 
PolgA+/mut and PolgAmut/mut mice diminishes hepatocellular proliferation. At 3 months, 
thresholds for deficiency may have not been exceeded to induce an aberrant 
phenotype in PolgA mice, with enough mitochondrial function remaining to permit 
normal liver regeneration. Compensatory mechanisms may also contribute to the 
maintenance of hepatic recovery, including the upregulation of TNFα signalling and 
mito-inhibitory TGFβ signalling that are altered at 6 months of age. Age-associated 
accumulation of mitochondrial respiratory dysfunction is therefore likely to diminish 
post-surgical parenchymal recovery in PolgAmut/mut mice with age, due to insufficient 
mitochondrial respiratory chain capacity to meet the energetic demands of post-PHx 
liver regeneration. Further work is needed to determine this: including 
complementary studies on hepatocellular regenerative signalling and cell cycle 












































5.7 Chapter 5 Key Summary Points 
 
• Despite COX deficiency shown periportally and changes in Mt-CO1 protein 
expression, results from 3-month post-PHx surgery suggests that the 
threshold required for mtDNA mutation-induced respiratory dysfunction in 
PolgA mice is unlikely to be exceeded, thereby permitting hepatic recovery 
  
• Inability to recover liver mass during 6-month post-PHx hepatocellular 
regeneration is likely to be ascribed to reduced complex I (NDUFB8) protein 
expression following age-associated accumulation of mtDNA mutations, as 
well as changes in hepato-proliferative signalling. 
 
• In 6-month PolgAmut/mut mice, alterations to hepato-protective TNFα may 
increase susceptibility to apoptosis, whilst elevated changes to TGFβ 
expression may prevent proliferative signalling. Taken together, this may limit 
liver recovery post-PHx in these mice. 
 
• Surgical intervention appears to exacerbate respiratory chain dysfunction. 
Changes to anti-oxidant enzyme SOD1 gene expression was found in the 
presence of homozygous PolgA-induced respiratory chain dysfunction, 
indicating greater ROS production / insufficient ROS scavenging. This may be 
ascribed to increased energetic demand upon remaining respiratory deficient 
cells, resulting in excess ROS production post-PHx.  
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Chapter 6 | Liver Regeneration in Response to Oxidative Stress 
  
6.1 Introduction 
Mitochondria are recognised as important arbitrators of reactive oxygen species 
(ROS) production, highly reactive oxygen-containing molecules well established as 
oxidative phosphorylation (OXPHOS) by-products that occurs during cellular energy 
metabolism. Understood to chiefly emanate from complex I and III of the electron 
transport chain (ETC) and dependent on NADH and coenzyme Q (CoQ) pools, they 
include for example, superoxide (O2*), singlet oxygen (1O2) molecules, hydroxyl 
(OH*), hydroperoxyl (HO2*) and peroxyl (RO2*) radicals, although work to date has 
predominantly focused on the peroximal mitochondrial O2*, shown within isolated 
mitochondria to arise from one electron reduction of oxygen (Chance et al., 1979; 
Murphy, 2009). Controlling the levels of O2* and other ROS within cells through 
defensive antioxidant enzymes such as SOD (superoxide dismutase), catalase and 
glutathione peroxidase (GPx) provides further evidence for in vivo ROS. For 
example, genetic ablation and conditional knockout of SOD is demonstrated to have 
curtailed lifespan and pathological effects in mice due to failure in O2* dismutation 
into oxygen and hydrogen peroxide (H2O2) (Li et al., 1995; Uchiyama et al., 2006; 
Watanabe et al., 2013).  Such deleterious effects are associated with failure to 
balance the pro-oxidant environment with antioxidant scavenging, which under 
normal homeostatic conditions supports a variety of functions like ROS-mediated cell 
signalling and ROS-inducing phagocytosis by neutrophil and macrophage immune 
cells. Excess ROS levels and leakage from the mitochondria are therefore 
understood to result in aberrant redox-induced activation of transcriptional signalling 
and inflammation, as well as reactivity with cell DNA, protein and lipid 
macromolecules, leading to damaging oxidative tissue stress (Sharma et al., 2003). 
As such, cumulative oxidative damage to cellular components has been observed in 
a number of chronic low grade proinflammatory conditions, including neurological 
diseases, cancer, cardiovascular disease, diabetes, as well as ageing (Dhalla et al., 
2000; Sayre et al., 2001; Jenner, 2003; Dalle-Donne et al., 2006).  
 
Oxidative stress secondary to endogenous excess ROS was first popularised in 
Harman’s mitochondrial free radical theory (of ageing). The degenerative ageing 
process outlined to share common pathological mechanisms with cancer biology and 
radiation toxicity, through the generation of  deleterious cumulative free radicals 
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generated from mitochondrial oxygen consumption (Harman, 1956; Harman, 1972; 
Boveris and Chance, 1973). Dysfunctional mitochondria, in particular, are proposed 
as less efficient at ATP synthesis yet produce greater levels of ROS and present a 
possible major source of oxidative imbalance in many chronic and age-associated 
pathologies, including those of the liver like non-alcoholic fatty liver disease (NAFLD), 
that also coincides with detected impairment of normal mitochondrial function 
(Caldwell et al., 1999; Sanyal et al., 2001). Interestingly, when assessing oxidative 
stress in mitochondria, the mitochondrial genome (mtDNA) that encodes 13 of the 
genes required for respiratory complex protein subunits, demonstrates a 50-fold 
greater vulnerability to ROS-induced mutagenesis over nuclear DNA; perhaps 
unsurprisingly, ascribed to the close proximity of mtDNA molecules’ to the ETC 
oxidative environment. Taken together, the observations invariably lend support 
towards a ‘vicious cycle’ hypothesis: ROS targets mtDNA that in turn induces further 
aberrant mtDNA oxidative damage (Harman, 1956; Harman, 1972). Amongst 
alterations observed from mtDNA oxidised mutagens, for example, is the loss of 
mitochondrial membrane potential (ΔΨm), able to affect ETC productivity as well as 
mitochondrial membrane permeability that can lead to downstream pro-apoptotic 
signalling; oxidised mtDNA may also act as ‘alarmins,’ resulting in activation of the 
NLRP3 inflammasome and proinflammatory IL-1β secretion (Lopez-Armada et al., 
2006; Shimada et al., 2012).  
 
In vivo, treatment of aberrant ROS signalling is understood to ameliorate pathogenic 
onset and survival in a number of conditions; yet, in PolgAmut/mut mice, evidence for 
mitochondrial dysfunction and oxidative stress appears to be conflicting.  On one 
hand, some previous PolgAmut/mut mice studies report negligible changes in ROS 
production or oxidative damage markers despite an age-associated accumulation of 
mtDNA mutations (Trifunovic et al., 2004; Kujoth et al., 2005; Hiona et al., 2010). Yet 
advancements of quantifiable PCR and bioanalytical techniques beyond early 
biochemistry-based methods, has enabled other studies to demonstrate evidence of 
increased ROS in PolgAmut/mut whether it be measured directly or indirectly, via 
antioxidant changes (Vermulst et al., 2008; Logan et al., 2014). In specific, findings 
by Logan and colleagues (2014) show augmented in vivo levels of oxidative stress 
marker H2O2 in ageing PolgAmut/mut mice through detection via mitochondria-targeted 
mass spectrometry probe MitoB, suggesting its contribution to progeroid ageing. 
However, this occurs in the absence of altered and detectable changes in markers of 
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oxidative markers or ex vivo ROS. These findings in older PolgAmut/mut mice could 
therefore suggest that a vicious cycle of mitochondrially disruptive oxidative damage 
in potentiating the degenerative ageing process. It was therefore hypothesised in the 
present study, that mitochondrial dysfunction that arises from defective PolgA and 
ensuing mtDNA mutations results in the production of ROS, which in turn contributes 
to reduced post-injury hepatocellular recovery. 
 
6.2 Aims 
The aim of this chapter was to investigate the effects of mitochondrial dysfunction on 
the PolgA+/mut and PolgAmut/mut liver repair following acute CCl4-induced oxidative 
stress. 
 
6.3 Acute CCl4 injury induces greater oxidative stress to mitochondria in the 
presence of respiratory dysfunction 
Single dose CCl4 injection induces a transient acute inflammatory response 
encompassing hepatocellular apoptosis and necrosis, minimal hepatic stellate cell 
(HSC) activation, extracellular matrix (ECM) deposition, and the stimulated 
regeneration of the liver parenchyma around 48 hours post-injury (Weber et al., 
2003). Damage follows oxidative stress stimulated by the cytochrome P450 CYP2E1-
mediated metabolism of CCl4 into CCl3* and CCl3OO* radicals, understood to exert 
cellular cytotoxicity through lipid peroxidising effects. Since oxidising effects of CCl4 
also include the induction of mitochondrial respiratory dysfunction, we hypothesised 
that CCl4-induced chemical stresses on PolgA+/mut and PolgAmut/mut mice could further 
reduce the ability for hepatocellular regeneration secondary to additional oxidative 
damage to mtDNA (Knockaert et al., 2011). Therefore, at 8-12 weeks of age, WT, 
PolgA+/mut and PolgAmut/mut mice were injected with a single acute dose of CCl4 and 
allowed to recover until sacrificial time points; livers were then harvested and 






6.3.1 Acute CCl4 induces additional mitochondrial respiratory 
dysfunction 
PolgAmut/mut are characterised by accelerated progeroid ageing with phenotypic onset 
occurring approximately around 6 months of age and ascribed to somatic mtDNA 
mutations and respiratory dysfunction accumulated with time (Trifunovic et al., 2004; 
Kujoth et al., 2005). Interestingly, even in the absence of ageing symptoms, 1-3 
month old PolgAmut/mut mice observe a 7-11 fold increase in mtDNA mutations 
(Vermulst et al., 2008). To therefore test whether oxidative stress had a 
compounding effect on present mitochondrial respiratory dysfunction, harvested CCl4 
and olive oil injected livers were subjected to dual COX/SDH staining. Here, 
histological examination revealed that even at 8-12 weeks, olive oil control 
PolgAmut/mut mice displayed signs of greater cytochrome c oxidase (COX) deficiency 
that emanates periportally, when compared to WT and PolgA+/mut livers (figure 6-1, 
A). The acute administration of CCl4 induced COX deficiency across all genotypes at 
48 hours, which failed to varying extents to return to control olive oil levels observed. 
Such an effect was more pronounced in PolgAmut/mut mice, suggesting that the basal 
presence of respiratory deficiency further perpetuates mitochondrial dysfunction in 
response to oxidative tissue injury - making it possible that subsequent failure in 
parenchymal recovery may be secondary to greater respiratory dysfunction. These 
findings were inconclusive, however, due to the difficulty in quantifying COX 
deficiency in the presence of necrotic liver damage.  
 
To test for specific mitochondrial respiratory complex deficiencies, protein expression 
was determined in WT, PolgA+/mut and PolgAmut/mut liver tissues from olive oil and 
CCl4 injected mice via western blot. Interestingly, despite observations of complex IV 
(COX) deficient staining following CCl4 injection in all genotypes and in olive oil 
PolgAmut/mut mice, no observable differences in Mt-CO1 protein expression could be 
detected (figure 6-5, B). Similar expression patterns were also observed for complex 
II (SDHB), complex III (UQCRC2) and complex V (ATPB). Instead, a gene-dose 
dependent reduction in expression of complex I (NDUFB8) was observed in olive oil 
PolgA+/mut and PolgAmut/mut mice, which following CCl4 intoxication, induced NDUFB8 
upregulation at 48 hours across all genotypes (figure 6-1, B). Interestingly, this 





Figure 6-1: Mitochondrial function and protein subunit expression following acute CCl4 administration. 





 mice. Mice were administered acute dose of CCl4 at 2 µl/g. Bars 50 µm. Representative of n=5 
mice per WT and PolgA+/mut groups and n=4 mice per PolgAmut/mut (B) Protein expression of mitochondrial 
protein complex I subunit (NDUFB8); complex II (SDHB); complex III (UQCRC2); complex IV (Mt-CO1); and 
complex V in WT, PolgA+/mut and PolgAmut/mut mice, n=3 mice are shown per genotype at each time point. 
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Changes in protein expression of mitochondrial complexes appeared to occur 
alongside changes in mitochondrial subunit gene expression, in which mRNA levels 
of complex I membrane-anchor subunit ND1 was shown to be significantly 
upregulated at 48 hours post-CCl4 injection in WT and PolgA+/mut livers, unfortunately 
failing to reach significance in PolgAmut/mut  48 hour groups (figure 6-2, A). By 
contrast, no differences in gene expression was observed for complex I subunit ND4 
(figure 6-2, B), perhaps ascribed to the temporal stages of complex I assembly and 
its involvement in the latter P module completion stages (Lazarou et al., 2009). For 
other mitochondrial respiratory complex genes cytochrome b, COX1 and ATP6, day 
5 CCl4 injured PolgAmut/mut mice demonstrated greater increases in expression of the 
markers when compared to olive oil and 48-hour post-injection controls, as well as 
during comparisons made to corresponding WT and PolgA+/mut mice (figure 6-2, C-D, 
F). Significantly increased mRNA gene expression of COX3 was only observed at 5 
days in PolgAmut/mut mice when compared to PolgAmut/mut olive oil controls (figure 6-2, 
































































































































































     
Figure 6-2: Gene expression of mitochondrial respiratory complex subunits. 
 
Mitochondrial gene expression of (A-B) ND1 and ND4, complex I; (C) cytochrome b, complex III; (D-E) COX1 
and COX3, complex IV and (F) ATP6, complex V subunits in olive oil control and acute CCl4 injected WT 
(n=5), PolgA+/mut and PolgAmut/mut (n=4 mice per gentoype). All P values were calculated using a two-way 




6.3.2 Acute CCl4 oxidative liver injury induces expression of a subset   
of antioxidant genes in PolgAmut/mut mice   
Whilst reports on antioxidant enzyme expression following oxidative cytotoxicity 
remain inconclusive, the upregulation of endogenous enzymes appears to minimise 
disease pathology including subsequent decreases of lipid peroxidising effects during 
CCl4 administration (Szymonik-Lesiuk et al., 2003; Venugopal et al., 2007; Knockaert 
et al., 2011). With the induction of mitochondrial respiratory dysfunction in 
PolgAmut/mut mice, gene expression of antioxidant enzymes were assessed for 
oxidative status following olive oil and acute CCl4 injury. As with previous rodent 
studies, CCl4 administration revealed no significant differences in GPX expression 
(figure 6-3, B); yet, when determining SOD1 expression, significantly greater levels in 
WT mice were observed at 5 days following CCl4 intoxication (Szymonik-Lesiuk et 
al., 2003). However, this response was impaired in PolgA+/mut and PolgAmut/mut mice, 
with PolgA+/mut mice presenting with an intermediate phenotype (figure 6-3, C). No 
differences were observed for mitochondrial SOD2 (figure 6-3, D) Furthermore, acute 
oxidative injury stimulated increases in glutathione synthetase (GSS) mRNA 
expression in PolgAmut/mut mice, significantly peaking at 48 hours before lowering to 
significantly elevated levels at 5 days post-administration (figure 6-3, A). Augmented 






Figure 6-3: Gene expression of antioxidant enzymes (A) GPX; gluthathione peroxidase; (B) SOD1, 
superoxide dismutase 1; (C) SOD2 and (D) GSS, glutathione synthetase 
 
qRT-PCR measurement of mRNA expression for antioxidant genes SOD1, SOD2, GSS and GPX in olive oil 
and acute CCl4 treated WT, PolgA+/mut and Polgmut/mut livers. N=3 for olive oil groups, n=5 for WT and 
PolgA+/mut CCl4 treatment groups, n=4 for PolgAmut/mut CCl4 treated mice. All P values were calculated using a 




6.4  Liver tissue damage and regeneration following acute CCl4-induced  
oxidative hepatic injury  
  
6.4.1 Hepatocellular damage and necrosis ensues following acute 
CCl4 administration in PolgA mice 
Liver tissue damage was initially evaluated by macroscopic analysis and H&E 
staining, revealing acute CCl4 dosing to induce liver swelling and centrilobular 
necrosis at 48 hours that resolved to varying extents across all genotypes within 5 
days (figure 6-4, figure 6-5). In specific, H&E staining observed hepatocytes to 
undergo ballooning and tissue injury. As expected, analysis of necrotic liver tissue 
confirmed that the percentage area of necrotic tissue significantly increased at 48 
hours post-injury in WT, PolgA+/mut and PolgAmut/mut mice. Although no significant 
differences were recognised between genotypes, at 5 days post-injection, the 
necrotic tissue area in PolgAmut/mut mice remained slightly elevated, suggestive of a 
delayed wound healing response and failure to fully resolve liver injury (figure 6-5, A-
B). Establishing whether possible sustained necrosis was a result of greater recipient 
tissue damage, the lipid peroxidation marker 4-hydroxynonenal (4HNE) was 
assessed in livers for oxidative injury. Observed by western blot, 4HNE protein 
expression was increased at 48 hours post-CCl4 injection with a seemingly more 
pronounced detection in PolgA+/mut and PolgAmut/mut mice: possibly indicating greater 
CCl4-induced oxidative tissue injury (figure 6-6). As expected, increased lipid 
peroxidation coincided with the similar diminution of CYP2E1 protein expression at 
48 hours across all genotypes (figure 6-6), in which CCl4-derived metabolite CCl3* is 
understood to bind to the CYP2E1 active site that subsequently leads to the 
enzyme’s inactivation and degradation (Tierney et al., 1992; Dai and Cederbaum, 
1995). Despite observing more tissue necrosis histologically in PolgAmut/mut injured 
mice, evidence for greater oxidative tissue damage remains inconclusive, since 
serum quantification of the liver damage marker aspartate transaminase (AST) at 24 
hour post- CCl4 injury reveal no significant differences in AST levels in WT, PolgA+/mut 
and PolgAmut/mut mice. This indicated that levels of CCl4-induced liver damage was 
comparable across all genotypes, suggesting that the failure to fully resolve the injury 



















Figure 6-4: Macroscopic images of livers harvested from olive oil, 48 hour (48h) and 5-day post-acute 












(A) Representative photomicrographs of H&E 





 mice. Mice were 
administered acute dose of CCl4 at 2 µl/g. Bars 
100 µm. (B) Necrotic tissue area in olive oil and 





mice. Necrotic tissue area results expressed as 
a mean percentage of total analysed tissue. N=3 
for olive oil groups, n=5 for WT and PolgA+/mut 
CCl4 treatment groups, n=4 for PolgAmut/mut CCl4 
treated mice. All P values were calculated using 










































     
Figure 6-7 (left): Serum 
aspartate transaminase 
(AST) levels in olive oil and 



































Figure 6-6 (above): Protein expression detecting 4-hydroxynenonal (4HNE) and CCl4 detoxifying 
cytochrome P450 enzyme CYP2E1 in olive oil and acute CCl4 administered WT, PolgA+/mut and 
PolgAmut/mut mice livers. Protein expression of lipid peroxidation marker 4HNE and CYP2E1 was detected 





6.4.2 Liver regeneration is delayed in PolgAmut/mut mice in response 
to acute oxidative CCl4 injury 
With the liver’s remarkable ability to recover lost cellular mass and function, 
hepatocyte regeneration ensues in response to tissue injury. Testing if oxidative 
injury in the context of dysfunctional liver mitochondria hinders parenchymal 
recovery, indices of hepatocellular regeneration by means of liver to body weight 
ratios (figure 6-8) appear to indicate no significant difference between WT, PolgA+/mut 
and PolgAmut/mut olive oil and CCl4 groups. This is despite previous likely inability of 
PolgAmut/mut to fully resolve necrotic tissue injury following CCl4 intoxication (figure 6-
5). These findings are similar to the indifferences observed across the liver to body 
weight ratios seen in WT and PolgA following partial hepatectomy (PHx). By contrast, 
hepatocellular proliferation quantified from H&E staining (figure 6-5, A) reveals that 
levels of mitotic bodies (MB) peak 48 hours post-injection and return within 5 days to 
vehicle olive oil levels in WT and PolgA+/mut mice (figure 6-9, B). These findings were 
similar in PolgAmut/mut livers; however, mitotic hepatocytes were still present at 5 days, 
perhaps indicating a delayed regenerative response. Comparable trends were also 
demonstrated by proliferating cell nuclear antigen (PCNA) IHC, with further analysis 
indicating a significant decrease in proliferating PolgAmut/mut hepatocytes compared to 
WT livers at 48 hours post-CCl4 injection (figure 6-9, A, C). The results would 
therefore suggest that the presence of mitochondrial respiratory deficiency in PolgA 
mut/mut mice diminishes hepatocellular regeneration following further oxidative tissue 




































Figure 6-8: Liver to body weight ratio of olive oil and acute CCl4 treated WT, PolgA+/mut and PolgAmut/mut 
mice.  
 
Liver to body weight quantified as ratio of excised liver weight at 48 hour or 5d post-CCl4 to body weight pre-
CCl4 injection. N=3 for all olive oil treatment groups, n=5 for WT and PolgA+/mut CCl4 treatment groups, n=4 for 











 mice.  
 
Regenerative response following CCl4 intoxication in control and CCl4 treated mice was analysed by mitotic 
bodies quantified from H&E (figure 6-5) and PCNA staining (above). Bars 100 µm. N=3 for all olive oil 
treatment groups, n=5 for WT and PolgA+/mut CCl4 treatment groups, n=4 for PolgAmut/mut CCl4 treated mice. 
























































































Reductions in liver regeneration could be ascribed to cell cycle arrest which can be 
detected by quantifying P16INK4a protein levels.  P16INK4a is elevated in PolgAmut/mut 
livers from 48 hours to 5 days following acute CCl4 injury (figure 6-10, A) and 
constitutively expressed at 5 days when compared to WT and PolgA+/mut mice. This 
constitutive expression is likely to limit post-injury hepatocellular proliferation, as 
initiated by the shift of normally quiescent G0 hepatocytes into G1 phase. Specifically, 
P16INK4a is understood to negatively regulate cyclin D and its interaction with CDK4/6, 
and as such, is able to halt cell cycle progression at the G0-G1 phase transition 
(Pavletich, 1999; Jeffrey et al., 2000). Across all genotypes, it was also observed that 
P16INK4a expression was induced at 48 hours and coincided with increased 
expression of cyclin D1 (G0/G1; figure 6-10B). Changes at 48 hours post-CCl4 were 
also seen for cyclin A2 (G2M), E1 (G1/S) and H (all cell cycle phases) (figure 6-10B). 
No obvious differences in all expression patterns between the three genotypes were 
observed for these cyclins, except for the constitutive expression of cyclin H, even at 
5 days in PolgAmut/mut CCl4-injured mice. Less is understood regarding cyclin H and 
its role in cell cycle, however, as part of the trimeric CDK activating kinase (CAK) 
complex, cyclin H assists in the activation of CDKs including during the 
phosphorylation of G1 phase CDK6 following association with its relevant cyclin (Lolli 
and Johnson, 2005). During cell cycle, cyclin H concentration and activity of its 
corresponding kinase CDK7 also remains invariant; however the return to cellular 
quiescence reduces levels – reflecting observations seen in 5-day CCl4 WT and 
PolgA+/mut mice (Lolli and Johnson, 2005). Taken together, it is therefore plausible 
that in mitochondrially deficient PolgAmut/mut mice, oxidative CCl4 injury further 
compounds hepatocellular regeneration by halting entry of quiescent state 
hepatocytes into the cell cycle via P16INK4a-mediated signalling. This leads to a 
reduction in cellular proliferation, therefore hindering liver recovery following oxidative 





     
Figure 6-10: Western blot analysis of P16INK4a and cyclins A2, D1, E1 and H protein expression in WT, 
PolgA+/mut and PolgAmut/mut mice livers following CCl4 injury.  
 
Changes in protein expression observed at 48 and 72 hour time points post-CCl4 intoxication for: (A) P16INK4a 
expression in olive oil and CCl4 treated WT, PolgA+/mut and PolgAmut/mut mice (B) Acute CCl4 induced changes 
in cyclin A2, D1, E1 and H in WT, PolgA+/mut and PolgAmut/mut mice. N=3 mice per genotype, per time point.  
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6.4.3 Acute CCl4 liver injury induces proapoptotic signalling in 
PolgAmut/mut livers 
Small wave apoptosis is typically required to correct excess hepatocytes produced 
during liver restoration: failure to incite apoptosis can lead to excess hyperplasia or 
tumorigenesis, whilst excessive apoptosis can lead to hepatocyte cell loss and liver 
damage (Sakamoto et al., 1999). In the present study, it was suggested that 
alterations to the homeostatic balance between cell survival and programmed cell 
death signalling is altered during post-CCl4 parenchymal recovery, with delays at 5 
day post-CCl4 injection coinciding with upregulated changes in mRNA expression of 
anti-apoptotic and pro-apoptotic genes. Indeed, PolgAmut/mut mice demonstrated 
significant elevations in anti-apoptotic genes Bcl-2 and BclXL at 5 days post-CCl4 
intoxication when compared to other treatment groups, yet no significance was 
observed between genotypes (figure 6-11, A-B). No differences between genotypes 
were also observed for pro-apoptotic gene Bid, in which expression was significantly 
downregulated in response to CCl4 administration as Bid truncates to assist with 
proapoptotic signalling figure (6-11, C). Instead, when assessing pro-apoptotic gene 
expression, BAX observed a 500-fold increase in 5 day PolgAmut/mut livers, greatly 
significant when comparing expression from other treatment groups and WT and 
PolgA+/mut genotypes (figure 6-11, D). Taken together, the results could therefore 
suggest alterations to the anti-apoptotic/pro-apoptotic signalling balance in favour of 
the latter, corroborating with failure to resolve pro-necrotic tissue damage as a result 






Figure 6-11: Apoptotic gene expression in WT, PolgA+/mut and PolgAmut/mut mice livers treated with olive 
oil and acute CCl4 intoxication.  
 
CCl4 injection induced alterations in anti-apoptotic Bcl-2 and BCLXL and pro-apoptotic BAX and Bid genes in 
olive oil and CCl4 treated WT, PolgA+/mut and PolgAmut/mut mice. N=3 for all olive oil treatment groups, n=5 for 
WT and PolgA+/mut CCl4 treatment groups, n=4 for PolgAmut/mut CCl4 treated mice. All P values were calculated 













































































































6.5  Inflammatory cell infiltration in response to acute CCl4 oxidative injury 
With clear failure to resolve proinflammatory liver necrosis and a diminished 
hepatocellular regenerative response following acute CCl4 intoxication in PolgAmut/mut 
mice, IHC staining for immune cells markers CD68 and NIMP were utilised to assess 
proinflammatory status within the oxidatively stressed liver. Staining with CD68 and 
NIMP indeed found proinflammatory infiltration following CCl4 injury, of which the 
infiltrate was a mixture of monocyte, macrophages and neutrophils. Present in 
significantly greater numbers than olive oil controls, CD68 staining positively 
identified, following injury, increased liver monocyte and macrophages at 48 hours in 
PolgAmut/mut mice, as well as at 5 days in WT and PolgA groups (figure 6-12, A-B). 
These changes appeared to be typical of downstream proinflammatory immune cell 
recruitment following injury; however, no significant differences were observed 
between the different genotypes. In addition, proinflammatory neutrophil recruitment 
was also reflected through significantly greater levels of NIMP positive cells at 48 
hours post-injection in WT, PolgA+/mut and PolgAmut/mut mice, which in the latter then 
failed to return to control olive oil levels at 5 days post injection (figure 6-13, A-B).  
  
The recruitment of such immune cells appears to be downstream of proinflammatory 
signalling. CCl4 injection induces gene expression of chemokine (C-X-C motif) ligand 
2 (CXCL2) and tumour necrosis factor alpha (TNFα) in all genotypes within 48 hours 
and at 5 days. In addition, there were significantly higher expression of these 
cytokines in PolgAmut/mut mice when compared to WT and PolgA+/mut groups (figure 6-
14, B-C). CXCL2 and TNFα are identified as chemotactic factors for neutrophils 
(Wolpe et al., 1989; Colletti et al., 1996). Gene expression for neutrophil chemotactic 
factor CXCL1 was also elevated at 5 days post-injection, reaching significance only 
in PolgAmut/mut mice when compared to olive oil controls and other genotypes (figure 
6-14, A).  By contrast, no obvious differences were observed between genotypes 
when assessing predominantly monocyte recruiting cytokines, monocyte 
chemoattractant protein-1 (MCP-1) and RANTES (C-C motif chemokine ligand 5), 
with peak gene expression at 48 hours and at 5 days post-injection respectively in 
WT, PolgA+/mut and PolgAmut/mut mice (figure 6-14, D-E). Taken together, these results 
suggest that CCl4-induced oxidative stress, could stimulate a greater proinflammatory 
phenotype in the presence of greater mitochondrial respiratory dysfunction, which 
subsequently may perpetuate acute oxidative tissue injury and diminish parenchymal 





Figure 6-12: CD68 immunohistochemistry of acute 







(A) Representative photomicrographs of CD68 





 mice. Mice were 
administered acute dose of CCl4 at 2 µl/g. Bars 100 
µm. (B) Quantification of CD68 positive cells in olive 
oil controls and in mice 48  hours and 5 days post-
CCl4 administration.  CD68 positively stained cells 
were counted in 15 HPF at x20 magnification. N=3 for 
all olive oil treatment groups, n=5 for WT and 
PolgA+/mut CCl4 treatment groups, n=4 for PolgAmut/mut 
CCl4 treated mice. All p values were calculated using 
a two-way ANOVA *p<0.05, ** = 0.01, **** p = 0.0001.  
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Figure 6-13: NIMP immunohistochemistry in 





 mice livers. 
 
(A) Representative photomicrographs of NIMP 
immunohistochemistry on livers from 8-12 week 





Mice were administered acute dose of CCl4 at 2 





 mice (n = >3, p = 
0.05) at 48 hours and 5 days post-injection and 
in olive oil controls. NIMP positive neutrophils 
were counted in 15 HPF at x20 magnification. 
N=3 for all olive oil treatment groups, n=5 for 
WT and PolgA+/mut CCl4 treatment groups, n=4 
for PolgAmut/mut CCl4 treated mice. All p values 
were calculated using a two-way ANOVA 








































Figure	  6-­‐15:	  mRNA	  gene	  expression	  of	  proinflammatory	  
genes.	  
(A)	  Representative	  photomicrographs	  of	  NIMP	  






	  mice.	  Mice	  were	  
administered	  acute	  dose	  of	  CCl
4
	  at	  2	  μl/g.	  Bars	  50	  μm.	  (B)	  
Administration	  of	  acute	  CCl
4
	  significantly	  increases	  






mice	  (n	  =	  >3,	  p	  =	  0.05)	  at	  48	  hours.	  NIMP	  positive	  cell	  levels	  
remained	  constitutively	  increased	  in	  5	  day	  PolgAmut/mut	  
livers.	  NIMP	  positive	  cells	  were	  counted	  in	  15	  HPF	  at	  x20	  
magnification.	  N=3	  for	  all	  olive	  oil	  treatment	  groups,	  n=5	  
for	  WT	  and	  PolgA+/mut	  CCl4	  treatment	  groups,	  n=4	  for	  
PolgAmut/mut	  CCl4	  treated	  mice.	  All	  P	  values	  were	  calculated	  
using	  a	  two-­‐way	  ANOVA	  *p<0.05,	  ***	  =	  0.005,	  ****	  p	  =	  
0.001.	  	  
Fi ure 6-14: Gen  xpr ion of 
proinflammatory genes in olive oil and acute 
CCl4 treated WT, PolgA+/mut and PolgAmut/mut 
mice.  
 
mRNA expression levels of proinflammatory 
genes (A) CXCL1 (chemokine C-X-C motif ligand 
1); (B) CXCL2; (C) TNFα (tumour necrosis factor-
alpha); (D) MCP-1 (monocyte chemoattractant 
protein 1); and (E) RANTES  (C-C motif 
chemokine ligand 5) in 8-12 week mice livers. N=3 
for all olive oil treatment groups, n=5 for WT and 
PolgA+/mut CCl4 treatment groups, n=4 for 
PolgAmut/mut CCl4 treated mice. All p values were 
calculated using a two-way ANOVA *p<0.05, 






















































































































































6.6  Fibrogenic activation in PolgAmut/mut mice 
Liver regeneration and repair encompass highly coordinated and complex wound 
healing processes that are key to resuming tissue homeostasis following physical 
stress and toxic injury to the liver parenchyma. Specifically, the term regeneration 
applies to compensatory hypertrophy and hyperplasia with no lasting damage on 
tissue morphology, often observed during partial liver resection. Tissues that cannot 
undergo regeneration undertake repair mechanisms that frequently lead to tissue 
fibrosis, characterised by ensuing ECM deposition during scar formation (Pinzani and 
Rombouts, 2004; Pellicoro et al., 2014). Within the liver, fibrosis leads to deposition 
of non-functional ECM by activated HSCs in place of healthy parenchymal tissue 
(Pinzani and Rombouts, 2004; Pellicoro et al., 2014). Whether liver regeneration or 
profibrotic repair mechanisms take place, depend on the burden of injury: larger, 
chronic and irreparable injuries often lead to fibrosis that can impair organ function 
whereas acute or smaller injuries result in the return of normal tissue function.  
 
Key to the re-establishment of tissue homeostasis is the complex coordination of 
haemostatic factors and proinflammatory immune cell recruitment with downstream 
activation of normally quiescent resident HSCs, cells essential in liver repair 
processes. Activated in response to proinflammatory cytokines like IL-1 and TGFβ, 
as well as growth factors such as platelet derived growth factor (PDGF) and 
connective tissue growth factor (CTGF), activated HSCs or ‘myofibroblasts’ support 
post-injury cell repopulation via the establishment of a temporary organ scaffold, 
generated by myofibroblastic secretion of ECM (Baiocchini et al., 2016). Once 
repopulated under normal reparative conditions, myofibroblasts typically undergo 
removal from the liver by apoptosis; they may also secrete metalloproteinases 
(MMPs) that break down formed granulation tissue and crosslink collagenous fibres 
to strengthen any scar tissue permanently deposited (Iredale et al., 1998; Wright et 
al., 2001). Indeed following acute liver injury, repair processes are transient and 
result in the rapid resolution of proinflammatory cell signalling and hepatic tissue 
vasculature to re-establish homeostasis. However, where failure to remove the 
causal insult exists, such repair processes can become dysregulated, resulting in 
chronic tissue damage, inflammation, sustained HSC activation and ultimately the 
imbalance of tissue repair and excess myofibroblast ECM scar formation that 
contribute to disease pathogenesis. As such, to determine whether the presence of 
mitochondrial respiratory dysfunction dysregulates hepatocellular regeneration and 
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repair mechanisms in response to oxidative injury, fibrotic status was assessed in 
olive oil and acute CCl4-injured WT, PolgA+/mut and PolgAmut/mut mice.  
 
6.6.1 Presence of mitochondrial respiratory dysfunction promotes  
persistent HSC activation following acute CCl4 oxidative damage 
Activation of liver fibroblastic HSCs following injury results in the switching from a 
normally quiescent, retinoid storing state into an active myofibroblast characterised 
immunophenotypically by expression of ECM and fibrosis-associated genes such as 
tissue inhibitor of metalloproteinase (TIMP), α-smooth muscle actin (αSMA) and type 
I collagens (COL1A1) (Higashi et al., 2017). Following acute oxidative CCl4 injury, 
myofibroblast populations in the WT, PolgA+/mut and PolgAmut/mut livers were 
visualised with αSMA immunohistochemistry. Corresponding to the induction of 
parenchymal necrosis by CCl4, αSMA positive staining showed significantly more 
activated myofibroblasts at 48 hours post-injury across all genotypes when compared 
to olive oil controls and 5 day groups (figure 6-15, A, B). Subsequently, levels of CCl4 
activated αSMA-positive myofibroblasts observed reductions in parallel with the 
resolution of necrotic tissue injury within 5 days post-intoxication, limiting cell 
positivity solely to endothelial cells lining hepatic blood vessels in WT and PolgA+/mut 
mice. Whereas, αSMA positive cells were significantly increased in 48 hours CCl4 
PolgAmut/mut mice compared to olive oil PolgAmut/mut  and remain elevated at 5 days 
post-injury. It is therefore plausible to suggest that the presence of mitochondrial 
respiratory dysfunction further compounds hepatocellular regeneration and repair 
following oxidative tissue injury via persistent profibrotic activity. Where comparisons 
were made between WT, PolgA+/mut and PolgAmut/mut mice, observations failed to 
reach significance. The persistence of αSMA-positive myofibroblasts in PolgAmut/mut 
mice was confirmed by western blot. Figure 6-16 shows constitutive αSMA protein 
expression in CCl4 injured PolgAmut/mut mice when compared to WT and PolgA+/mut 
controls, indicating sustained myofibroblast activation even after cessation of acute 
CCl4 injury.  
 
To therefore test if diminished liver regeneration and repair processes were a result 
of dysregulated fibrogenic response, mRNA expression of fibrosis-associated genes 
were measured and the fold change quantified. Expectedly, αSMA gene expression 
was upregulated across all genotypes at 48 hours as reflected in prior 
immunohistological staining, with significantly elevated levels in PolgA+/mut mice when 
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compared to other experimental groups (figure 6-17, A). The quantification of αSMA 
mRNA also revealed αSMA expression to be significantly upregulated in 5-day CCl4 
PolgAmut/mut mice when compared to WT and PolgA+/mut controls, consistent with the 
constitutive PolgAmut/mut αSMA protein expression seen via western blot and IHC. In 
line with a sustained fibrogenic response in PolgAmut/mut mice, mRNA expression of 
profibrogenic genes COL1A1 and TIMP1 were also elevated in 5 day CCl4 
PolgAmut/mut mice compared to WT and PolgA+/mut controls (figure 6-17, B-C). By 
contrast no differences were observed between genotypes for myofibroblast 
activating factor TGFβ following CCl4 injury, albeit stimulated expression at 48 hours 
across all genotypes (6-17, D). Observations of these profibrogenic genes would 
therefore appear to indicate the persistence of myofibroblastic activation which in turn 




Figure 6-15: αSMA 
immunohistochemistry in acute 





 mice livers. 
 
(A) Representative photomicrographs 
of α-smooth muscle actin (αSMA) 
immunohistochemistry on livers from 





 mice. Mice were 
administered acute dose of CCl4 at 2 
µl/g. Bars 100 µm. (B) Quantification 
of αSMA positive staining as a 
percentage of total tissue area at x20 
magnification. N=3 for all olive oil 
treatment groups, n=5 for WT and 
PolgA+/mut CCl4 treatment groups, n=4 
for PolgAmut/mut CCl4 treated mice. All p 
values were calculated using a two-
way ANOVA *p<0.05, *** = 0.005, **** 




Figure 6-16: α-smooth muscle actin (αSMA) protein expression in livers of olive oil and acute CCl4 
administered WT, PolgA+/mut and PolgAmut/mut mice.  
 




Figure 6-17: Fibrogenic gene expression in livers of olive oil and acute CCl4 administered WT, 
PolgA+/mut  and PolgAmut/mut mice. 
 
Quantification of mRNA expression of (A) alpha smooth muscle actin (αSMA); (B) collagen type I alpha chain 
(COL1A1); (C) tissue inhibitor of metalloproteinase 1 (TIMP1); and (C) tumour growth factor beta (TGFβ) at 48 
hour and 5 days following acute CCl4 administration in WT, PolgA+/mut and PolgAmut/mut mice. N=3 for all olive 
oil treatment groups, n=5 for WT and PolgA+/mut CCl4 treatment groups, n=4 for PolgAmut/mut CCl4 treated mice. 
























































































































6.6.2 Activation of hepatic stellate cells 
Whereas previous results show an inability for PolgAmut/mut hepatocytes to survive in 
culture, no similar defects were observed for isolated HSCs. In similarity to WT 
controls, transdifferentiation of quiescent HSC into hepatic myofibroblasts ensued 
around day 3; however, PolgAmut/mut HSCs appeared to undergo fibroblastic 
activation in greater numbers between day 3 and day 7 than in WTs when examined 
by cell microscopy (figure 6-19). Although this observation is interesting, no 
conclusive remarks can be generated from simple cell cultures with regards to 
sustained myofibroblastic activation and persistent fibrogenic activity. To determine 
whether the profibrogenic phenotype of PolgA mice is increased relative to control 
cells will require further work in isolated HSCs including the biochemical assessment 
of basal and activated phenotypic characteristics such as expression of fibrogenic 























































































Even at 8-12 weeks of age, PolgAmut/mut display alterations to normal mitochondrial 
function, characterised by deficient COX staining and the decreased expression of 
complex I NDUFB8 proteins in the absence of any acute CCl4 insult. Despite 
absence of any obvious pathologies, previous findings show that 1-3 month old 
PolgAmut/mut mice possess somatic mtDNA mutations 7-11 fold higher than WT and 
PolgA+/mut tissues (Vermulst et al., 2008). Interestingly, when challenged by CCl4-
induced oxidative stress, PolgAmut/mut livers were found to harbour greater levels of 
COX deficiency than 48 hour CCl4 injured WT and PolgA+/mut mice and had a lesser 
ability to resolve CCl4-induced respiratory deficiency within 5 days. Such findings 
could be attributed to PolgAmut/mut failure in the upregulation of complex I ND1 gene 
expression at 48 hours, albeit no differences were observed between genotypes. 
Rather, induced respiratory deficiency following intoxication did lead to the significant 
upregulation of mitochondrial genes cytochrome b, COX1, COX3 and ATP6 in 5 day 
CCl4 PolgAmut/mut mice - perhaps indicative of compensatory mechanisms associated 
with respiratory complex I deficiency. Indeed in PolgAmut/mut livers, inability to 
significantly upregulate ND1 coincided with failure to constitutively activate NDUFB8 
protein expression at 5 days post-CCl4 intoxication when compared to WTs. Whether 
this is associated with the observed diminished response in resolving CCl4-induced 
tissue injury is unclear, since NDUFB8 was similarly expressed in the 5-day 
PolgA+/mut group as to the PolgAmut/mut mice.  
 
Alterations to mitochondrial function also coincided with the significant upregulation 
of antioxidant gluthathione synthesising enzyme GSS and elevations of SOD1 at 48 
hours in PolgAmut/mut mice, enzymes understood to be involved in the scavenging of 
O2* and other ROS. In specific, glutathione has been shown to indirectly stabilise 
redox imbalance following formation of lipid oxy-radicals via reduction of ER-
associated dehyroascorbic acid (Mehlhorn, 1991; Espinosa-Diez et al., 2015). At 5-
day post-CCl4 SOD1 levels were observed to be decreased in a gene-dose 
dependent manner in PolgA+/mut and significantly so in PolgAmut/mut mice. It is 
therefore plausible that the presence of mitochondrial respiratory dysfunction 
increases susceptibility to oxidative lipid peroxidation stress, which in turn could 
further induce mtDNA mutagenesis that drives greater mitochondrial respiratory 
dysfunction, ROS production and possible tissue damage in a vicious cycle. 
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Certainly, in PolgA+/mut and PolgAmut/mut mice, 4HNE expression appears to indicate 
greater levels of lipid peroxidation, however, whether this is correlated to 
susceptibility via mitochondrial respiratory dysfunction is unclear, since mitochondrial 
assays conducted were unquantifiable.  It would therefore be useful to assess other 
assays and parameters of mitochondrial function, including mtDNA mutation load and 
mitochondrial ROS, as well as alternative markers of oxidative damage such as 
malondialdehyde and 8-OHdG.  
 
In the present study it was hypothesised that CCl4-induced oxidative stress in 
PolgA+/mut and PolgAmut/mut could further compound any hepatocellular recovery 
secondary to mtDNA oxidative damage. The greater presence of mitochondrial 
respiratory deficiency coincided with diminished recovery in post-CCl4 PolgAmut/mut 
mice from necrotic tissue damage and significantly decreased parenchymal 
regeneration, despite no differences in liver to body weight ratios across genotypes 
and experimental treatment groups. Whether delay in liver regeneration could be 
attributed in some part to failure in meeting any energetic demands would require 
additional experimentation; however, it is possible that findings in PolgAmut/mut mice 
could attribute loss of recovery to P16INK4a-induced cell cycle arrest at G0/G1 phase 
transition, with constitutive expression observed at 48 hours to 5 days post-CCl4 
intoxication. Failure to enter cell cycle at G1 phase would inevitably limit regenerative 
response; however, no obvious effects on the majority of cyclin protein expression 
profiles such as cyclin D1 and E1 were observed across genotypes, albeit persistent 
expression of cyclin H in olive oil and CCl4 treated PolgAmut/mut mice. To date, little is 
understood regarding cyclin H in the literature, except its participatory role in cell 
cycle proliferation via its part in the CAK complex. Alternatively, P16INK4a upregulation 
is also typically associated with cellular senescence, in which previous acute CCl4 
studies show induction of HSC senescence to limit fibrogenic response to acute 
tissue damage under normal liver repair mechanisms (Krizhanovsky et al., 2008). In 
the present study, persistent activation of αSMA-positive myofibroblasts in 
PolgAmut/mut livers was accompanied by the significant upregulation of profibrogenic 
genes αSMA at 48 hours, as well as the ECM-associated genes COL1A1 and TIMP1 
at 5 days post-CCl4 administration, when compared to WT and PolgA+/mut mice. It is 
therefore plausible that the presence of mitochondrial respiratory dysfunction could 
otherwise diminish hepatocellular recovery via sustained lipid peroxidising tissue 
damage and dysregulated fibrogenic response. To attribute diminished hepatocellular 
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recovery in the presence of mitochondrial respiratory dysfunction to either the 
P16INK4a-induced inhibition of cell cycle proliferation or chronic liver repair 
mechanisms would no doubt require additional work; necessitating further 
assessment of corresponding cyclin dependent kinases (CDKs) and other INK4, 
Cip/Kip family of cell cycle inhibitors, as well as additional markers of cellular 
senescence and tissue oxidative tissue damage at both tissue and cellular level.  
 
Failure to fully regenerate and sustained necrotic tissue injury in the presence of 
mitochondrial respiratory dysfunction appears to be inflammatory driven, with 
PolgAmut/mut mice showing persistent inflammatory cell infiltration and signalling within 
the liver. Specifically, the continued levels of NIMP positive neutrophils during 
PolgAmut/mut parenchymal regeneration even after 5 days coincided with the 
upregulated gene expression of proinflammatory cytokines CXCL1, CXCL2 and 
TNFα, all known to be chemotactic for neutrophils. The prolonged presence of 
neutrophils in these mice supports growing evidence that persistent inflammation 
diminishes normal hepatic wound healing and repair processes, ascribed to the 
promotion of a pro-oxidant environment via neutrophil ROS production which in turn 
further amplifies inflammatory status and diminishes parenchymal recovery 
(Theilgaard-Monch et al., 2004). It is therefore likely that failure to resolve necrotic 
tissue injury is linked to inflammatory cell infiltration, although augmented tissue 
necrosis and increased lipid peroxidation can also incite additional neutrophilic 
infiltration via ROS-mediated processes or complement activation from DAMPs 
(Marriott et al., 2008; Wera et al., 2016). When assessing whether sustained necrosis 
in PolgAmut/mut livers was a result of greater recipient tissue damage from acute CCl4 
intoxication, no differences in serum AST levels between genotypes were observed - 
subsequently indicating no differences in the tissue damage received and perhaps 
indicating that failure to recover from oxidative tissue injury is due to inflammation. 
Moreover, secondary to this inflammation is stimulation of fibrogenic and 
proapoptotic responses by proinflammatory cytokines released during post-CCl4 
repair mechanisms - in which cytokine release leads to the activation of HSCs into 
ECM synthesising myofibroblasts. 
 
Under irreparable tissue damage such as observed failure to clear necrotic liver 
tissue and upregulated gene expression of the pro-apoptotic signalling protein BAX, 
functional liver parenchyma is replaced with non-functional scar forming ECM. With 
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sustained proinflammatory neutrophil infiltration, PolgAmut/mut livers also demonstrated 
dyregulated myofibroblast activation and profibrogenic signalling. Taken together, the 
observations would appear to suggest that diminished hepatocellular regeneration 
could be a consequence of dysregulated neutrophil driven profibrogenic wound 
healing responses. Therefore, determining whether increased presence of 
mitochondrial respiratory deficiency and the subsequent heightened sensitivity to 
oxidative tissue damage and ROS production lends itself to altered repair 
mechanisms would require further work - perhaps including the separate and co-
culture cell based assays of neutrophils, hepatocytes and HSCs to determine if cell 
inherent defects are present. Initial steps have already been taken to show that 
basally cultured PolgAmut/mut HSCs, although smaller, appeared to readily undergo 
fibroblastic activation in greater numbers than in WT cells. However, these findings 
remain inconclusive, particularly in the absence of work that determines 
mitochondrial function, gene and protein complex expression, cell cycle/senescence, 
inflammatory and ROS signalling as well as fibrogenic responses in these cells both 
basally and in the presence of acute CCl4 oxidative stress.  
 
Observations in response to acute CCl4 oxidative damage in WT, PolgA+/mut and 
PolgAmut/mut mice would appear to suggest that in the liver, greater presence of 
mitochondrial deficiencies appears to reduce ability for the liver to regenerate and 
could induce further respiratory dysfunction. A key onset effect following CCl4 
intoxication is the reduction in the extent of hepatocellular regeneration that appears 
following stimulation of profibrogenic tissue repair responses, secondary to 
dysregulated proinflammatory signalling. Certainly, failure to resolve oxidative injury 
in the PolgAmut/mut liver parenchyma would appear to support a dysfunctional wound 
healing response, whereby neutrophils recruited to the site are a rich source of ROS 
and proinflammatory cytokines, which when released into the damaged environment, 
can activate myofibroblastic activity. Alternatively, where failure to resolve injury 
results in prolonged wound healing and fibrotic scar formation, fibroblasts may also 
become senescent and further contribute to disease pathogenesis and the oxidative 
microenvironment through further ROS production, though this was an avenue not 
further explored (Campisi, 1996; Krizhanovsky et al., 2008; Kim et al., 2013). 
Consequently, if allowed more time much further work would be required to discern if 
the presence of mitochondrial respiratory deficiency affects hepatocellular 
regeneration post-oxidative injury through dysregulated inflammatory and pro-
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apoptotic signalling, including assessing in vitro effects of oxidative stress on 
mitochondria and the mimicking of the oxidative microenvironment during post-CCl4 
























































































6.8 Chapter 6 Key Summary Points 
  
• When challenged by acute CCl4-induced liver injury, PolgAmut/mut mice appear 
to harbour greater levels of COX deficiency and a lesser ability to resolve 
induced respiratory deficiency and tissue damage within 5 days. This is likely 
to be attributed, in some way, to failure in the ability to upregulate complex I 
gene (ND1) and protein (NDUFB8) expression. 
  
• Alterations in 4HNE protein expression suggest that in the presence of greater 
respiratory dysfunction, PolgAmut/mut mice have greater susceptibility to the lipid 
peroxidising effects of CCl4 injury.  
 
• Decreased changes in antioxidant enzyme SOD1 was observed and could 
also indicate increased lipid peroxidation stress. This in turn could induce 
more mtDNA mutations, respiratory dysfunction, ROS production and tissue 
damage.  
 
• Loss of post-CCl4 tissue recovery in PolgAmut/mut mice may also be attributed to 
halting of cell cycle due to constitutive P16INK4a. 
 
• Liver tissue damage and recovery is accompanied by greater profibrogenic 
signalling in PolgAmut/mut mice and leads to stellate cell activation, potentially 
sustaining acute CCl4-induced tissue injury.  
 
• Sustained necrotic tissue in Polgmut/mut mice appears to be inflammatory driven 
as seen by persistent inflammatory NIMP positive neutrophil infiltrations and 
cytokine signalling in the liver. This may be augmented by lipid peroxidation 
stress which can incite additional inflammatory cell recruitment.  
 
• Results taken together support dysfunctional wound healing processes in 
PolgAmut/mut mice following acute CCl4 injury. In a vicious cycle, it is possible 
that greater lipid peroxidation stress following CCl4 leads to ROS and 
recruitment of proinflammatory cytokine-rich neutrophils, which when released 
promotes profibrogenic myofibroblastic activation and signalling and prolongs 




Chapter 7 | Discussion 
 
The link between the inexorable decline of liver homeostasis and increased 
mitochondrial dysfunction with age is clear. Greater morbidity, mortality and hallmark 
mitochondrial dysfunction is observed in aged patients for human chronic liver 
diseases whilst increased mitochondrial DNA (mtDNA) mutagenesis is also 
recognised to be linked to accelerated ageing. Such observations are yet to be fully 
elucidated mechanistically as mutually inclusive; however, at a functional level, the 
liver’s demanding roles are widely acknowledged to be supported by the 
hepatocytes’ abundant mitochondria, for example, mitochondria have a functional 
role in apoptosis, ROS and calcium signalling, glucose metabolism and fatty acid β-
oxidation (Grattagliano et al., 2011). It is therefore unsurprising that any molecular 
changes associated with mitochondrial dysfunction such as loss of mitochondrial 
membrane potential, reduced transportation of mitochondrial metabolites or changes 
to oxidative phosphorylation (OXPHOS) can lead to deleterious cellular effects, 
including, the depletion of ATP production, leakage of reactive oxygen species (ROS) 
as well as excess lipid storage within the mitochondria (Auger et al., 2015; Salazar-
Roa and Malumbres, 2017). Perturbation of mitochondrial function may also be 
considered an impeding factor: diminishing bioenergetic supply channelled towards 
compensatory hepatocellular regeneration that often follows hepatic injury and 
pathogenesis (Salazar-Roa and Malumbres, 2017). As such, mitochondrial 
dysfunction and mtDNA mutagenesis observed typically with normal organismal 
ageing, is suggested to lend itself to the development of liver disease such as 
NAFLD, steatohepatitis, fibrosis and cirrhosis and hepatocellular carcinoma (HCC) 
due to reduced regenerative capacity of the aged liver (Auger et al., 2015). It was 
therefore in the present study that the role of mitochondrial dysfunction was 
examined in the context of ageing liver regeneration.  
 
7.1 Mitochondrial dysfunction appears to reduce hepatocellular turnover and 
ageing liver regeneration 
Liver regeneration is an important hepatocellular process that allows the liver to 
maintain organ homeostasis, as well as recover cellular mass and function following 
tissue injury. Regeneration is a highly complex and coordinated process, in which 
hepatic integrity appears to be maintained through mechanisms involving expansion 
and differentiation of stem / progenitor cells portions during basal homeostasis, whilst 
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larger tissue injuries appear to result in the hypertrophy and proliferation of pre-
existing hepatocytes with minor input from progenitor cells (Kuwahara et al., 2008; 
Fellous et al., 2009; Furuyama et al., 2011; Tarlow et al., 2014). Critical to liver 
regeneration is the tight coordination of cell signalling, that involves the release of 
tissue growth factors and proinflammatory cytokines by several cell types, such as 
inflammatory cells. If dysregulated, this can lead to disrupted liver regeneration and 
even the exacerbation of hepatic tissue injury. The decline of normal liver 
homeostasis, for example, is widely implicated during the ageing process, enhancing 
an organism’s vulnerability to liver injury and disease. Significantly, models of 
regeneration utilising partial hepatectomy (PHx) have shown reduced survival in 
aged subjects, ascribed to lower hepatocyte response to proliferative and cell cycle 
signalling with age (Huh et al., 2004; Enkhbold et al., 2015).  
 
Underpinning the pathogenesis of age-associated decline in liver homeostasis is the 
complex interplay of molecular mechanisms that contribute to the ageing process; 
several common hallmarks acting in concert towards an organism’s progressive 
decline. Amongst them, mitochondrial dysfunction is a potential critical factor for age-
associated reduction in hepatic regenerative capacity, with earlier studies showing 
decline in mtDNA copy and organelle numbers, changes to the mitochondrial 
ultrastructure and significant reduction in respiratory capacity observed within livers 
of ageing humans and rodent models (Tauchi and Sato, 1968; Herbener, 1976; 
Stocco et al., 1977; Stocco and Hutson, 1978; Yen et al., 1989). Meanwhile, in 
pathologies of the liver, such as non-alcoholic steatohepatitis (NASH) and chronic 
viral hepatitis infection, increased mitochondrial dysfunction appears to be correlated 
with disease stage progression (Auger et al., 2015). 
 
Evidence notably reports mitochondrial dysfunction to primarily affect tissues with 
high energetic demand (Gonzalez-Freire et al., 2015). Within the liver, normal 
mitochondrial function is critical within the energy intensive process of liver 
regeneration: playing important roles in the control of respiratory and phosphorylation 
rates, as well as distinguished responsibilities in mediating functional metabolism and 
heterogeneity of hepatocytes following PHx (Yang et al., 2004; Ferri et al., 2005). In 
humans and rodent models, however, clonal expansion of respiratory chain deficient 
cytochrome c oxidase (COX)-deficient hepatocytes has been observed with growing 
occurrence (McDonald et al., 2008; Fellous et al., 2009). The increasing presence of 
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respiratory dysfunction, particularly within replicating cell populations is noted to have 
an attenuative and proapoptotic outcome on cell proliferation, ascribed in a study to 
the deleterious effects by age-accumulated mtDNA mutations (Nooteboom et al., 
2010). Elucidating the role of mitochondrial dysfunction in tissue ageing is therefore 
critical in order to identify how age-acquired mtDNA mutations may negatively 
contribute to liver injury and disease. 
 
The reduction in proliferating cell nuclear antigen (PCNA) markers of regeneration 
appeared to be associated with mitochondrial dysfunction, with significant increases 
in mitochondrial COX deficient areas and reduced expression of complex I NDUFB8 
concurrent with PCNA marker reductions in 12-month aged PolgAmut/mut mice. In line 
with previous human liver studies, the incidence of increasing mitochondrial defects 
also occurs during normal murine ageing, with deficiency originating in all mice 
groups around the periportal area and expanding in the direction of liver’s sinusoidal 
blood flow with age, in support of the ‘streaming’ hypothesis for hepatocellular 
turnover (Muller-Hocker et al., 1997; Fellous et al., 2009; Furuyama et al., 2011). 
Specific to PolgAmut/mut mice, defective mitochondrial patches are shown 
immunohistochemically to be approximately four to eight times larger than patches 
within age-matched WT controls. The greater occurrence of these deficient areas are 
likely attributed to the accelerated age-associated accumulation of mtDNA mutations 
within tissues of aged PolgAmut/mut mice, including the liver, that is noted to undelie 
the model’s premature development of ageing (Trifunovic et al., 2004; Kujoth et al., 
2005; Vermulst et al., 2007). Taken together, these data suggest that greater levels 
of mitochondrial dysfunction, including deficiencies of complex I, appear to be a 
contributing factor in the reduction of basal hepatocellular turnover within older 
PolgAmut/mut mice.  
 
The present study documents for the first time the role of age-acquired mtDNA 
mutations and resultant mitochondrial dysfunction in active liver regeneration, 
showing that the increased presence of mitochondrial dysfunction appears to have a 
deleterious effect on hepatic recovery, including the reduction in PCNA and mitotic 
body (MB) regenerative observed in both 70% partial hepatectomy (PHx) and CCl4 
oxidative injuries. Focussing on the former, specific failure to recover lost hepatic 
mass post-PHx was apparent in older PolgAmut/mut mice, supported by a reduction in 
MB and PCNA markers of regeneration. Analyses of regeneration markers, however, 
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also appeared to show that a certain threshold of mitochondrial dysfunction is 
required to attenuate post-PHx recovery: despite some reductions in PolgAmut/mut MB 
and PCNA at younger ages. Interestingly, young PolgAmut/mut mice have been shown 
previously to withstand a 500-fold higher mtDNA mutation frequency burden without 
the onset of ageing features (Vermulst et al., 2007). Therefore at younger ages, 
enough normal mitochondrial function is likely to remain within PolgAmut/mut mice to 
permit normal liver regeneration. This may be additional aided by the significantly 
increased expression of cytokine signalling molecule tumour necrosis factor α (TNFα) 
within PolgAmut/mut mice, which even under normal circumstances ensues following 
PHx. Acting in a compensatory manner, overexpression of TNFα, for example, is 
noted in one study to induce activation of anti-apoptotic pathways (Kubota et al., 
2001).  
 
7.2 Defective liver regeneration due to mitochondrial dysfunction could be 
associated with cell cycle arrest 
There is growing evidence to show that mitochondrial function is intimately linked 
with cellular proliferation and cell cycle progression (Salazar-Roa and Malumbres, 
2017). For example, cyclin D1 is shown to modulate in vivo mitochondrial activity 
during oxidative glycolysis; accumulation of cyclin E is linked with formation of a 
hyperfused ATP-synthesising mitochondrial network at  the G1-S phase transition; 
whilst inhibition of mitochondrial OXPHOS activity is found to halt cell proliferation via 
cell cycle arrest and apoptosis (Sakamaki et al., 2006; Wang et al., 2006; Srivastava 
and Panda, 2007; Taguchi et al., 2007; Mitra et al., 2009; Wang et al., 2014). In the 
present study, a consistent loss of complex I NDUFB8 expression is described within 
aged PolgAmut/mut hepatocytes and during defective PolgAmut/mut hepatocellular 
turnover and regeneration and alludes to a possible critical role for complex I in 
attenuating liver regeneration. Prior studies by Wang and colleagues (2014), for 
example, note the inability to phosphorylate complex I subunits and results in the 
arrest of cell proliferation at the G2/M of the cell cycle, whilst disruption of complex I 
by genetic ablation or inhibitory means is described to retard cell cycle during G1-S 
transition (Srivastava and Panda, 2007; Owusu-Ansah et al., 2008; Wang et al., 
2014).  Therefore, our results suggest that mitochondrial dysfunction arises primarily 
from complex I deficiency in PolgAmut/mut mice and could have a mechanistic role in 
preventing normal liver regeneration via cell cycle arrest within these mice. The 
present data is unable to conclude, however, the role of complex IV COX deficiency 
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in the observed PolgAmut/mut phenotype due to inconsistent protein detection despite 
histological COX-negative detection.  
 
An additional supporting explanation for mitochondrial deficiency-mediated cell cycle 
arrest is the expression of p16INK4A and cyclin H (figure 6-11) during CCl4 oxidative 
injury that coincides with failure to resolve necrotic tissue injury within PolgAmut/mut 
mice. Specifically, p16INK4A is understood to inhibit the cyclin D1/ cyclin dependent 
kinase (CDK) 4/6 complex that prevents phosphorylation of the retinoblastoma (Rb) 
protein, resulting in the blockage of G1-S phase transition during cell cycle (Bruce et 
al., 2000). However, inability to detect differences in cyclin D1 expression makes it 
unlikely for p16INK4A-induced arrest to be mediated in this manner: P16INK4A is noted 
alternatively in one study to associate with the RNA polymerase II C-terminal domain 
(CTD) and general transcription factor TFIIH, of which cyclin H forms a subunit, to 
regulate gene transcription during cell cycle at G1 phase (Serizawa, 1998). 
Therefore, since constitutive expression of cyclin H was observed in the present 
study in Polgmut/mut whole livers, failure to recover from oxidative hepatic stress could 
be ascribed to cell cycle arrest at G1-S phase transition via P16INKA-mediated 
inhibition of CTD phosphorylation by TFIIH. In order to definitively assess whether a 
p16INK4A-cyclin H mechanism plays a cell cycle arresting role during liver ageing and 
hepatocellular regeneration, measurements of cyclin protein expression would be 
consequently extended to hepatectomised and basally ageing models used within 
the present study. Moreover, since little difference in expression was observed 
between checkpoint cyclins following CCl4 injury, a future possibility would be to 
alternatively determine expression levels of cyclin kinases like CDK4/6 and other 
cyclin-dependent kinase inhibitors (CKIs) including p21 and p27 of the CIP/KIP 
family.  
 
In addition, to determine if induction of hepatocyte cell cycle arrest arises from 
increased mitochondrial complex I respiratory deficiency, a natural progression would 
be to measure these cell cycle proteins in WT, PolgA+/mut and PolgAmut/mut 
hepatocytes. Difficulty in establishing and maintaining PolgAmut/mut hepatocyte cell 
viability was experienced in the present study and consequently was not an avenue 
further explored. Future possibilities could include measuring these parameters in 
hepatocyte model involving pharmacological inhibition or siRNA knock-down of 
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complex I in WT hepatocytes, as previously demonstrated (Fato et al., 2009; He et 
al., 2013). 
 
7.3 Mitochondrial dysfunction is an inducer of apoptosis 
Mitochondria are widely acknowledged to regulate apoptosis, with alterations to 
typical mitochondrial function and dynamics noted to accompany the release of 
signalling factors during activated pathways of cell death (Otera and Mihara, 2012). 
Complex I has been specifically identified as an important substrate for caspase 3, in 
which p75 nicotinamide adenine dinucleotide (NADH) dehydrogenase (ubiquinone 
Fe-S protein I) complex I subunit is cleaved and complex I inhibited, resulting in the 
collapse of the mitochondrial transmembrane potential (ΔΨM) and increase in 
reactive oxygen species (ROS) production (Ricci et al., 2004). Chemical inhibition of 
complex I by rotenone is also understood to produce a similar response (Li et al., 
2003).  Therefore, in response to deficiency of complex I with age, PolgAmut/mut mice 
may exhibit a similar phenotype that results in the downstream activation of apoptotic 
signalling. Immunohistological analyses of caspase-3 within basally aged tissues 
indeed demonstrates increasingly elevated levels of hepatocyte apoptosis correlate 
with age-associated increases in mitochondrial dysfunction.  These data are 
supported by mRNA gene expression in favour of pro-apoptotic signalling activation 
in basally aged PolgAmut/mut mice (figure 4-1; figure 4-11). As such, these findings 
appear to reaffirm the well-established relationship between mitochondrial function 
and apoptosis, whilst suggesting a more detailed role for complex I deficiency within 
the activation of apoptotic cell death.  
 
Enhanced apoptosis is shown to delay liver regeneration (Yamada et al., 1998; 
Kovalovich et al., 2000; López-Fontal et al., 2010). Therefore, mitochondrial 
deficiency-induced cell death may be a critical driver in reduced PolgA+/mut and 
Polgmut/mut liver regeneration where hepatocellular proliferation is attenuated; the 
regulation of intrinsic mitochondrially mediated apoptosis carefully balanced by BCL-
2 protein family members – namely by anti-apoptotic BCL-2 and proapoptotic BAX 
proteins (Dai et al., 2018). BCL-2 and pro-apoptotic BCLXL are noted in the early 
priming phase of hepatic recovery to increase in expression levels and inhibit 
proapoptotic cytochrome c release: changes that are somewhat reflected in trends 
within the present study during the recovery period that follows CCl4 oxidative injury 
(Fausto, 2000; Su et al., 2002; Jiang et al., 2004; Chung et al., 2005). Whilst, Bax 
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signalling induces apoptosis through insertion into the mitochondrial outer membrane 
to mediate the release of apoptotic factors. Gene expression analyses of 5-day CCl4 
injected PolgAmut/mut mice reveals a 500-fold increase in BAX (figure 6-12), as well as 
enhanced levels with normal PolgAmut/mut ageing that is concurrent with significant 
increases in caspase-3 positive hepatocytes.  Together these data suggest biological 
skewing of apoptotic signalling with age-accumulated mitochondrial dysfunction, in 
favour of cell death. In agreement, significant increases in the BAX/BCL-2 ratio and 
expression of cleaved caspase-3 has been shown to be an indicator for the initiation 
of apoptosis (Dai et al., 2018).  
 
It is likely that accumulation of mitochondrial respiratory chain dysfunction with age is 
a critical contributor in the activation of pro-apoptotic signalling. However, 
unfortunately due to the time limitations of the study, were unable to extend direct 
measurements of apoptotic gene expression to PHx in WT and PolgA mice.  
However, the prediction would be that the effect of mitochondrial dysfunction in 
PolgA mice would result in exacerbated pro-apoptotic signalling due tto significant 
tumour growth factor beta (TGFβ1) upregulation post-PHx. TGFβ1 is widely 
understood to exert anti-proliferative effects under normal conditions via the induction 
of apoptosis to correct excess parenchymal recovery (Sakamoto et al., 1999). It is 
therefore possible that failure to recover lost cellular mass in 6-month PolgAmut/mut 
mice may be alluded to the induction of apoptosis. In the post-PHx setting, 6 month 
TNFα expression was also downregulated, minimising its known effect on preventing 
apoptotic signalling (Takehara et al., 1998; Flusberg and Sorger, 2015). 
 
Apoptosis is one of several outcomes that can follow cell cycle arrest, in which 
previous literature frequently establishes transcription factor p53 activity to be a 
critical decider of cell fate (Hafner et al., 2019). The expression of pro-apoptotic BCL-
2 and BAX genes, in particular, are understood to be under transcriptional control of 
p53; in which both are demonstrated here to be significantly upregulated in basally 
aged and CCl4-injured PolgAmut/mut mice.  Evidence suggests that the levels of p53 
are correlated with the induction of apoptosis: higher levels resulting in activation of 
apoptotic processes, whilst cell cycle arrest is induced at lower concentrations – 
despite inconsistencies between the onset of apoptosis, p53 levels and apoptotic 
gene promoter binding (Chen et al., 1996; Kapoor and Lozano, 1998; Appella and 
Anderson, 2001; Lavin and Gueven, 2006). Alternatively, p53-regulated cell fate is 
208  
  
proposed to be mediated through repressive functions: cyclin B1 for example is 
repressed following partial binding of p53 dimers to promoter CCBN1’s head-to-tail 
element (Lipski et al., 2012). 
 
Despite this critical role, p53 activity was not assayed in the present study, and if 
allowed more time would be assessed to determine a possible mechanistic link 
between mitochondrial respiratory dysfunction and the induction of apoptosis, as 
apparent within ageing PolgAmut/mut mice and PolgAmut/mut liver regeneration. 
Conversely the p16INK4A signalling pathway is understood to play an overlapping role 
with p53 in cell cycle arrest, with initial emerging data showing p16INK4a to negatively 
regulate p53 through prevention of MDM2-mediated degradation of p53 (Al-Khalaf 
and Aboussekhra, 2018). More notably P14ARF, also encoded by the same CDKN2A 
gene, is well established in the disruption between inhibitory MDM2 and its substrate 
p53 (Zhang et al., 1998; Vivo et al., 2015). Inhibition results in transcriptionally active 
p53 accumulation, able to direct cell fate towards either arrest or apoptosis. Taken 
together, our results could indicate that constitutive expression of p16INK4a in 
PolgAmut/mut mice, as seen following CCl4 intoxication, may lead to cross-talk inhibition 
of MDM2, resulting in p53-mediated apoptosis. Confirmation of such a hypothesis 
thereby requiring measurements of p53 expression.  
 
7.3.1  Apoptosis could be additionally stimulated by increased ROS which 
together drives reduced liver regeneration in ageing PolgAmut/mut mice 
Excess ROS production is hypothesised to be a major contributing factor to the 
ageing process, ascribed to the cumulative effect of increased oxidative tissue injury 
(Harman, 1972; Lopez-Otin et al., 2013). Through Harman’s well-established Theory 
of Ageing, age-associated biological decline is understood to arise from oxidative 
free radical reactions by reactive oxygen species (ROS), formed from the leakage of 
electrons from the mitochondrial respiratory electron transport chain (ETC) (Harman, 
1972). In progeroid PolgAmut/mut mice, earlier studies demonstrate a lack of oxidative 
tissue damage despite presence of mitochondrial respiratory dysfunction; however, 
more recent methodologies involving in vivo ROS measurements of redox signalling 
molecule H2O2 (hydrogen peroxide) appears to coincide with abnormal activation of 
pro-apoptotic and pro-inflammatory signalling pathways (Logan et al., 2014). An 
observation seemingly consistent with reductions in anti-oxidant genes glutathione 
synthetase (GSS) and glutathione peroxidase (GPx) and increases in mitochondrial 
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ROS scavenger superoxide dismutase 2 (SOD2) and peroxisome proliferator 
activated receptor gamma coactivator 1 alpha (PGC1α), that is concurrent with 
increased cell death observed within PolgAmut/mut primary hepatocytes and ageing 
livers (St-Pierre et al., 2003; Valle et al., 2005; St-Pierre et al., 2006). In line with this, 
deficiency of oxidant-catalysing enzymes GPx and GSS are understood to increase 
ROS-induced oxidative stress, whilst ablation of SOD2 in homozygous and 
heterozygous mice exhibit reduced mitochondrial respiration and heightened 
sensitivity to apoptosis, due to increased predilection of MPTP (mitochondrial 
permeability transition pore) transition in response to superoxide (O2*) species 
(Kokoszka et al., 2001; Espinosa-Diez et al., 2015). Indeed, depolarisation of the 
mitochondrial membrane leads to uncoupling of the respiratory chain, mitochondrial 
swelling and rupture, and ultimately, release of apoptosis-inducing factors such as 
cytochrome c, endonuclease G and apoptosis inducing factor (AIF) (Low, 2003; 
Alexandris et al., 2004; Wang and Youle, 2009). Taken together, results in the 
present study could therefore similarly indicate abnormal activation of a ROS-
apoptotic pathway in PolgAmut/mut mice, as seen by Logan and colleagues (2014), 
ultimately contributing to the observable reduction in basal hepatocellular turnover 
seen with age.  
 
Oxidant homeostasis plays a critical protective role within the liver against oxidative 
stress: particularly given the organ’s normal physiological exposure to a variety of 
endogenous and environmental stressors. Hepatocytes protect the liver from harmful 
oxidants, including ROS, predominantly through capacity to produce anti-oxidant 
glutathione (GSH), which undergoes reductive and oxidative redox reactions 
catalysed GPx and glutathione disulphide (GSSG) respectively to achieve anti-
oxidant function (Lu, 2009). Alterations to GSH homeostasis can result in oxidative 
damage, of which hepato-pathophysiological changes can occur: such as hepatic 
steatosis, hepatic inflammation leading to fibrosis, and liver failure due to 
dysregulation of lipid metabolism, inflammatory and apoptotic pathways respectively 
(Mansouri et al., 2018). Such changes may also manifest into disease including non-
alcoholic fatty liver disease (NASH), alcoholic and drug-induced liver diseases.  
Prior studies show that active liver regeneration influences the oxidative state within 
the normal and pathological liver (Huang et al., 1998; Alexandris et al., 2004; Yang et 
al., 2004). GSH is noted to immediately decrease following surgical PHx and 
oxidative CCl4 injury, with decreased levels recovering soon thereafter (Nishida et al., 
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1996; Huang et al., 1998). Such findings appear consistent with the present PHx 
study, in which glutathione synthesising enzyme, glutathione synthetase (GSS), 
decreases in 6-month PolgA mice in the periods following injury. These levels, 
however, fail to recover post-injury - indicating a possibility for the presence of 
mitochondrial dysfunction to have a deleterious role in GSH production.  
 
Of particular interest, is the noted reduced ability to produce GSH in disorders that 
affect mitochondrial respiratory function, which may explain limited detection of GSS 
in partial hepatectomised 3-month PolgAmut/mut mice (Atkuri et al., 2009). Yet in 6-
month T0 livers, GSS is significantly raised compared to WT T0 controls. It is 
therefore plausible that in PolgAmut/mut mice, the accumulation of mitochondrial 
dysfunction with age results in greater oxidative stress from generated ROS and 
likely lends itself minimisation of oxidant tissue damage via GSS-mediated GSH 
synthesis. This could be additionally supported by increases in ROS scavenger 
SOD1 post-PHx which increases in 6-month PolgAmut/mut mice, whilst such claims 
may be further substantiated by analyses of liver regeneration following oxidative 
stress, in which CCl4 oxidative injury significantly induces GSS production. Given the 
additive level of oxidative stress to this model, it is therefore possible that defence 
mechanisms of PolgAmut/mut mice in response to greater levels of ROS requires a 
threshold of oxidative injury to stimulate antioxidant processes, that include GSH 
production.  
  
The present data does not confirm whether dysfunctional mitochondria are a source 
of endogenous ROS nor directly results in observable age-associated oxidative 
tissue damage in PolgA mice. Regrettably neither in vivo ROS concentrations nor 
direct measures of oxidative tissue damage, such as malonadialdehyde (MDA), 
4HNE (4-hydroxy-2-nonenal) and 8-OHdG (8-hydroxy-2-deoxyguanosine), were 
further investigated in PolgA mice, but if allowed more time would be undertaken. 
Indirect measures of COX negative areas, however, imply greater mitochondrial 
dysfunction and abnormal release of electrons at 12 months of age, as inferred 
biochemically by the reduction of electron acceptor nitroblue tetrazolium (NBT) in the 
absence of complex I NDUFB8 expression (Ross, 2011). This could therefore 
support a role within PolgAmut/mut mice for mitochondrially-produced ROS in the 
abnormal stimulation of apoptotic signalling, that in turn reduces hepatocellular 
turnover. Such claims for activation of ROS-induced apoptosis in the presence of 
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increased mitochondrial dysfunction is the concurrent alterations of anti-oxidant and 
pro-apoptotic markers alongside harboured levels of COX deficiency and reduced 
complex I expression in PHx and CCl4-injured PolgAmut/mut mice. Given the reduced 
ability of these models to recover lost cellular mass and normal tissue physiology 
respectively, the data suggests that the presence of mitochondrial dysfunction in 
PolgAmut/mut mice results increased ROS production, which in turn leads to activation 
of apoptotic signalling and reduced hepatoregenerative capacity following injury.  
 
7.4 Mitochondrial ROS plays a critical role in proinflammatory and apoptotic 
signalling in ageing liver regeneration  
Whilst accelerated PolgAmut/mut ageing is presently suggested to increase oxidative 
stress and ROS-mediated stimulation of apoptosis, a further explanation could be 
attributed to the additional activation of pro-inflammatory signalling. Certainly, 
apoptosis and inflammation are widely understood to be intricately linked, and in 
Logan’s study (2014) age-associated increases in ROS in PolgAmut/mut mice was 
shown to induce elevated serum cytokine levels concurrent with activation of pro-
apoptotic pathways. A finding that corroborated data in aged Polgmut/mut mice in the 
present study, where both elevations of serum cytokines and mRNA expression of 
inflammatory genes are observed in conjunction with alterations in anti-oxidant gene 
expression and markers of cell death.  
 
ROS are acknowledged to exert their effects across of plethora of pro-inflammatory 
signalling modules including the NLRP3 (nod-like receptor family pyrin domain 
containing 3) inflammasome and the redox-sensitive transcription factor nuclear 
factor κB (NF-κB), both of which are also known to partake in the regulation of cell 
death (Morgan and Liu, 2011; Abais et al., 2015). In both systems H2O2, as well as 
other ROS such as peroxynitrite (ONOO-) that are likely to arise from age-associated 
mitochondrial electron leakage, are well documented to be inducing factors of these 
signalling modules (Bai et al., 2015). The NLRP3 inflammasome has been shown, for 
example, to be activated by mitochondrial ROS during ETC complex I and III 
disruption, and able to translocate to the mitochondria on ROS-induced stimulation 
(Bulua et al., 2011; Zhou et al., 2011; Abais et al., 2015). Activation occurs in a two-
step signalling mechanism that ultimately converges on the NF-κB-dependent 
maturation of cytokine interleukin-1β (IL-1β) and the proteolytic cleavage of pro-
apoptotic procaspase-1, yet inconsistently no increases to serum IL-1β were 
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observed (Abais et al., 2015). On this basis, NLRP3 involvement could be lacking in 
the suggested ROS-apoptotic proinflammatory axis; however, it is important to note 
that inability to serologically detect changes could be ascribed to IL-1β’s short half-life 
(Kudo et al., 1990). Therefore to fully exclude its involvement, additional 
quantification of IL-1β and indicators of NLRP3 signalling may therefore be required: 
including IL-1β mRNA expression, as well as protein-level or histological detection of 
caspase-1 functions. 
 
On the other hand, NF-κB is shown previously to undergo a series of direct and 
indirect H2O2-induced phosphorylative modifications that help present NF-κB as a 
redox-sensitive factor: most likely involved in serving activation of both pro- 
inflammatory and apoptotic pathways within this study (Schoonbroodt and Piette, 
2000; Takada et al., 2003). Apoptotic signalling is particularly understood to arise 
from NF- κB’s mediatory role in transcribing a number of pro-apoptotic inflammatory 
cytokines, including TNFα and IL-6 (Hayden and Ghosh, 2014). Both cytokines are 
noted in the present PolgAmut/mut study to show increases basally and in response to 
CCl4-induced liver regeneration both serologically and at a gene expression level 
(figure 4-16, 6-15), therefore proposing a possible role for NF-κB signalling in the 
activation of the apoptotic-proinflammatory pathway axis as suggested within the 
presence of PolgA-induced mitochondrial dysfunction (Logan et al., 2014).  
 
As well as regulating inflammatory pathways, there is a clear link between NF-κB and 
the potentiating role it plays in anti-oxidant activity (Morgan and Liu, 2011). Targets 
include a diverse array of anti-oxidant proteins, including targeting of the SOD2 
promoter binding site by translocated p50 and p65 NF-κB subunits following TNFα 
stimulation, as well as the presence of NF-κB binding sites in SOD1 (Jones et al., 
1997; Maehara et al., 2000; Morgan and Liu, 2011). Whilst NF-κB remains to be 
further investigated, in this context it is possible to suggest that induction of 
proinflammatory cytokines TNFα and IL-6, stimulates anti-oxidant gene transcription. 
SOD2 appears to show trends of increasing expression with age concurrent with 
significantly increased serological levels and expression of proinflammatory cytokines 
within 12-month PolgAmut/mut mice. Such rises in anti-oxidants are likely an attempt to 
minimise effects of inflammation and pro-apoptotic oxidative stress due to increased 
ROS during mitochondrial dysfunction. Certainly this is plausible with ablation and 
knockdown of SOD2, for example, having been shown previously to increase cellular 
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sensitivity to apoptotic signalling, as well as induce inflammation in response to 
oxidative stress (Ishihara et al., 2015).  
 
By contrast, similarities were not observed in response to liver injury, with variety in 
the correlation between inflammatory and anti-oxidant signalling likely to arise from 
complex regulatory molecular mechanisms that control these pathways (Hayden and 
Ghosh, 2014). Notably TNFα is a key regulator of NF-κB via inhibitor of kappa-B 
(IκB), in which expression terminates NF-κB, as well as TNF-dependent responses 
(Brown et al., 1993; de Martin et al., 1993; Sun et al., 1993; Klement et al., 1996). It 
is therefore possible that during CCl4 injury, the inability to detect changes in SOD2 
may be ascribed to the PolgAmut/mut mice having a ~2.3 fold increase in TNFα, in the 
period following intoxication. Significantly increased TNFα expression could, in turn, 
provide a negative feedback loop which represses NF-κB-induced SOD2 expression. 
Conversely within partial hepatectomised mice, changes in SOD1 appeared to 
oppositely mirror elevations in TNFα. These expression patterns may be alluded to 
the previously reviewed poor response of the SOD1 promoter NF-κB binding site to 
external stimuli; however, could also result from the antagonising regulatory effect of 
SOD1 upon TNFα expression (Afonso et al., 2006; Dimayuga et al., 2007; Miao and 
St Clair, 2009). Nonetheless, the present analyses highlights a relationship between 
the activation of inflammatory pathways and the induction of apoptosis and anti-
oxidant signalling, ascribed to the abnormal release of ROS during age-accumulated 
mitochondrial respiratory dysfunction.  
 
7.5 Mitochondrial respiratory dysfunction and oxidative stress play key roles in 
the activation of liver cell senescence 
Biologically, mitochondria play a number of key tightly regulated roles across a 
plethora of cellular processes that include cell cycle regulation, apoptosis, and 
energy production via ATP biosynthesis (Nunnari and Suomalainen, 2012). 
Alterations to normal function unsurprisingly results in pathophysiological 
manifestations, including abnormal activation of ROS signalling, cell death and 
inflammatory pathways as alluded above, as well as the development of disease and 
organismal age-associated decline (Nunnari and Suomalainen, 2012).  
 
Amongst other findings, cumulative evidence shows that mitochondrial dysfunction 
can induce cellular senescence, one of several key hallmarks of ageing 
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characterised by incessant cell cycle arrest and a biological programme of changes 
including increased β-galactosidase activity and chronic low-grade inflammation 
(Lopez-Armada et al., 2013; Chapman et al., 2019). Thought to be a mechanistic 
pathway evolved to evade cellular replication in the presence of DNA damage, 
senescent cells feature mitochondrial alterations: including increases in mitochondrial 
mass and hyperfusion, decreased membrane potential and the resultant increase in 
ROS production and proton leakage (Passos et al., 2007; Moiseeva et al., 2009; 
Passos et al., 2010). Moreover, the selective removal of dysfunctional mitochondria 
from senescent cells was shown to ameliorate the senescent phenotype (Correia-
Melo et al., 2016). To this end, analyses of the present data could suggest a 
mediatory role for mitochondrial dysfunction in ageing liver regeneration - via 
activation of hepatocyte senescent cell cycle arrest.  
 
An induction of cellular senescence may be subsequently ascribed to its onset in 
response to oxidative stress, in which earlier steps undertaken to minimise 
mitochondrial ROS species are shown to delay oxidative DNA damage-induced 
cellular senescence and increase replicative lifespan (Packer and Fuehr, 1977; Chen 
et al., 1995). Increased SOD2 gene expression, concurrent with reductions in 
hepatoproliferative markers within basally 12-month aged PolgAmut/mut mice could 
likely be a consequence of senescent cell cycle arrest due to exacerbated ROS 
production due to age-accumulated mtDNA mutations. In this context, excessive pro-
oxidants from mitochondrial dysfunction may be a contributory factor as a 
combination of increased production and the inability to scavenge these eletron 
transport chain (ETC) by-products: both of which are features observed elsewhere 
(Passos et al., 2007). The confirmation of senescent induction would however require 
further investigation of cell cycle mediators to confirm arrest, involving the profiling of 
proteins like cell cyclins, CDKs and cell cycle regulatory factors such as p16, p21 and 
p53.  
 
Further establishment of ROS involvement in senescence also suggests a capacity 
for oxidant signalling in potentiating downstream senescent effector pathways via 
stabilisation of induced cell cycle arrest. Supporting this is the prominent feature of 
ROS generation following activation of senescence-associated pathways that include 
p16, p21 and p53 cell cycle mediators (Macip et al., 2002; Macip et al., 2003; 
Takahashi et al., 2006). Whilst there is considerable overlap between these 
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pathways, constitutive expression of arresting p16INK4A was noted alongside reduced 
post-CCl4 hepatic regeneration in PolgAmut/mut mice.  The acutely damaging 
hepatotoxin which allows for clear pathophysiological liver necrosis following 
cytochrome P450-mediated metabolism into lipid reactive radicals, as well as induce 
dysfunctional changes within hepatocyte mitochondria, appeared to have changes in 
line with typical findings. These include histological necrosis, inflammation and 
increased expression of lipid peroxidation 4HNE and cytochrome CYP2E1 markers 
at 48 hours post-CCl4 intoxication (Knockaert et al., 2011). However, unlike PHx and 
basally aged Polgmut/mut mice, alterations in superoxide dismutase (SOD) levels did 
not accompany putative p16INK4A-cyclin H cell cycle arrest, as perhaps alluded to the 
abovementioned repression of SOD2 gene expression by increased TNFα. Despite 
this, CCl4 intoxication did show significantly greater GSS expression at 48 hours 
within PolgAmut/mut mice, alternatively suggesting the presence of glutathione anti-
oxidant defence mechanisms to combat CCl4-induced oxidative injury. Elevations in 
GSS also proceeded consistent p16INK4A expression at 5 days, therefore the present 
data suggests that the presence of mitochondrial dysfunction increases liver 
senescence following the inability to combat oxidative stress – ultimately impacting 
on the livers ability to regenerate.   
 
Senescence is also shown to involve other signalling pathways including the DNA 
damage stress response as a consequence of excessive ROS (Chen et al., 1995). 
Telomeric regions of DNA chromosomes, for example, are shown to be highly 
sensitive to the oxidising effects of ROS, with mitochondrial ROS, in particular, 
shown to induce telomere DNA dysfunction and stimulate premature senescence 
(Petersen et al., 1998; Passos et al., 2007; Hewitt et al., 2012). The manipulation of 
SOD2 is likewise shown to increase the likelihood of inducing age-dependent 
telomere dysfunction, whilst steps to minimise production including antioxidant 
scavenging with MitoQ and partial ETC uncoupling are demonstrated as preventative 
measures (Saretzki et al., 2003). Regrettably, ROS-induced effects of DNA damage 
was not an avenue further explored, especially given the contribution of ROS in 
reinforcing senescent cell cycle arrest via persistent activation of damage responses. 
Assays may include looking at damage foci markers such as γH2.AX and TAF, which 




7.5.1 Mitochondrial respiratory dysfunction potentiates the senescent 
inflammatory phenotype 
As previously mentioned, chronic low-grade inflammation forms as part of the 
senescent-associated secretory phenotype (SASP) that accompanies cellular 
senescence. A hallmark of physiological ageing, the SASP is thought to contribute to 
age-related deterioration through intensification of senescent cell accumulation, 
driven by NF-κB mediated bystander processes (Birch and Passos, 2017; Nelson et 
al., 2018). Subsequent removal of senescent cells ameliorates this secretory 
phenotype (Baker et al., 2011; Baker et al., 2016). To this end, age-accumulation of 
mitochondrial complex I dysfunction in basally aged PolgAmut/mut mice appears to 
potentially elicit ROS-induced senescence, in which these mice results in significantly 
increased levels of cytokines TNFα and IL-6, which are primarily associated with the 
SASP. Accordingly, PolgAmut/mut mice have been previously shown to demonstrate an 
increased level of senescent cells within tissues, in which Willey and colleagues 
(2016) propose induction and accumulation of senescent cells in vivo in response to 
the PolgA D257A mutation. 
 
Evidence also shows that the SASP appears to be mediated at a number other 
levels, including stabilisation of the arrested state in an autocrine manner (Malaquin 
et al., 2019). Consequently, mitochondrial-dysfunction-induced senescence may be a 
significant cause of further putative cellular senescence and proinflammatory SASP 
in PolgAmut/mut mice. Activation of the DNA damage response in senescent cells, for 
example, causes senescence-associated mitochondrial dysfunction characterised by 
depolarisation of the mitochondrial membrane and exacerbated ROS production 
(Passos et al., 2007; Passos et al., 2010). The removal of dysfunctional 
mitochondria, as alluded to previously in studies by Correria-Melo and colleagues 
(2017), was shown to alleviate pro-oxidative senescent associated stress. Likely 
induced by initial mitochondrial ROS signalling, senescent-associated mitochondrial 
dysfunction is shown to be a critical driver of ROS production in vicious cyclical 
manner within this context. Within this, senescent-associated mitochondrial 
dysfunction establishes cellular senescence in an autocrine manner via exacerbated 
ROS formation, whilst ROS as part of the inflammatory senescent programme further 
contributes to senescent cell cycle arrest in surrounding bystander cells through NF-
κB processes (Nelson et al., 2012; Nelson et al., 2018). 
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7.5.2 Mitochondrial respiratory dysfunction perturbs recovery from oxidative 
liver injury due to activation and senescent activity of stellate cells 
As previously highlighted, senescence is critical in preventing replication of old or 
damaged cells. Its induction is also noted to limit tissue fibrogenesis by hepatic 
stellate cells (HSCs) on CCl4 injury, following DNA damaging formation of adducts 
between cellular DNA and lipid peroxidation by CCl3OO* (Krizhanovsky et al., 2008; 
Knockaert et al., 2011; Scholten et al., 2015) . The constitutive expression of p16INK4A 
following CCl4 injury in PolgAmut/mut mice may therefore be attributed to activated scar 
forming hepatic stellate cells (HSCs), in which upregulation of p16 and senescence 
coincides within chronic CCl4-induced fibrotic extracellular matrix (ECM) deposits 
(Krizhanovsky et al., 2008). Activation of HSCs typically follows an induced 
programme of inflammatory signalling that recruits immune cells to the site of injury. 
During the inflammatory phase of liver recovery, 0-48 hours post-CCl4 intoxication, 
WT and PolgA mice demonstrated significant increases in innate proinflammatory 
NIMP positive neutrophils and increased expression of potent HSC activating 
cytokine TGFβ1, as well as ECM-associated markers tissue inhibitor of 
metalloproteinase (TIMP) and α-smooth muscle actin (αSMA), analysed through 
histological and molecular techniques. Such changes in markers are associated with 
the transition of HSCs into hepatic myofibroblasts (HM), which include innate immune 
cell-mediated activation via TLR (toll-like receptor) and DAMP (damage-associated 
molecular pattern) signalling, as well as downstream TGFβ effector pathways like 
SMAD are noted to be involved (Hellerbrand et al., 1999; Breitkopf et al., 2006; 
Pellicoro et al., 2014; Tsuchida and Friedman, 2017). However, the data 
demonstrates no extensive differences in these markers associated with HSC 
activation at 48 hours post-CCl4 between WT and PolgA genotypes.  
Taken together, these data show that during acute CCl4 toxic injury, activation of 
HSCs does not significantly differ between WT, PolgA+/mut and PolgAmut/mut mice. The 
data does not confirm that the inability to recover from oxidative CCl4-induced stress 
is due  to greater HSC fibrogenic activation. Failure to resolve CCl4 tissue injury 
observed in PolgAmut/mut mice, however, may be ascribed to constitutively active HSC 
activity further potentiated by the inability to clear neutrophils at 5 days, due to 
increases in chemoattractants CXCL1/2 (C-X-C chemokine ligand) expression and 
MCP-1 (monocyte chemoattractant protein-1) mediated CD68 inflammatory cell 
infiltration. Macrophages and neutrophils produce a plethora of cytokines and 
chemokines that mediate HSC activation, including IL-1β and TNFα, which promotes 
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HSC survival through NF-κB activation (Pradere et al., 2013; Pellicoro et al., 2014). 
To this end, the inability to recover from oxidative tissue injury in PolgAmut/mut mice 
may be ascribed to persistent inflammatory-induced activity in the presence of 
greater mitochondrial dysfunction. 
 
Evidence suggests that in the wider context, HSC senescence is a mechanism 
undertaken to re-establish the quiescent hepatocellular environment. Senescence is 
noted to limit fibrotic activity through downregulated ECM production, as well as 
upregulation of immunomodulatory genes thought to mark senescent cells for 
apoptotic clearance by immune cells (Schnabl et al., 2003; Krizhanovsky et al., 
2008). Pro-apoptotic BAX expression is certainly observed in PolgAmut/mut mice at 
significantly greater levels alongside p16INK4A expression at 5 days, yet the data 
cannot exclude the possibility of spontaneous liver cell apoptosis elsewhere in 
response to oxidative stress. Especially given the increased susceptibility to 
apoptosis in the presence of mitochondrial dysfunction observed in PolgA mice. 
Moreover, HSC-secreted ECM genes TIMP1 and COL1A1 were significantly 
upregulated at 5 days post-CCl4 injury within PolgAmut/mut mice. This expression could 
therefore suggest that constitutive p16INK4A liver senescence is alternatively due to 
hepatocytes, not HSCs, and could also be ascribed to the observed reductions in 
PCNA and MB markers of regeneration. This could be partially tested through 
measurement of senescent markers including p16INK4A following acute CCl4 injury in 
hepatocytes isolated from PolgAmut/mut mice; however, the ability to culture these 
hepatocytes would require further optimisation given the difficulty of these cells to 
thrive in vitro. Alternatively, inhibitors of mitochondrial complex function in WT 
hepatocytes could be utilised (Heinz et al., 2017). Drawing these results together, 
greater mitochondrial dysfunction in PolgAmut/mut mice results in the inability to 
recover from a vicious cycle of CCl4 induced oxidative injury, most likely ascribed to 
the persistent inflammatory-induced activity of HSCs and cell cycle arrest of 
proliferative hepatocytes (figure 7-1). 
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Figure 7-1: Schematic showing the role of mitochondrial dysfunction in response to CCl4 toxic 
injury. CCl4 injury induces oxidative stress and increases ROS production, which in turn elicits cellular 
senescence in hepatocytes alongside its senescent-associated secretory phenotype (SASP) comprising 
proinflammatory cytokine TNFα and IL-6 production and ROS. Meanwhile, inability to repair and resolve the 
necrotic tissue injury is likely ascribed to hepatic stellate cell (HSC) activation due to ROS-induced 
stimulation of NF-κB and it’s downstream-mediated expression of proinflammatory cytokines TNFα and IL-
1β that promote HSC survival and their profibrogenic ECM functional programme. In a vicious cycle ROS 
produced from the senescent phenotype may further exacerbate mitochondrial dysfunction and 






7.6 Mitochondrial respiratory dysfunction is a critical mediator of immune cell 
homeostasis 
Elimination of damaged mitochondria has been shown to alleviate chronic 
inflammatory disease, including pathology of the liver, and implicates mitochondrial 
dysfunction in the activation of proinflammatory signalling (Zhong et al., 2016). Whilst 
the present study alludes to possible aberrant ROS-mediated induced senescence 
that leads to proinflammatory secretions, the data cannot exclude the possible direct 
correlation of dysregulated immune cell signalling to age-accumulated complex I 
mitochondrial dysfunction, exclusive of senescent cell cycle arrest. Specifically, 
histological, serological and gene expression analyses demonstrate a 
proinflammatory environment, reflected in significant increases in TNFα, IL-6, and 
S100A9, as well as greater levels of NIMP positive neutrophils within the PolgAmut/mut 
ageing liver and during post-oxidative CCl4 injury. These changes are highly 
suggestive of an activated neutrophilic innate immune response, which during tissue 
damage are rapidly mobilised to the site of injury and can activate or downregulate 
both innate and adaptive immunity through the active release of chemotactic factors 
(Rosales et al., 2017). Interestingly, basally aged PolgAmut/mut mice did show an age-
associated reduction in the number of positively stained adaptive CD3 T cells and 
CD45R B immune cells. This may be more in line with previous human and murine 
ageing models that demonstrate lymphopenic phenotypes, especially given the 
progeroid features of this model (Dennis et al., 1998; Montella et al., 2003; Nikolich-
Žugich, 2014). On the other hand, CD68 histological analyses showed no differences 
– indicating mitochondrial dysfunction and exacerbated ROS has no significant effect 
on monocyte and macrophage recruitment. This may be somewhat addressed by 
their resistance to oxidative stress factors by cytoprotective nitric oxide-catalase 
mechanisms (Yoshioka et al., 2006). Taken together, these data suggest that 
mitochondrial dysfunction is likely to result in dysregulated immune cell signalling; 
however, is likely to require a certain threshold of mtDNA mutations as highlighted by 
the gene-dose dependent phenotype observed in NIMP-positive neutrophils within 
the PolgA+/mut liver in the absence of significant changes to cytokine gene expression.  
 
Perturbations in mitochondrial physiology are understood to be able to stimulate 
inflammatory and innate immune responses through the release of mitochondrial 
damage-associated molecular patterns (mDAMPs) (Dela Cruz and Kang, 2018). 
Aberrant mtDNA release, for example, is able to elicit TLR9 signalling pathways via 
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its molecular non-methylated DNA (CpG motifs) similarities to typical bacterial TLR9-
binding substrates (Bao et al., 2016). In turn, inducing downstream NF-κB activation 
and the expression of proinflammatory cytokines like TNFα, IL-6, S100A9, in line with 
increased 12-month aged PolgAmut/mut neutrophilic expression patterns.  
As alluded to previously, evidence suggests that ROS plays an emerging central role 
in physiological cell signalling, with considerable overlap in the mediation of 
apoptosis and innate immune signalling (Chen et al., 2018). Activation of 
proinflammatory and apoptotic signalling pathways in response to aberrant 
mitochondrial ROS production appears to be similarly reflected in past and present 
PolgA data, proposing mitochondrial ROS as a core signalling factor in eliciting not 
only apoptosis but dysfunctional immune cell signalling as a result of age-associated 
accumulation of mitochondrial dysfunction (Logan et al., 2014). The putative 
involvement of NF-κB in both pathways also suggests that the primary contribution of 
mitochondrial ROS to the overall reduction of liver regeneration is via its dysregulated 
activation of NF-κB and its downstream proinflammatory and apoptotic pathways. As 
with senescence, emerging data also shows that NF-κB potentiates the SASP 
through additional effector pathways, including p38 MAPK (mitogen-activated protein 
kinase) and RIG-1 (retinoic acid-inducible gene I); the induction of p16INK4A is shown 
to have an inhibitory effect (Salminen et al., 2012). Taken together these data 
highlight the requirement to further delineate whether the observed reduction in the 
proliferative markers during basal hepatocellular turnover and models of regeneration 
within PolgAmut/mut mice is due to increased inflammation and apoptosis or cell cycle 
arrest, and its mechanistic basis. 
 
7.7 PolgAmut/mut neutrophils exacerbate oxidative stress and contribute to the 
inflammatory environment 
Neutrophils have been long appreciated in their role within the innate immune 
response, responding to myriad of perturbations, including mtDNA and ROS, to 
ensure removal of pathogens and cellular debris released within the host. Within this, 
neutrophils are primarily recruited to the site of injury or infection and undergo 
phagocytic and apoptotic processes to ensure removal of the injury stimulus. These 
processes are well established to involve NF-κB signalling and NADPH oxidase 2 
(NOX2) stimulated production of superoxide and other ROS during neutrophil 
oxidative burst (Winterbourn et al., 2016). Neutrophils also form a key part of tissue 
injury and repair, yet whilst neutropenia and inhibitions of neutrophil chemotaxis is 
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shown to delay liver regeneration following insult, persistent activation of neutrophils 
are also generally thought to exacerbate tissue injury and promote hepatic 
pathophysiology (Selzner et al., 2003; Slaba et al., 2015). Despite this, there is 
limited evidence to date outlining mitochondrial relevance for normal functioning of 
neutrophils beyond provision of activatory signals. Accordingly, stimulation of formyl 
peptide receptors, on neutrophils, for example, increases mitochondrial membrane 
potential and ATP production to elicit metabolic switching and the activation of 
downstream oxidative burst and phagocytic processes by autocrine purinergic 
signalling (Bao et al., 2014). The presence of a neutrophil proinflammatory 
environment within the PolgAmut/mut model was therefore postulated to have a limiting 
effect upon basal hepatocellular turnover and hepatic repair. We also present for the 
first time, data showing in vivo PolgA-induced age-accumulated mitochondrial 
dysfunction as a critical regulator of neutrophil activation.  
 
During basal ageing, stimulation of chemotaxis appeared to be amplified within 
PolgAmut/mut neutrophils, whilst also demonstrating significantly greater ability to 
phagocytose zymogen particles when compared to WT and Polg+/mut neutrophils. 
These differences may account for greater activated neutrophils presented within the 
liver, as recruited by neutrophilic chemotactic factors, as well as the greater numbers 
that remain in the liver following CCl4 injury. Elsewhere, however, loss of enzymatic 
ETC function through PolgA neutrophil specific deletion and complex I inhibition is 
shown is shown to negatively impact on neutrophil motility through NF-κB 
accumulation (Zmijewski et al., 2008; Zhou et al., 2018). A phenotype that appears to 
be rescued by SOD1 and SOD2 overexpression (Zhou et al., 2018). Differences in 
these findings could be ascribed to the study of neutrophil functionality within 
different settings: that is observations following murine lung injury as well as within 
zebrafish. It must be also noted that isolation of neutrophils from the bone marrow, 
independent of stimulation is still able to induce neutrophil activation and could be 
accountable for greater zymogen uptake. Whilst our findings point to a pro-
neutrophilic environment, to fully elucidate whether greater neutrophil chemotaxis is 
an observable phenotype within PolgAmut/mut mice, further study involving more 
subject numbers will be required.  
 
Although not well characterised, activation of neutrophils by N-formylmethionine-
leucyl-phenylalanin (FMLP) is shown to be induced via the effects of the NF-κB 
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pathway in previous studies, that could result in functional ROS production 
(McDonald et al., 1997). However, when ROS production is exacerbated, neutrophils 
can elicit deleterious effects on the host (Mittal et al., 2014). The present data shows 
that ROS levels produced by blood and liver-isolated PolgAmut/mut neutrophils 
increased with age basally and production intensified when exposed to platelet 
activating factor (PAF) and FMLP stimuli. Neutrophils numbers were also greater in 
the liver when compared the blood.  These data suggest that PolgAmut/mut neutrophils 
are basally more primed for tissue recruitment and galvinisation than WTs and 
subsequently produce more ROS when activated. The increase in intracellular 
superoxide has been demonstrated to activate NF-κB, inducing proinflammatory 
cytokine expression and therefore provides one possible explanation for the 
PolgAmut/mut liver’s neutrophilic environment (Zmijewski et al., 2008). To put into 
context, the data could suggest that greater mitochondrial dysfunction is highly likely 
to promote recruitment of actively ‘primed’ neutrophils to the liver, either by means of 
ROS or DAMP signalling, whereby activation releases more ROS and promotes 
cyclical immune cell recruitment via NF-κB-mediated activation of proinflammatory 
and apoptotic signalling. Neutrophils are therefore key contributors to the oxidative 
pro-inflammatory observed within PolgAmut/mut (figure 7-2). To support this, further 
work is likely required including the confirmation of the PolgAmut/mut susceptible 
phenotype and immune cell recruitment from the blood into the liver. One possibility 
could include neutrophil tracking, in which isolated PolgAmut/mut neutrophils could be 
tagged and tracked in vivo by a fluorescent and bioluminescent imaging system 
following adoptive transfer into recipient WT and PolgA mice, and vice versa. By 

































































































































































































































































































































































































































































































































































7.8 Use of murine models to study ageing liver regeneration 
The use of animal models in elucidating the physiological effect of mitochondrial 
dysfunction, specifically in liver regeneration is critical. However, as with most murine 
models there are inherent limitations particularly when attempting to capture features 
typical of human ageing. As such, results derived from these murine studies must be 
interpreted with careful attention.  
 
The classical use of two-thirds PHx is widely used for studying liver regeneration, in 
which 70% removal of the liver results in the restoration of original liver mass through 
growth of the remnant liver. PHx is also undertaken within humans; however, it is 
typically elective in a tumorigenic setting and therefore not typical of the insult 
potentially experienced by the human liver. Moreover, in mice that are genetically-
modified, like PolgA D257A, higher mortality rates may be increased especially given 
the highly energetic demands on mitochondria from the regenerative process 
(Nevzorova et al., 2015). Since mtDNA mutations accumulate with age in 
PolgAmut/mut, we were not able to undertake PHx within 12-month aged mice due to 
mortality burden, making it difficult to accrue the proinflammatory phenotype 
observed in basally aged PolgAmut/mut mice to 6-month PHx mice. 
 
Similarly in the present study, lack of confirmatory evidence between Mt-CO1 
western blotting and COX deficiency during COX/SDH staining was observed in 
PolgAmut/mut mice, admittedly providing some difficulty in corroborating the 
mechanistic link between PolgAmut/mut complex I deficiency with reduced liver 
regeneration. Certainly, such discrepancies may be ascribed to the differences 
between the use of western blot antibody detection for protein complexes versus 
histochemical staining of complex IV activity; yet highlights the future need for further 
supportive evidence. Of those suggested is the additional characterisation of 
respiratory chain function and mitochondrial ATP production (MAPR) by biochemical 
means previously outlined to indeed confirm the mechanistic involvement of complex 
I and IV in the present study (Wibom et al., 2002; Trifunovic et al., 2005). 
Furthermore, whilst PCR and gel electrophoresis were used to confirm the genotypes 
of WT and mutant PolgA mice alike (appendix I), mutational burden assays was an 
avenue not further explored here. In this setting, quantifying mutational burden may 
also provide additional support in corroborating the present data, should accumulated 
mutations be shown to occur time. Indeed, previous PolgA studies outline increased 
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mutational burdens within the complex I and IV-encoded gene locus’, providing some 
mechanistic basis for our findings in corroborating complex I deficiencies with 
reduced liver regeneration (Vermulst et al., 2008; Kim et al., 2019). 
 
Lastly,  the PolgAmut/mut mice model exhibits several ageing phenotypes ascribed to 
stimulation of apoptotic pathways and ROS production via accumulated mtDNA 
mutations  (Trifunovic et al., 2004; Kujoth et al., 2005; Hiona et al., 2010; Logan et 
al., 2014). These mice, however, are shown to carry a significantly higher mtDNA 
mutation burden over WTs, exhibited from 2 months of age and significantly 
increases to detectable levels only once the observable ageing phenotype arises due 
to accumulation of mitochondrial dysfunction (Trifunovic et al., 2004; Vermulst et al., 
2007). The speed at which mitochondrial dysfunction is accumulated in PolgA and 
the type of mutations may not be necessarily reflective on normal ageing (Williams et 
al., 2010). Indeed, heterozygous PolgA+/mut show an absence of the progeroid 
phenotype and in this study, signs of reduced liver regeneration despite a higher 
mutation load than WT mice (Vermulst et al., 2007). This difference as alluded to 
earlier may suggest the presence of a threshold that is required to be superseded 
before any aberrant changes are observed. 
 
7.9 Conclusion 
The role of mitochondrial dysfunction in reduced hepatocellular regeneration is 
complex, facilitated by a plethora of interconnected signalling pathways, each of 
which appear to be potentiated in some part by mitochondrial function. Mitochondria 
are critical for a number of biological functions, ranging from ATP production and 
apoptotic cell death to inducing senescent cell cycle arrest; dysfunction of these 
tightly regulated pathways are unsurprisingly widely documented to result in 
pathophysiological development. Underpinning the reduction in liver regeneration 
seen in PolgAmut/mut mice is the production of mitochondrial ROS due to age-
associated accumulation of mitochondrial dysfunction, specifically complex I. 
Enzymatic ETC loss and subsequent aberrant ROS production appears to elicit a 
number of downstream effects that can  impinge on liver regeneration both basally 
and in response to injury: these include, the induction of cell cycle arrest and 
apoptosis, as well as dysregulated immune cell signalling.  Contribution of 
exacerbated inflammation is further hindered by dysregulated innate immune 
signalling, specifically increased levels of neutrophils, which further contributes to the 
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pro-inflammatory oxidative phenotype through further ROS production. I therefore 
present this vicious cyclical effect following PolgA-induced mitochondrial dysfunction 
simply as follows: age-associated accumulation of mtDNA mutations and resultant 
complex I mitochondrial dysfunction appears to be highly correlated with the 
reduction of liver regeneration, in which resultant mitochondrial ROS from ETC 
leakage induces activation of cell cycle arrest and a proinflammatory-pro-apoptotic 
axis, which in turn  appears to accelerate the ageing and reduced proliferative 


































Appendix I: Representative gel showing genotyping of PolgA+/+ (WT), PolgA+/mut and PolgAmut/mutmice. PCR 
products separated on a 2% agarose gel. Expected band sizes for WT (296 bp) and homozygous mutant alleles 
(268 bp) were observed. 
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1M HEPES 238g 
2.7mM KCl 200mg 
135mM NaCl 8g 
250µM HNa2 PO4 0.033g 
Made up to 500 ml with dH2O 
 
 
To make HEPES CaCl2 buffer: 
 
• Prepare stock of CaCl2 7.5g in 20ml dH2O 




Appendix III: RIPA Buffer Recipe 
  
Final concentration: 
150mM NaCl (Sigma) 
50mM Tris pH 7.5 (Sigma) 
0.1% SDS 
1% Triton x-100 
0.5% Deoxycholic acid 
Phosphatase inhibitor 10µl/ml 
Protease inhibitor 1 tablet per 50ml 
 
To make 50ml: 
 
• Weigh out 2.5g Deoxycholic acid and dissolve in 25ml nanopure water by 
vortexing until clear 
• Add 1.5ml 5M NaCl 
• Then add 2.5ml 1M Tris pH 7.5 
• Dissolve 1 protease inhibitor tablet in 1ml nanopure water and add to mixture 
• Add 0.5ml of 10% SDS 
• Add 0.5ml Triton x-100 
• Add 500µl Protease inhibitor 
• Make up to 50ml with nanopure water 
• Vortex to mix 




Appendix IV: H&E staining and quantification of 
regenerative markers PCNA and mitotic bodies in livers 
excised from male WT mice following median 
laparotomy only (T0/Sham) and at 2-, 24-, 48-, 72 hours 
and 5 days post partial hepatectomy (PHx),.   Bars 100 
µm. P values calculated by two-way ANOVA *p=0.05, 
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